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ABSTRACT 
Asthma and atopic dermatitis are common diseases in childhood and lower 
respiratory tract infections (LRTIs) are the leading cause of hospitalization in 
preschool children. Very preterm birth (<32 weeks of gestational age, GA) has been 
associated with an increased risk of asthma and respiratory infectionǦrelated hospital 
admissions in childhood, whereas the risk of atopic dermatitis in cases of very 
preterm birth has been found to be decreased compared with children born at term. 
Long term respiratory morbidity and the risk of atopic dermatitis among children 
born moderately (MP; 32+0-33+0 weeks) and late preterm (LP; 34+0-36+0 weeks) and 
among subǦgroups of term-born children, i.e. early-term (37+0-38+6 weeks), full-term 
(39+0-40+6 weeks), late-term (41+0-41+6 weeks) and post-term (≥42 weeks), are less 
well studied. It is suggested that, in addition to GA at birth, some early-life exposures 
may also play a role in the pathogenesis of these diseases. 
The aim of this study was to compare the incidence and risk of long-term 
respiratory morbidity and severe atopic dermatitis in MP and LP children with those 
in very preterm and term children by school age. The study also aimed to evaluate 
the association of early-term, late-term and post-term birth with later risk of asthma, 
atopic dermatitis and LRTIs. Maternal-, delivery- and newborn-related factors 
associated with increased long-term respiratory morbidity and atopic dermatitis in 
relation to GA at birth were explored. 
This national register study included all children born in Finland between 1991 
and 2008 based on data derived from the Medical Birth Register (n=1,039,263). After 
excluding infants with missing data on GA, those with any major congenital 
anomalies, and those who died before the age of one year, the remaining cohort of 
1,018,256 (98.0% of all children born) were analyzed as follows: very preterm 
(n=6,329), MP (n=6,796), LP (n=39,928) and term (n=965,203). In addition, 
children born after 37 weeks (n=965,203) were divided into four subgroups: early-
term (n=181,667), full-term (n=546,845), late-term (n=189,373) and post-term 
(n=47,318). The incidence and risk factors for asthma, atopic dermatitis and LRTIs 
by seven years of age were evaluated by linking the health register data. Maternal and 
neonatal factors associated with the risk of asthma, atopic dermatitis and LRTIs were 
assessed using multivariable analysis.  
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The results of this study showed that MP and LP born children received asthma 
medication reimbursement and were admitted to hospital for asthma and LRTIs 
more often than term controls but less frequently than very preterm children. Early-
term birth was also a predictor of asthma, while late- and post-term births appeared 
to be associated with a decreased risk of asthma compared with fullǦterm birth. There 
was a decreasing trend in hospital visits due to asthma and LRTIs with increasing 
GA. Instead, the incidence of hospital visits due to atopic dermatitis rose with 
increasing GA and post-term birth associated with an increased risk of atopic 
dermatitis. Risk factors for respiratory morbidity in fully adjusted models included 
maternal smoking during pregnancy, birth by cesarean section, male sex, admission 
to a neonatal unit and ventilator therapy, and neonatal antibiotic therapy was also 
associated with the risk of LRTIs. The most relevant risk factors for atopic dermatitis 
were male sex, being first-born, birth in a level II hospital and birth by cesarean 
section. 
In conclusion, these results suggest that in addition to very preterm birth, MP, 
LP and early-term births are also associated with an increased risk of asthma and 
LRTIs in early childhood whereas post-term birth appears to reduce this risk. 
Interestingly, preterm birth seemed to decrease the risk of atopic dermatitis and post-
term birth associated with an increased risk of atopic dermatitis. Means to affect 
underlying modifiable risk factors, such as smoking during pregnancy, timing of birth 
by elective cesarean section, neonatal ventilator therapy and antibiotic therapy 
should be considered in clinical practice. 
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TIIVISTELMÄ 
Astma ja atooppinen ihottuma ovat yleisiä lapsuusiän sairauksia ja 
alahengitystieinfektiot ovat alle kouluikäisten lasten yleisimpiä sairaalahoidon syitä. 
Hyvin ennenaikaiseen syntymään (<32 raskausviikolla) liittyy lisääntynyt lapsuusiän 
astmariski ja sairaalahoidon tarve hengitystieinfektioiden vuoksi täysiaikaisena 
syntyneisiin verrattuna. Toisaalta tässä ryhmässä on raportoitu atooppisen ihottuman 
riskin olevan vähäisempi. Pitkäaikaisesta hengitystiesairastuvuudesta ja atooppisen 
ihottuman esiintymistä on vähemmän tutkimustietoa kohtalaisen (32+0-33+6 
raskausviikoilla) ja hieman (34+0-36+6 raskausviikolla) ennenaikaisesti syntyneiden 
lasten ryhmistä sekä täysiaikaisena syntyneiden lasten alaryhmistä eriteltynä: 
varhainen täysiaikainen (37+0-38+6 raskausviikkoa), ’täysi’ täysiaikainen (39+0-40+6 
raskausviikkoa), hieman yliaikainen (41+0-41+6) ja yliaikainen (≥42 raskausviikkoa. 
Syntymäraskausviikkojen lisäksi myös varhaisen elämän vaiheen altistuksilla näyttäsi 
olevan merkitystä näiden sairauksien synnyssä.  
Tämän väitöskirjan tavoitteena oli verrata kohtalaisen ja hieman ennenaikaisena 
syntyneiden lasten pitkäaikaista hengitystiesairastuvauutta ja vaikean atooppisen 
ihottuman ilmaantuvuutta ja mahdollisia riskitekijöitä suhteessa hyvin 
ennenaikaisena ja täysiaikaisena (>37 raskausviikkoa) syntyneisiin lapsiin. Lisäksi 
tutkimuksessa selvitettiin täysiaikaisina syntyneillä raskausviikkoryhmittäin eriteltynä 
yhteyttä myöhempään astman, atooppisen ihottuman ja alahengitystieinfektioiden 
sairastumisriskiin. Tutkimuksessa arvioitiin äidin raskaudenaikaisia ja synnytykseen 
sekä vastasyntyneisyyskauteen liittyviä riskitekijöitä pitkäaikaisen 
hengitystiesairastuvuuden ja atooppisen ihottuman selittäjinä. 
Tähän kansalliseen rekisteritutkimukseen otettiin mukaan kaikki Suomessa 
syntymärekisterin tietojen mukaan vuosina 1991-2008 syntyneet lapset 
(n=1,039,263). Tutkimuksesta suljettiin pois lapset, joilta puuttui tieto 
raskaudenkestosta, joilla oli merkittävä synnynnäinen epämuodostuma ja ne, jotka 
kuolivat ennen yhden vuoden ikää. Lopullinen tutkimuskohortti (n=1,018,256, joka 
98% kaikista) analysoitiin neljässä raskausviikkojen mukaisessa ryhmässä: hyvin 
ennenaikaiset (n=6,329), kohtalaisen ennenaikaiset (n=6,796), hieman ennenaikaiset 
(n=39,928) ja täysiaikaiset (n=965,203). Lisäksi täysiaikaisena syntyneet lapset jaettiin 
vielä neljään ala-ryhmään: varhainen täysiaikainen (n=181,667), ’täysi’ täysiaikainen 
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(n=546,928), hieman yliaikainen (n=189,373) ja yliaikainen (n=47,318). 
Rekisteritietoja yhdistämällä selvitettiin astman, atooppisen ihottuman ja 
alahengitystieinfektioiden ilmaantuvuutta ja riskitekijöitä eri raskausviikkoryhmissä 
seitsemään ikävuoteen mennessä. Monimuuttuja-analyysillä selvitettiin 
raskaudenaikaisia, synnytykseen ja vastasyntyneisyyskauteen liittyviä riskitekijöitä. 
Tutkimuksen tulokset osoittivat, että kohtalaisen ja hieman ennenaikaisena 
syntyneillä lapsilla oli enemmän astmalääkekorvattavuuksia ja sairaalakäyntejä astman 
ja alahengitystieinfektioiden vuoksi kuin täysiaikaisena syntyneillä, mutta vähemmän 
kuin hyvin ennenaikaisesti syntyneillä. Myös varhaiseen täysiaikaiseen syntymään 
liittyi lisääntynyt astmariski, mutta hieman yliaikainen ja yliaikainen syntymä näyttivät 
suojaavan astmalta verrattuna ’täyteen’ täysiaikaiseen syntymään. Astmaan ja 
alahengitystieinfektioihin liittyvien sairaalakäyntien ilmaantuvuus väheni 
raskausviikkojen lisääntyessä. Sitä vastoin, atooppisen ihottuman vuoksi 
sairaalakäynnit lisääntyivät syntymäraskausviikkojen kasvaessa ja yliaikainen syntymä 
yhdistyi lisääntyneeseen riskiin.  Vakioidussa monimuuttuja-analyysissä 
hengitystiesairastuvuutta lisääviä riskitekijöitä olivat äidin raskaudenaikainen 
tupakointi, syntymä keisarileikkauksella, pojan sukupuoli, hoitojakso 
vastasyntyneiden osastolla ja hengityskonehoito. Lisäksi vastasyntyneisyyskauden 
antibioottihoito yhdistyi alahengitystieinfektiosairastavuuteen. Merkittävimpiä 
atooppista ihottumaa ennustavia tekijöitä olivat pojan sukupuoli, esikoisuus, syntymä 
keskus- tai aluesairaalassa ja syntymä keisarileikkauksella. 
Johtopäätöksenä voidaan todeta, että hyvin ennenaikaisesti syntyneiden lasten 
lisäksi myös kohtalaiseen ja hieman ennenaikaiseen syntymään kuten myös 
varhaiseen täysiaikaiseen syntymään liittyy lisääntynyt sairastuvuus astmaan ja 
alahengitystieinfektioihin varhaislapsuudessa, mutta yliaikainen syntymä näyttäisi 
vähentävän tätä sairastuvuutta. Atooppisen ihottuman sairastuvuutta ennenaikaisuus 
näyttäsi vähentävän, mutta yliaikaisuus vastaavasti lisäävän tätä. Keinoja vaikuttaa 
sairastumisriskiä vähentäviin tekijöihin, kuten raskaudenaikainen tupakointi, 
elektiivisen keisarileikkauksen ajankohta, vastasyntyneisyyskauden 
hengityskonehoito ja antibioottien käyttö, tulisi harkita käytännön työssä.   
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1 INTRODUCTION 
Asthma and atopic dermatitis are common diseases in childhood, affecting 
approximately 10% of children in Western countries (Asher et al. 2006; Roduit et. al 
2017), and lower respiratory tract infections (LRTIs) are the leading cause of 
hospitalization in preschool children (Nair et al. 2013). Children born preterm appear 
to carry an increased risk of asthma and respiratory infectionǦrelated hospital 
admissions in childhood (Been et al. 2014; Boyle et al. 2012; Miller et al. 2016), 
whereas the risk of atopic dermatitis has been found to be reduced (Trønnes et al. 
2013; Barbarot et al. 2013) compared with children born at a later gestational age 
(GA).  
Moderately and late preterm (MP and LP) children born at 32+0-36+6 weeks of 
GA currently constitute more than 80 % of all preterm births (Shapiro-Mendoza 
2012). These infants are at a greater risk of early neonatal morbidities and are more 
likely to be readmitted to hospital after the neonatal period (Boyle et al. 2015; 
Kuzniewicz et al. 2013). Because of the reported health risks to the mother and infant 
after elective deliveries prior to 39 weeks of GA, sub-grouping the term birth into 
early-term (37+0-38+6 weeks), full-term (39+0-40+6 weeks), late-term (41+0-
41+6weeks) and post-term (≥42 weeks) birth has been recommended (American 
College of Obstetricians and Gynecologists ACOG 2014, Spong 2013). The health 
problems of early-term, late-term and post-term infants are milder and less common 
than in the most premature groups but may result in a substantial public health 
burden due to the high number of infants (ACOG 2014; Gill & Boyle 2017).  
It has been suggested that not only GA at birth but also some peri- and neonatal 
factors may play a role in the development of asthma and atopic dermatitis (Martino 
& Prescott 2011) and may increase the risk of infections in early childhood 
(Kristensen & Henriksen 2016). Intrauterine and postnatal period have been 
suggested to be a phase, when specific exposures may have an influence on later 
disease risk by modifying the development of lungs and immune system. Many 
obstetrical decisions during the final weeks of a pregnancy involve weighing the risks 
and benefits of delivering an infant prior or after the due date (Rusconi et al. 2017). 
A more precise understanding of the risks including long-term respiratory morbidity 
18 
related to GA is necessary. Most previous studies have focused on long-term 
respiratory health following very preterm birth. There has been rather little research 
on respiratory health-related outcomes of MP and LP births and term subgroups in 
later childhood. 
This study compared the incidence and risk of long-term respiratory morbidity 
and severe atopic dermatitis in MP and LP children with those in very preterm and 
term children by seven years of age in a national register-based birth cohort. This 
study also aimed to evaluate the association of early-term, late-term and post-term 
birth with later risk of asthma, atopic dermatitis and LRTIs. Additionally, the study 
explored maternal-, delivery- and newborn-related factors associated with increased 
long-term respiratory morbidity and atopic dermatitis in relation to GA at birth. 
19 
2 REVIEW OF THE LITERATURE 
2.1 Gestational age (GA) groups 
Gestational age indicates the duration of pregnancy, dated from the first day of the 
last menstrual period. The more accurate assessment of GA is done by measuring 
the crown-rump length of the fetus during a first-trimester ultrasonographic 
examination. The general practice in Finland is that the estimation of GA is corrected 
according to ultrasonographic evaluation if there is a discrepancy of more than 5–7 
days compared with GA based on the last menstrual period (National Institute for 
Health and Welfare, THL). In Finland, ultrasonographic evaluation of pregnancy has 
been performed in clinical practice since 1980s (Saari-Kemppainen et al. 1990). 
2.1.1 Preterm birth and birth weight 
Preterm birth is defined by the World Health Organization (WHO) as birth before 
37 completed weeks of gestation (WHO 1977). Preterm birth can be classified based 
on GA as extremely preterm (22+0-27+6 weeks), very preterm (28+0-32+0 weeks), 
moderately preterm (MP, 32+0-33+6 weeks) and late preterm (LP, 34+0-36+6 weeks) 
(Figure 1). 
Low birth weight is defined as weight of less than 2,500g, very low birth weight 
as less than 1,500g and extremely low birth weight as less than 1,000g (WHO 2004). 
Birth weight for gestational age can be defined in all GA groups. Small for GA (SGA) 
infants are defined as those with a birth weight more than 2.0 standard deviations 
(SD) below the average for GA and large for GA (LGA) infants as those with a birth 
weight more than 2.0 SD above the mean weight for GA according to sex-specific 
fetal growth curves (Pihkala et al. 1989).  
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2.1.2 Term and post-term birth 
Term birth has been defined as a birth between 37 and 42 weeks of gestation and 
post-term birth as a birth at or beyond 42 weeks of gestation, respectively. Recent 
recommendations suggest sub-categorization of birth after 37 weeks to provide 
more accurate descriptions of deliveries and their outcomes (ACOG 2014; Spong 
2013). These subgroups of children born after 37 weeks are: early-term (37+0-38+6 
weeks), full-term (39+0-40+6 weeks), late-term (41+0-41+6 weeks) and post-term 
(42+0 weeks and beyond) (Figure 1).  
Figure 1.  Gestational age groups (modified from Gill & Boyle 2017). 
2.1.3 Epidemiology of preterm, term and post-term birth 
Approximately 11.1% of all live births worldwide are preterm births with rates 
ranging from 5.0% in Europe to 18.0% in Africa (Blencowe et al. 2012). Preterm 
birth rates have increased during recent decades, mostly due to the increase in LP 
births in several countries, especially in the U.S (Davidoff et al. 2006; Shapiro-
Mendoza & Lackritz 2012). Recently the rates in the U.S began to decrease because 
of declining elective late preterm deliveries (Ananth et al. 2018). The rates of LP 
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births range from 3.0% to 6.0% of live singleton births and constitute between 65% 
and 75% of preterm births in high-income countries according to data from 2010 
(Delnord et. al 2019). The preterm birth rate in Finland has been approximately 5% 
and has not increased markedly over the last decade (Jakobsson et al. 2008; THL 
perinatal statistics Finland). Worldwide the complications of preterm birth are the 
second highest cause of early childhood mortality, after pneumonia (Liu et al. 2012). 
Early-term births are approximately five times more common than LP births, 
with percentges ranging from 15% to 30% internationally (Delnord et. al 2019; 
Richards et al. 2016). Trends in early-term births vary by mode of onset. Early-term 
birth rates are estimated to range between 9.8% and 16.6% for spontaneous and 
4.3% and 15.5% for iatrogenic early-term births (Delnord et al. 2019).  
The incidence of post-term birth is approximately 3%–5% of all births. This 
varies depending on population characteristics, such as the percentage of 
primigravidas in the population, the prevalence of obesity, numbers of parturients 
with a history of previous post-term pregnancy, genetic predisposition and local 
management practices (Timonen 2015). Recent recommendations suggest induction 
of labor after 42+0 weeks and by 42+6 weeks of gestation, given evidence of an 
increase in perinatal morbidity and mortality (ACOG 2014). In Finland national 
guidelines have recommended clinical assessment at 41-42 weeks of gestation and 
possible induction of labor at or after 42+0 weeks of gestation. The post-term birth 
rate has remained at approximately 4.1-5.3% over the past 20 years (Timonen 2015, 
THL perinatal statistics Finland). 
2.2 Aspects of respiratory and immunological maturation 
2.2.1 Lung development 
The prenatal growth and development of the human lung have traditionally been 
divided into five stages (Joshi & Kotecha 2007). This is illustrated in Figure 2 and 
Table 1. 
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Figure 2. Stages of lung development (modified based on the text by Joshi & Kotecha 2007). 
Table 1. Stages of lung growth and maturation (modified from Joshi & Kotecha 2007). 
Embryonic 0–7 weeks Formation of lung bud, trachea, right and left main bronchi and 
segmental bronchi, vasculogenesis around air bugs 
Pseudoglandular 7–17 weeks Formation of conduction airway and terminal bronchioles, formation 
of pulmonary arteries and veins 
Canalicular 17–27 weeks Formation of respiratory bronchioles, alveolar ducts and primitive 
alveoli, formation of alveolar capillary barrier 
Saccular 28–36 weeks Formation of saccules, alveolar ducts and air sacs, increment in 
gas exchange areas 
Alveolar 36 weeks–2 years Septation and multiplication of alveoli 
Microvascular maturation Birth to 2–3 years Fusion of double alveolar capillary network into a single layer 
The conducting airways are formed mainly during embryonic and 
pseudoglandular stages. The formation of alveolar structures in the canalicular and 
saccular stages of lung development enables gas exchange (Joshi & Kotecha 2007). 
The third trimester of pregnancy represents a rapid stage of lung growth, 
characterized by transition from the terminal sac period to the alveolar period of 
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development. During the saccular stage, numbers of bronchi are increasing, saccules 
start to form alveoli, and surfactant production occurs. The alveolar stage of lung 
development starts at 36 weeks gestation, and continues into childhood. Preterm 
birth at the canalicular or saccular stage disrupts normal lung development (Joshi & 
Kotecha 2007). Alveoli are not completely mature until 36 weeks of GA (Langston 
et al. 1984). This causes inadequate maintenance of functional residual capacity, 
decreased compliance, and smaller airway diameters compared to term infants (Colin 
et al. 2010). Total lung volume increases during the last trimester of gestation, the 
air-space walls decrease in thickness, and a fourfold increase in air-space surface area 
occurs. At 34 weeks of GA lung volume only reaches 47% of the final volume at 
term (Langston et al. 1984). The immature lung structure present before term may 
be associated functionally with delayed intrapulmonary fluid absorption, surfactant 
insufficiency, and inefficient gas exchange (Mahoney & Jain 2013). In addition to 
very preterm infants, these physiologic deficiencies may contribute to the 
vulnerability of MP and LP infants to respiratory morbidity both in the neonatal 
period and long-term. 
Alveolar multiplication continues in the postnatal period at least up to the age of 
2–3 years and alveolar size and surface increase until after adolescence. Besides the 
multiplication and enlargement of airspaces, the stage of microvascular maturation 
occurs after birth (several months to 2–3 years). During this period of postnatal lung 
growth, new alveolar septa can be formed as a result of angiogenesis and 
alveolization (Burri 2006).  
2.2.2 Early-life immune maturation and the microbiota 
The fetus and newborn face many immunological demands, including protection 
against infection, avoidance of harmful inflammatory immune responses that can 
lead to preterm delivery, and balancing the transition from intra-uterine environment 
to the outside world, which is rich in foreign antigens. This process of immune 
maturation is driven by a variety of cell-intrinsic and extrinsic factors. The newborn 
is mainly dependent on innate immunity and maternal antibodies, most of which are 
passively acquired during the third trimester (Ygberg 2012). Innate immunity 
provides the first line of immune defense against pathogens. The slower adaptive 
immune response follows the innate response and generates the immunological 
memory.  
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Preterm infants have immature immune responses, both innate and adaptive 
immunity. In comparison to term infants, preterm infants present with a smaller pool 
of monocytes and neutrophils, impaired ability of these cells to kill pathogens, and 
lower production of cytokines which limits T cell activation and reduces the ability 
to fight bacteria and detect viruses in cells (Melville et al. 2013). It has been suggested 
that the development of antigen-specific immune responses is restricted to the 
period after birth; however, in utero exposure to environmental antigens has been 
detected in cord blood and amniotic fluid (Pastor-Vargas et al. 2016).  
The two integral subgroups of T cells in adaptive immunity with separate immune 
functions are CD4+ helper T cells and CD8+ cytotoxic T cells. T helper cells can 
be subdivided into effector cells and regulatory cells (Ygberg 2012). Traditionally T 
helper cells are further divided into T helper 1 (Th1) and T helper 2 (Th2) cells, with 
specific roles in immune responses according to their cytokine production, but this 
classification has recently been considered to be more plastic in terms of Th cell 
subtypes and their functions (Zhu 2018).  
During pregnancy normal fetal development occurs in a Th2-biased environment 
that protects the fetus from the maternal immune response (McFadden et al 2015). 
The immunologic competence of the newborn progresses rapidly in the first three 
months of life when acquired immunity cells mature and gain antigenic experience. 
The mature Th1/Th2 balance is acquired through exposure to microbial antigens 
during infancy. Regulatory T cells are considered key mediators in this balance by 
maintaining immune system homeostasis and tolerance to self-antigens. Stimulation 
of the Th1-type immune response by viral infections may attenuate the Th2-type 
response. As suggested by the ‘hygiene hypothesis’ diminished microbial exposure 
in early childhood may lead to Th1/Th2 imbalance favoring the Th2-type immune 
response and an increased risk of allergic diseases (Strachan 1989). However, recent 
findings suggests that timing of exposure, antigen dose and the genetic background 
of the child also influence whether antigen exposure will lead to beneficial or harmful 
effects (Ygberg 2012).  
The development of the microbiota has been assumed to start at birth, but recent 
observations suggest that gut colonization may already be initiated in utero (Collado 
et al. 2016). The bacterial colonization of the infant gut continues during early 
infancy and is influenced by several maternal and environmental factors such as the 
mode of delivery. GA at birth has a strong impact on gut microbiota development 
and in comparison to term infants, the gut microbiota of preterm infants is 
characterized by delayed colonization and by limited microbial diversity (Henderickx 
et al. 2019). Vaginal delivery exposes the infant to the maternal vaginal and intestinal 
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flora. In contrast, the intestinal microbiota in infants born by cesarean section is 
enriched by skin flora. Some other factors, such level of hygiene, early antibiotic 
exposure and breastfeeding, may also have influence on the composition of the 
infant’s intestinal microbiota (Collado et al. 2016; Rautava et al. 2012). The 
microbiota colonizing the gut after birth is thought to have an impact on the immune 
maturation process during the neonatal period and may have far-reaching 
consequences for later health. A current hypothesis suggests that the process and 
interaction between genetic factors, early environmental exposures, and alterations 
in the microbiota might influence a child’s susceptibility to asthma and atopic 
diseases, especially in early life when the immune system is maturating (Jackson et al. 
2017; Liu 2015).  
2.3 Asthma in childhood 
2.3.1 Definitions 
Asthma is considered a heterogeneous disease, usually characterized by chronic 
variable airway inflammation, airway obstruction, and airway hyperresponsiveness. 
According to the recently updated definition by the Global Initiative for Asthma 
(GINA), asthma is defined as a history of respiratory symptoms, such as wheeze, 
shortness of breath, chest tightness, and cough that varies over time and in intensity, 
together with variable expiratory airflow limitation, which reverses either 
spontaneously or after use of medication (GINA 2018). The direct application of 
this definition to pediatric patients remains limited, especially in patients less than 
six years of age (Papadopoulos et al. 2019). The individual clinical symptom patterns 
are diverse and wheezing is common during early childhood. Different wheezing 
phenotypes based on different pathogenesis, progression and outcomes have been 
identified in earlier studies (Martinez et al. 1995; Taussig et al. 2003). Majority of 
early-life wheezing children have transient symptoms only during respiratory tract 
infections and they become gradually asymptomatic after the age of three years and 
have small asthma risk. About half of wheezing children have continuous symptoms 
from the age of three until six years of age and half of these children become 
sensitized to an allergen and have persistent symptoms reflecting underlying chronic 
inflammation and increased asthma risk (Martinez et al. 1995; Taussig et al. 2003, 
Reddy et al. 2016). In older children, this may lead to permanent structural alterations 
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of the airway wall (airway remodeling) and potentially a more severe asthma 
phenotype (Taussig et al. 2003). Traditionally asthma is classified into nonǦallergic 
and allergic asthma and this classification has been recommended in Finnish 
guidelines for pediatric asthma (Pelkonen et al. 2006; Current Care Guidelines 2012). 
Allergic asthma is a common asthma phenotype in childhood and it is associated 
with IgE sensitization and Th2-type immune response (Wenzel 2006). Childhood 
asthma can also be classified into different phenotypes depending on the age of the 
children or on the underlying mechanism/trigger, such as viruses, exercise or 
allergens (Ducharme et al. 2014; Reddy et al. 2016; GINA 2018). Recently, asthma 
has not been considered a single disease entity but rather a variety of clinical 
presentations (phenotypes) and underlying mechanisms (endotypes), coupled with 
the presence of overlapping symptoms (Papadopoulos et al. 2012 & 2019; GINA 
2018). These classifications can help to understand the underlying genetics and 
pathophysiology and to modify the treatment (Papadopoulos et al. 2019). 
2.3.2 Epidemiology of childhood asthma 
Globally asthma is one of the most common chronic diseases and is considered as a 
major public health burden throughout the world (Masoli et al. 2004). Asthma 
prevalence among children has increased very considerably in recent decades, being 
highest in Western countries, approximately 10% of children in the European Union 
and North America, and lowest in Asia (Asher et al. 2006; Papadopoulos et al. 2012; 
Papadopoulos et al. 2019). In Finland, asthma is also the most common chronic 
disease in childhood (Säynäjäkangas et al. 2007) The overall incidence of asthma is 
7-9%, and a similar percentage of children have asthma-like symptoms (von Hertzen 
et al. 2006; Haahtela et al. 2013). The incidence of asthma has increased slightly over 
the past two decades, especially in younger age groups (Haahtela et al. 2013). 
Conversely, hospitalizations for asthma and the costs of asthma have decreased 
(Haahtela et al. 2006, 2017). In 1994, the Finnish national 10-year asthma program 
was established to lessen the burden of asthma to individuals and society. In 2002, 
the childhood asthma mini-program was launched to resolve specific problems 
related to pediatric asthma. After releasing more precise diagnostic criteria for 
asthma, the number of children receiving reimbursements for asthma medication 
has decreased by approximately 30% during the last ten years (Social Insurance 
Institution statistics). The reduction has been most prevalent among young children 
aged 0-4 years (Haahtela et al. 2013). 
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2.3.3 Diagnosis and treatment of childhood of asthma 
The diagnosis of childhood asthma is based on internationally accepted criteria 
(Current Care Guidelines 2012; Haahtela et al. 2013; GINA 2018; Papadopoulos et 
al. 2019). In Finland according to national guidelines, a specialist, usually a 
pediatrician in specialized health care unit, confirms the final diagnosis and the need 
for long-term medication. The diagnosis is based on the presence of typical 
symptoms and signs and/or pulmonary function tests confirming the variable or 
reversible airway obstruction depending on the age of the child (Papadopoulos et al. 
2012 & 2019; Martinez & Vercelli 2013). Further examinations in order to exclude 
alternative diagnoses (i.e. chest XǦrays) should be considered (Papadopoulos et al. 
2012 & 2019). Lung function tests, such as oscillometry, spirometry, peak expiratory 
flow tests or plethysmography, are recommended for children more than three years 
of age. Clinical exercise test, and inhaled methacholine/histamine challenge tests can 
also be used. Fractional exhaled nitric oxide measurements are used in assessing 
airway inflammation. Skin prick tests or serum allergenǦspecific IgE-tests against 
common allergens are used in the evaluation of atopy. (Current Care Guidelines 
2012) 
A short treatment trial with inhaled asthma medication is suggested for children 
under three years of age. In infants having had physician-diagnosed wheezing 
episodes three times per year, the diagnosis can be confirmed by using a special 
(asthma predictive) index score based on three main criteria, family history of 
asthma, atopic dermatitis diagnosed by a physician, and sensitization to inhaled 
allergens, and side criteria such as IgEǦmediated food allergy and wheezing without 
respiratory infection or eosinophilia. A need for inhaled corticosteroid treatment for 
more than six months is considered as diagnostic for asthma. (Current Care 
Guidelines 2012; Papadopoulos et al. 2012; Haahtela et al. 2013)  
The treatment aim is to use the lowest possible amount of medication to achieve 
adequate symptom control and to reduce future risks (Tesse et al. 2018). Anti-
asthmatic drugs are divided into beta̻2 agonists, corticosteroids and leukotriene̻
modifiers. In Finnish guidelines, anti-inflammatory inhaled corticosteroids have 
been recommended as first-line regular therapy for pediatric asthma. NonǦsteroidǦ
based biologic treatments (i.e. omalizumab) are also available for children >6 years 
(Papadopoulos et al. 2019). Pharmacological treatment is selected by age and a 
stepwise approach according to the severity of the disease (Current Care Guidelines 
2012; Tesse et al. 2018). Currently children must have a regular asthma medication 
for at least six months before entitlement to special reimbursement. AllergenǦspecific 
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immunotherapy can be considered for treatment of allergic asthma in children 
(Papadopoulos et al. 2012; Haahtela et al. 2013). The nonǦpharmacological treatment 
approaches include education and trigger avoidance. The evaluation and monitoring 
of asthma and treatment adequacy is recommended at least once or twice a year 
(Papadopoulos et al. 2019; Haahtela et al. 2013).  
2.3.4 Asthma medication reimbursement 
In Finland, reimbursement for medication expenses is based on the Health 
Insurance Act. Certain diagnostic criteria set by the Social Insurance Institution of 
Finland (KELA) must be fulfilled to be eligible for reimbursement payments under 
the special reimbursement category. The lower special rate of reimbursement for 
asthma medication is 65% of the costs (KELA 2019). Entitlement to special 
reimbursement for asthma medication can be granted for five years among children 
under the age of 16 and for two years among children under the age of three (KELA 
2019). 
2.4 Atopic dermatitis in childhood 
2.4.1 Definition and clinical presentation 
Atopic dermatitis is a chronic, pruritic, inflammatory skin disease (Kantor et al. 2016; 
Kapur et al. 2018). It follows a relapsing course with acute flares. Severe atopic 
dermatitis can significantly impact on the quality of life of affected children as well 
as their families and may result in hospitalization for the management of the disease 
and its complications. Although the pathogenesis of atopic dermatitis is not 
completely understood, it appears to result from the complex interplay between 
defects in skin barrier function, environmental and infectious agents, and immune 
dysregulation (Kapur et al. 2018). Atopic dermatitis is characterized by dry and 
pruritic skin, immune dysfunction, and dermatitis in typical anatomical sites. The 
clinical manifestations of atopic dermatitis vary depending on the age of onset and 
the natural course of the disease. Different phenotypes of atopic dermatitis have 
been suggested (Roduit et al. 2017). In infants, dermatitis usually appears on the 
cheeks. Older children often experience rashes in the folds of the knees or elbows, 
on the backs of hands or on the scalp. "Atopic" means that there is typically a genetic 
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tendency toward allergic disease. The diagnosis of atopic dermatitis is made clinically 
and is based on specific criteria (criteria proposed by Williams et al. 1994), which 
take into account the patient’s history and clinical manifestations. The diagnostic 
criteria in Finnish guidelines include an itching dermatitis in typical areas plus three 
or more of the following: history of flexural involvement, a history of asthma/hay 
fever, a history of a generalized dry skin, onset of rash under the age of two years, 
or visible flexural dermatitis (Current Care Guidelines 2016). In more than 60% of 
children the disease starts within the first two years of life (Kapur et al. 2018). Many 
children will outgrow the disease; in others it will persist. Atopic dermatitis is often 
the initial indication of later development of asthma and allergic rhinitis (Roduit el 
al. 2017). 
2.4.2 Epidemiology of atopic dermatitis 
Atopic dermatitis in childhood is common, with a rate of 10-20%, but its occurrence 
varies greatly throughout the world (Flohr et al 2014; Williams et al. 2008; Henriksen 
et. al 2015; Roduit 2017; Asher et al. 2006). In a European cohort, including Finland, 
the rate of atopic dermatitis was 27 % in four year old children (Roduit 2012). The 
incidence has increased by two- to three-fold during the recent decades in 
industrialized countries. The latest worldwide data showed that while atopic 
dermatitis seems to have reached a plateau in the countries with the highest 
prevalence such as the UK and New Zealand, atopic dermatitis continues to increase 
in low-income countries, such as those in Latin America or Southeast Asia, 
specifically in young children (Asher et. al 2006).  
2.4.3 Treatment of atopic dermatitis 
Self-management with moisturizers, periodical topical corticosteroids, daily bathing 
with water and avoiding irritating agents are the basis of the treatment. In Finland, 
children with a more severe atopic dermatitis or underlying food allergy are referred 
to specialized health care consultation. In cases of more severe atopic dermatitis, 
topical calcineurin inhibitors are used. Topical corticosteroids and calcineurin 
inhibitors can also be used twice weekly to reduce relapses (Current Care Guidelines 
2016). Recent trials have demonstrated the effectiveness of early, consistent 
application of emollients for infants at increased risk (Horimukai et al. 2014; 
Simpson et al 2014). These results suggest that reinforcing skin barrier function in 
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the neonatal period is a promising strategy for the prevention of atopic dermatitis. 
The administration of Lactobacillus rhamnosus GG starting 4 weeks prenatally and 
continuing for six months after birth may decrease the development of atopic 
dermatitis up to two years of age (Doege et al. 2012) 
2.5 Lower respiratory tract infections (LRTIs) in childhood 
2.5.1 Bronchiolitis, wheezing bronchitis and bronchitis 
2.5.1.1 Definition and clinical presentation 
Bronchiolitis in infancy is a lower respiratory tract infection caused by viral 
pathogens. The pathogenesis of bronchiolitis includes acute inflammation, edema 
and necrosis of epithelial cells in small airways, increased mucus production and 
bronchospasm (Meissner 2016). Acute wheezing in children under three years of age 
covers two clinical conditions, bronchiolitis and wheezing bronchitis. These are 
different in terms of causative agents, clinical symptoms, and outcomes (Tapiainen 
et. al 2016). In previous literature, these conditions are often included in the same 
studies. The term bronchiolitis is used for children under 24 months of age with 
wheezing in the U.S, but in Europe including Finland, it is restricted to children 
under 12 months of age experiencing their first virus-induced wheezing episode 
(Ralston et al. 2014; Mecklin et al. 2014). In Finland, wheezing (obstructive) 
bronchitis is defined as any wheezing in children aged 12 to 36 months during an 
acute respiratory viral infection or repeated wheezing in children aged 6 to 12 months 
(Mecklin et al. 2014; Tapiainen et al 2016). Recently it is also suggested that instead 
of using a certain cutoff age to diagnose bronchiolitis, the viral etiology could be 
used as the differentiating factor (Jartti et al. 2019). Acute childhood bronchitis is 
considered as an acute cough associated with a viral respiratory infection lasting less 
than three weeks (Tapiainen et al. 2016). However, these conditions may have a 
significant clinical overlap.  
The diagnosis of bronchiolitis is clinical. Typical clinical symptoms and signs 
associated with bronchiolitis are rhinitis, cough, wheezing, signs of respiratory 
distress such as tachypnea, the use of accessory muscles, and apneas in young babies, 
and widespread crackles on auscultation (Ralston et al. 2014; Smyth 2006). 
Bronchiolitis is most often seen in infants under six months of age during respiratory 
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syncytial virus (RSV) epidemics (Smyth 2006). In older children signs of respiratory 
distress and expiratory wheezing during acute respiratory viral infection are typical 
for wheezing bronchitis (Current Care Guidelines 2015).  
2.5.1.2 Epidemiology 
Bronchiolitis is a common disease with a high health care burden (Smyth 2006). 
According to population-based birth cohort studies, the occurrence of bronchiolitis 
is approximately 18-32% in the first year and 9-17% in the second year of life (Jartti 
& Korppi 2011). Approximately 3% of all infants are admitted to hospital for 
bronchiolitis during the first year of life, and 2-6% of these need intensive care unit 
treatment due to acute respiratory distress (Green et al. 2016, Smyth 2006). In a 
Finnish cohort of infants younger than six months with bronchiolitis, the incidence 
of emergency department visits was 37/1,000 per year. Seventy percent of these 
patients were hospitalized (Pruikkonen et al. 2014). In developed countries, the 
mortality rate for bronchiolitis has been low and is associated with underlying 
illnesses, such as chronic lung disease, neuromuscular disease, congenital heart 
disease, and immunodeficiency (Thorburn 2009). In the US and UK, the mortality 
rate for bronchiolitis has been at two to three per every 100,000 live births (Holman 
et al. 2003, Smyth & Openshaw 2006). Generally, wheezing associated with 
respiratory infection (i.e. wheezing bronchitis) occurs in approximately 30% of all 
children during the first three years of their lives (Martinez et al. 1995; Brand al. 2014; 
Henderson et al. 2008; Taussig et al. 2003). The majority of wheezing children grow 
out of the wheezing tendency by the age of 8 years. Those who continue to wheeze 
are later prone to developing asthma (Martinez et al. 1995; Taussig et. al 2003; 
Henderson et al. 2008).  
2.5.1.3 Microbiologic etiology of bronchiolitis and wheezing bronchitis 
The RSV is the most common virus causing bronchiolitis and is responsible for 50-
70% of all hospitalizations for bronchiolitis (Miller et al. 2013; Meissner 2016; 
Tapiainen et al 2016). In Finland, RSV epidemics used to occur every other year, but 
during the last few years RSV epidemics appear to be happening every year with the 
peak in the winter months (Tapiainen et al. 2016). Rhinoviruses are particularly 
associated with wheezing bronchitis and are detected more steadily throughout the 
year. Accordingly, RSV is the most important virus that causes wheezing in children 
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under one year of age and rhinoviruses are the most important in older children. The 
recently recognized respiratory viruses are the human metapneumovirus, which is 
associated with bronchiolitis, and the human bocavirus, which is associated with 
wheezing bronchitis. Coinfections are common in infants hospitalized with acute 
bronchiolitis up to 61% of all cases (Skjerven et al. 2016). Bacteria do not usually 
cause bronchiolitis or wheezing bronchitis in children (Tapiainen et al. 2016). 
2.5.1.4 Treatment of bronchiolitis and wheezing bronchitis 
A child with bronchiolitis should be admitted to hospital if his/her general condition 
is weakened or the oxygen saturation is decreased. Infants who experience 
bronchiolitis during the first weeks of life should usually be properly monitored due 
to a risk of apnea and deteriorating respiratory symptoms. Over the past decades, 
bronchiolitis has been treated with medication reflecting that of asthma treatment 
(i.e. corticosteroids, inhaled agents). However, these medications have failed to 
alleviate the course of disease (Meissner 2016). The current guidelines, including the 
Finnish Current Care Guidelines for the treatment of LRTIs in children published 
in 2015, recommend supportive care, i.e. monitoring of oxygenation, administration 
of supplemental oxygen and maintaining adequate hydration, as the goal of the 
treatment (Meissner 2016; Tapiainen et al. 2016). Inhalations of racemic epinephrine 
or nebulized hypertonic saline may be given for severe symptoms. Acute respiratory 
failure is treated with respiratory support such as continuous positive airway pressure 
and high-flow nasal oxygenation (Sinha 2015). Two to three percent of hospitalized 
infants require invasive ventilation (Hasegawa et al. 2015). Immunoprophylaxis with 
palivizumab can be used to prevent severe RSV bronchiolitis symptoms in high risk 
groups, such as those with chronic lung disease or heart disease (Meissner 2016). 
Salbutamol inhalations administered via a holding chamber may relieve the 
symptoms of wheezing bronchitis. Glucocorticoid inhalations are not recommended 
for the prevention of expiratory wheezing episodes induced by viral infections in 
children. Currently available drugs are not effective in relieving cough symptoms 
(Tapiainen et al. 2016).  
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2.5.2 Pneumonia 
2.5.2.1 Definition and clinical presentation 
The definition of pneumonia includes viral or bacterial infection of the pulmonary 
alveoli or interstitial tissue. It can be diagnosed by chest radiography and/or on the 
basis of clinical findings, such as the presence of fever and acute respiratory 
symptoms (McIntosh 2002; Don et al. 2010; Tapiainen et al. 2016). Community-
acquired pneumonia can be defined as the presence of signs and symptoms of 
pneumonia acquired outside the hospital in a previously healthy child (McIntosh 
2002; Harris et al. 2011). Pneumonia can be diagnosed on a clinical basis (Harris et 
al. 2011; Tapiainen et al. 2016). The most common indicative symptoms and findings 
of pneumonia are fever, cough and dyspnea and fine crepitations or silenced breath 
sounds on auscultation. Chest radiography showing a typical lung infiltration is 
useful for severely ill hospitalized children and in cases of complicated pneumonia, 
or a poor response to antimicrobial treatment (Tapiainen et al. 2016). Laboratory 
tests for infection and microbiological etiology could be considered. 
2.5.2.2 Epidemiology 
The annual incidence of community-acquired pneumonia in children of less than 5 
years of age has been reported to range from 0.2–0.33% to 3.5–4% (Don et al. 2010). 
Approximately half of the children with pneumonia in this age group and 20% of 
children aged between 5 and 10 years are treated in hospital (Heiskanen-Kosma et 
al. 1998; Don et al. 2010). In western countries the mortality due to pneumonia is 
low among previously healthy children without underlying conditions, but 
pneumonia in children younger than 5 years of age is responsible for 18.4% of 
mortality worldwide (Liu et al. 2012; Bhutta et al. 2013). 
2.5.2.3 Microbiologic etiology of pneumonia 
Respiratory viruses, such as the RSV, cause oneǦthird of childhood pneumonia cases. 
Viruses combined with bacteria account for another third and bacteria alone for the 
remaining third (Tapiainen et al 2016). Viral pneumonia is more common in children 
less than two years of age and bacterial etiology predominates at school age (Don et 
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al. 2010). The most common pathogen has been Streptococcus pneumoniae (Don 
et al. 2010), but pneumococcal bacteremia cases have markedly decreased since the 
introduction of pneumococcal vaccines (Korppi et al. 2013). Mycoplasma 
pneumoniae typically causes pneumonia in schoolǦaged children (Don et al. 2010). 
Chlamydia pneumoniae has been found in less than 10% of pneumonia cases in 
children (Don et al. 2010).  
2.5.2.4 Treatment of pneumonia  
In the Finnish guidelines orally administered amoxicillin is suggested for the 
treatment of pneumonia in previously healthy children whose clinical condition do 
not require hospitalization. Administration of GǦpenicillin intravenously is suggested 
if hospital treatment is required. Macrolides may be beneficial in treating pneumonia 
caused by Mycoplasma pneumoniae. Antiviral treatment against influenza should be 
considered. Children with suspected complications of pneumonia (i.e. empyema, 
lung abscess) should be treated in hospital (Current Care Guidelines 2015).  
2.6 Long-term respiratory morbidity and atopic dermatitis by 
gestational age at birth 
2.6.1 Children born preterm 
2.6.1.1 Asthma after preterm birth 
Systematic reviews and meta-analyses have shown that preterm birth (<37 weeks) is 
associated with an increased risk of asthma (Jaakkola et al. 2006; Sonnenschein-van 
der Voort et al. 2014), and the risk is particularly high among children born very 
preterm (<32 weeks) (Been et al. 2014). The associations between MP and LP birth 
and asthma in childhood have also been reported by previous studies (Been et al. 
2014; Boyle et al. 2012; Harju et al. 2014, Trønnes et al. 2014). In a retrospective 
cohort study persistent asthma and use of inhaled corticosteroids by 18 months were 
more common in LP infants compared with those born at term (Goyal et al. 2011). 
The incidence of asthma and wheeze were increased at 3 and 5 years of age in MP 
or LP children compared with term children, as was the risk of needing asthma 
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treatment with increasing prematurity (Boyle et al. 2012). Harju and associates also 
noted that LP children, born at 33–36 weeks’ gestation, had a higher adjusted OR 
1.7 (95% CI 1.4–2.0) of developing asthma compared with children born at 39–40 
weeks’ gestation (Harju et al. 2012). In contrast, no association was found between 
LP birth and the risk of asthma in a population of approximately 500 LP infants aged 
2–83 months (Abe et al. 2010). In the large UK Avon Longitudinal Study of Parents 
and Children (ALSPAC), the children born at 33–34 weeks of gestation had 
spirometry measures that were all significantly lower than those of term-born 
children at 8–9 years, the effect being similar to that seen in children born very 
preterm. The approximate differences compared with term infants after adjustment 
for age, gender and height were -143 ml for forced expiratory volume in 1 second 
(FEV1), -98 ml for forced vital capacity (FVC) and -253 ml/s for forced expiratory 
flow at 25-75% (FEF25–75) in the 33-34-week gestation group. By 14–17 years, 
FEV1 and FVC had improved, approaching values similar to those born at term, but 
differences in FEV1/FVC and forced expiratory flow at FEF25–75/FVC remained 
significant (Kotecha et al. 2012). 
2.6.1.2 Atopic dermatitis after preterm birth 
Preterm birth and very low birth weight (≤ 1500 g) have been linked to a decreased 
long-term risk of atopic sensitization (Siltanen et al. 2011), but the findings are 
inconsistent (Kvenshagen et al. 2009). One previous study on two independent 
cohorts of premature infants found that birth at very low GA (< 29 weeks) was 
associated with a reduced risk of atopic dermatitis compared with birth at 29–34 
weeks and term GA (Barbarot et al. 2013). Recent meta-analysis of 18 observational 
studies, including data from more than 2 million individuals, found that very preterm 
birth predicted a reduced risk of developing atopic eczema later in life (Zhu et. al 
2018). Compared with full-term infants, there were no associations between MP 
birth and eczema (Zhu et al 2018). Low birth weight <2500g has been presented as 
a protective factor for the development of atopic dermatitis in the meta-analysis of 
10 studies (Panduru et al. 2014).  
2.6.1.3 LRTIs after preterm birth 
Children born very preterm (<32 weeks) are at an increased risk of respiratory tract 
infections, the risk persisting into early childhood (Greenough 2013). Previous 
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studies have also confirmed the association between MP and LP birth and an 
increased incidence of hospital admissions for LRTIs (Boyle et al. 2012; Miller et al. 
2016; Parajonthy et al. 2013; Blanken et al. 2016; Vrijlandt et al. 2013). A Canadian 
retrospective health record linkage study of a total of 35,733 infants including 2,051 
LP (33Ǧ36 weeks) births revealed an increased risk of acute bronchiolitis/bronchitis 
(OR 1.64, 95%CI 1.13Ǧ2.39) and pneumonia (OR 1.17, 95% CI 1.05Ǧ1.30) in the first 
3 years of life in LP infants compared with term infants (Berard et al. 2012). The 
systematic review by Been and associates reported that children born at 32–36 weeks’ 
gestation had an increased risk of wheezing with an unadjusted OR 1.49 (95% CI, 
1.34–1.66) compared with term-born children (Been et al. 2014). This study also 
showed that this risk was threefold in those born very preterm (Been et al. 2014). 
Moreover, several studies in LP infants have shown increased hospital admission 
rates of RSV bronchiolitis during the first year of life (Helfrich et al. 2015; Isayama 
et al. 2017). LP infants with RSV bronchiolitis have a three-fold higher risk of 
respiratory support in comparison to full-term infants (Helfrich et al. 2015). 
2.6.2 Children born early-term and term 
2.6.2.1 Asthma after early-term and term birth 
EarlyǦterm birth has been associated with an increased risk of childhood asthma in 
comparison with full-term birth (Vogt et al. 2011; Boyle et al. 2012; Edwards et al. 
2015; Harju et al 2014). In a large Swedish cohort of 1,100,826 children and 
adolescents (6Ǧ19 years old), early-term children had an increased risk of inhaled 
corticosteroid use, evaluated by registered drug retrievals, compared with those born 
at 39Ǧ41 weeks of gestation (Vogt et al. 2011). A hospitalǦbased Finnish register study 
found that the burden of asthma in children was particularly associated with 
deliveries at 37Ǧ38 weeks of gestation (Harju 2014). In the UK ALSPAC cohort the 
spirometry measures at 8–9 years were lower in the early-term children compared 
with full-term born children, but the measures between the two groups were similar 
at 14–17 years of age (Kotecha et al. 2016). 
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2.6.2.2 Atopic dermatitis after early-term and term birth 
In previous reports on the prevalence and risk of atopic dermatitis, early-term-born 
children have often been included in the GA at group 37-42 weeks and thus the risk 
of atopic dermatitis is thought to be somewhat equal. 
2.6.2.3 LRTIs after early-term and term birth 
A population-based prospective cohort study of all singleton deliveries in a single 
tertiary center revealed an association between early-term birth and long-term 
respiratory morbidity (i.e. asthma, bronchiolitis, pneumonia) up to the age of 18 years 
when compared with births at full-term and late-term (Walfisch et al. 2017). In a 
large Australian register study in which follow-up lasted from birth to 18 years of 
age, increased relative risks of admission for LRTIs were found in children born at 
37–38 weeks of GA, whereas birth at 41 weeks or later was associated with modestly 
reduced rates of admission (Miller 2016). In another cohort study in which children 
born via induced early-term delivery were compared with those born full-term or 
late-term, early-term birth predicted an increased risk of admission for bronchiolitis 
but not for pneumonia before the age of five. This risk persisted after excluding 
infants who had received intensive care and/or respiratory care in the neonatal 
period (Tickell et al. 2015). 
2.6.3 Children born late- and post-term 
2.6.3.1 Asthma after late- and post-term birth 
In previous reports late-term (Harju et al. 2014) and post-term (Harju et al. 2014; 
Källen et al. 2013) births have been associated with a decreased risk of childhood 
asthma compared with full-term birth. In a birth cohort study of 8327 Chinese 
children followed up to 12 years of age post-term births (≥42 weeks) were associated 
with a decreased risk of hospitalization for asthma and other wheezing disorders HR 
0.56 (95% CI 0.32, 0.98).  In late-term births (41 to <42 weeks), HR did not reach 
statistical significance HR 0.77 (95% 0.59, 1.01) (Leung et al. 2016). 
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2.6.3.2 Atopic dermatitis after late- and post-term birth 
A large Norwegian birth cohort study of 1,000,000 children is the only earlier report 
suggesting an increased risk of atopic dermatitis by school age in children born post-
term (Trønnes et al. 2013). 
2.6.3.3 LRTIs after late- and post-term birth 
In a large Australian register study by Miller et al., birth at 41 weeks or later was 
associated with modestly reduced rates of admission for LRTIs (Miller et al. 2016). 
In another population-based cohort study, late-term birth also predicted a decreased 
risk of  long-term respiratory infectious morbidity (i.e. bronchiolitis, pneumonia) up 
to the age of 18 years, while no significant association was seen with post-term birth 
(Walfisch et al. 2017). 
2.6.4 Limitations in comparing outcome studies  
Some important factors should be taken into account when comparing outcome 
studies of early childhood asthma, wheezing, atopic dermatitis and LRTIs. The 
definitions may be heterogeneous between studies. The definition of GA categories 
in the preterm and term birth groups may vary among studies. GA group 
comparisons and exclusion criteria may also be different. The clinical assessment, 
diagnostic methods and recording practices may vary between sites and time periods. 
The definition of acute bronchiolitis in particular may vary in terms of age but also 
in terms of symptoms. The use of terminology in allergic disorders may also be 
inconsistent in different study designs and this should be recognized when 
comparing prevalence and time trends of asthma and allergies. In addition, treatment 
practices in peri- and neonatal care have changed and improved over time. For 
example there may be variations in the indications for cesarean delivery and non-
invasive ventilation practices have been improved. 
Routinely collected health data obtained for administrative and clinical purposes 
are increasingly used in epidemiological studies. The reliability and validation of the 
used register data, standardization in terminology and information on disease 
severity are important in the comparison of study results.  
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2.7 Early-life risk factors for childhood asthma, atopic dermatitis 
and LRTIs 
The risks of developing heterogeneous diseases, asthma and atopic dermatitis, are 
related to a complex interaction between genetic susceptibility and early-life 
exposures. Many genetic, epidemiological and environmental factors that have not 
been fully explored are linked to later childhood respiratory morbidity and atopic 
tendency. In recent years, research interest has been focused on identifying specific 
genes connected to susceptibility to asthma and allergies (Vercelli et al. 2008) and 
also to bronchiolitis occurrence and severity (Pasanen et al. 2017). Increasing 
research evidence also suggests that epigenetic variation (such as DNA methylation) 
can contribute to asthma as well as to bronchiolitis susceptibility (Xu et al. 2018; 
Elgizouli et al. 2017). However, these explain only a part of the variation in this risk. 
The rapid increase in the prevalence of allergic diseases proposes that environmental 
factors and early-life exposures might play an important role in the pathogenesis of 
these diseases. Most of the studied early-life risk factors are related to maternal 
factors, to the maturation of the immune system, and to lung development and the 
maturity of the newborn. As proposed by previous birth cohort and epidemiological 
studies, specific exposures in the fetal and early postnatal periods may influence lung 
growth and immune development (Keil et al. 2004; Hofman et al. 2004; Taussig et 
al. 2003; Martino 2011) and modify later risk of allergic diseases (McKeever et al. 
2002; Prescott et al. 2013) and LRTIs (Vissing et al. 2018). 
2.7.1 Maternal, pregnancy and delivery related factors 
2.7.1.1 Maternal age and socioeconomic status (SES) 
A higher maternal age has been related to adverse neonatal risks, but maternal age at 
birth may also reflect other health and social processes (Goisis et al. 2017). Advanced 
maternal age ≥40 years has been previously associated with the development of 
asthma in the offspring (Aspberg et al. 2010), but this has not been studied 
extensively. Risks associated with maternal age are linked with maternal SES and 
smoking. Young maternal age and low SES have been associated with an increased 
risk of hospital admission for bronchiolitis (Green et al. 2013, Lanari et al. 2015). 
Smoking during pregnancy correlates strongly with lower maternal SES in Finland 
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(Ekblad et al. 2014; Rumrich et al. 2018). Mothers with lower SES tend to continue 
smoking after delivery and breastfeed their offspring less often compared with 
mothers with higher SES (Ruijsbroek et al. 2011). In a previous Finnish register-
based study maternal SES played a substantial role in preterm births after adjustment 
for numerous birth characteristics and reproductive risk factors (Räisänen et al. 
2013). The incidence of preterm births was mostly higher among blue-collar 
compared to white-collar workers. In some reports, lower maternal education has 
been associated with preterm birth (Ruiz et al 2015). In other words, many of these 
factors linked to maternal SES may influence the burden of later childhood 
respiratory morbidity via indirect pathways. 
2.7.1.2 Maternal smoking during pregnancy 
The association between maternal smoking during pregnancy and later childhood 
asthma has been established in numerous studies (Burke et al. 2012; Jaakkola et al. 
2004; Silvestri et al. 2015).  Maternal smoking during pregnancy affects fetal lung 
development, inducing long-lasting structural changes, and it may predispose to 
preterm delivery (McEvoy et al. 2017). According to a meta-analysis, exposure to 
prenatal smoking has increased the risk of wheezing in <6-year-old children and the 
risk of wheezing or asthma in ≥6-year-old children (Silvestri et al. 2015). A recent 
review and meta-analysis concluded that pre- or postnatal passive smoke exposure 
increases the incidence of wheeze and asthma in children and young people by at 
least 20% (Burke et al. 2012). Results of the study using data from eight European 
birth cohorts showed that maternal smoking during pregnancy also increased the 
risk of wheeze and asthma among children who were not exposed to maternal 
smoking after birth (Neuman et al. 2012). Maternal smoking during pregnancy is also 
associated with bronchiolitis in infancy (Green et al. 2016). Tobacco smoke exposure 
during pregnancy might preclude sensitization through an immunosuppressive effect 
(Thacher et al. 2016) and might alter the later risk of development of atopic 
dermatitis. 
2.7.1.3 Maternal diabetes and obesity 
Fetal exposure to hyperglycemia affects lung growth and alveolization (Koskinen 
2014) and may increase the risk of neonatal respiratory problems (Michael Weindling 
2009) and thus the subsequent development of asthma. A previous register-based 
41 
study by Aspberg and associates showed a weak association between maternal 
diabetes and increased prescription of antiǦasthmatic medication during childhood 
(Aspberg et al. 2010). However, in a pooled analysis of 14 European birth cohorts 
after adjusting for several complications of pregnancy, no association was found 
between gestational and/or pregestational diabetes with the risk of wheezing up to 
24 months of life (Rusconi et al. 2018). Maternal obesity has been associated with 
increased asthma and wheezing among offspring, especially with non-atopic asthma 
(Forno et al. 2014). Maternal obesity is related to fetal growth (Duijts 2012) and is 
also associated with other underlying conditions, such as hypertension and the need 
for cesarean delivery. Thus, it seems to indirectly increase the risk of wheezing and 
asthma in the offspring (Rusconi et al. 2018). 
2.7.1.4 Maternal infection and antibiotic use 
Maternal infection and antibiotic therapy during pregnancy are associated with a 
higher risk of childhood asthma (Stokholm et al. 2014) Chorioamnionitis is a cause 
of fetal inflammation. It increases the risk of developing lung morbidity and thus 
may increase the risk of developing asthma (Kumar et al. 2008). The Danish National 
Birth Cohort confirmed the increased risk of asthma hospitalization HR 1.17(1.00-
1.36) and use of inhaled corticosteroids HR 1.18(1.10-1.27) in children below the age 
of five if mothers had been exposed to antibiotics at any time during pregnancy. No 
association was found in terms of a child's risk of eczema (Stensballe et. al 2013).  
2.7.1.5 Maternal asthma and atopy 
Maternal asthma is the main risk factor associated with the development of 
childhood asthma (Litonjua et al. 1998). A meta-analysis conducted by Lim et al. 
showed that children of mothers with maternal asthma had approximately a 
threefold risk of asthma compared with those children without maternal asthma 
(Lim et al. 2010). Maternal atopy is associated with higher prevalence of asthma, 
atopy and allergic rhinitis in the offspring (Wang et al. 2012). 
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2.7.1.6 Mode of delivery 
Previous studies have revealed an association between delivery by cesarean section 
and childhood asthma and infectious respiratory morbidity (Thavagnanam et al. 
2008; Huang et al. 2015; Kristensen et al. 2016; Leung et al. 2015; Moore et al. 2012; 
Sevelsted et al. 2015). A metaǦanalysis has shown a 20% increase in childhood 
asthma risk after birth by cesarean delivery (Huang et al. 2015). ). In previous reports, 
the risk of later asthma has been increased particularly after elective cesarean section 
(Kristensen et al. 2016), but in another study also after emergency cesarean section 
(Tollånes et al. 2008). According to a recent Danish national registerǦbased cohort 
study, children delivered by elective cesarean section also had an increased risk of 
LRTIs (Kristensen et al. 2016). Infants born by cesarean section, especially by 
elective cesarean section, are exposed differently to maternal hormones and 
microbiota compared with those born by vaginal delivery, and these differences 
could predispose an infant to an adverse respiratory outcome (Kotecha et al. 2016; 
Vissing et al. 2018). The indication of cesarean section could also be a reflection of 
other risk factors influencing the outcome. Children born by vaginal delivery are 
exposed to diverse microbiological flora from the birth canal and subsequent 
colonization of the gut and airways alters immune modulation and susceptibility to 
LRTIs (Kotecha et al. 2016; Vissing 2018). The association of the mode of delivery 
with the risk of atopic dermatitis is controversial. Some studies have found no 
association (Bager et al. 2008; Kvenshagen et al. 2009) whereas others have 
associated atopic dermatitis with cesarean delivery (Yu et al. 2015). 
2.7.2 Gestational age at birth 
Preterm-born children are at risk of later respiratory morbidity due to birth at an 
immature stage of lung development and influenced by complications of preterm 
birth and medical interventions such as mechanical ventilation. Bronchopulmonary 
dysplasia is a chronic respiratory disease associated with premature birth that 
primarily affects infants born at less than 28 weeks of GA (Greenough 2013). 
Bronchopulmonary dysplasia is associated with bronchiolitis, recurrent wheezing, 
and asthma in early childhood (Greenough 2013; Davidson et al. 2017). Preterm 
birth and later respiratory morbidity may also have common genetic components. 
Some prenatal exposures that could induce preterm birth, such as smoking, could 
also influence the risk of asthma postnatally (McEvoy et al. 2017; Leps 2018). 
Preterm infants are also more often delivered by cesarean section than term infants 
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(Zeitlin et al. 2010). Antenatal corticosteroid therapy administered for fetal lung 
maturation in cases of imminent preterm delivery, has previously been associated 
with childhood asthma (Pole et al. 2009). The effects of corticosteroids on fetal 
growth (Murphy et al. 2012), the hypothalamus-pituitary axis, the immune function 
(Prescott 2009), and kidneys, as well as subsequent hypertension, and subsequently 
may have a role in the development of asthma (Pole et al. 2009). Susceptibility to 
LRTIs during early infancy in very preterm, but also in MP and LP born infants, 
might be caused by incomplete transfer of maternal antibodies as a result of 
premature birth and immaturity of the neonatal immune system. Final maturation of 
the immune system occurs during the first six months of life (Ygberg et al. 2012). 
The association of early-term birth with an increased risk of long-term respiratory 
morbidity could be partly explained by continuous intrauterine maturation of the 
airways. The last weeks of gestation represent a critical period of lung growth and 
development with both short- and long-term health consequences (Gill & Boyle 
2017).  
It is unclear why very preterm birth is associated with a reduced risk of atopic 
dermatitis and post-term birth with an increased risk on the other hand. Many 
underlying mechanisms have been proposed. Antenatal exposures or earlier 
exposure to the extrauterine environment may modulate the disease risk by 
influencing the Th1/Th2 balance (Martino 2011). The epidermal maturation of the 
skin is complete by 34 weeks of GA and stratum corneum is fully formed a few 
weeks after birth (Oranges et al. 2015; Goedicke-Fritz et al. 2017). Preterm infants 
have functionally impaired skin barriers resulting in early transcutaneous exposure 
to antigens and the development of tolerance (Barbarot et al. 2014; Goedicke-Fritz 
et al. 2017). Very preterm infants also have reduced diversity of intestinal microflora, 
and this could influence the acquisition of immune tolerance and lead to a reduced 
risk of atopic dermatitis (Barbarot et al. 2014). As previously suggested, Th2 
predominance leads to increased secretion of proinflammatory and Th2 cytokines, 
and this might promote immunoglobulin E production and, subsequently, atopic 
inflammation and diseases (Martino 2011). A shorter period of exposure to Th2 
cytokines during pregnancy could also modulate the fetal immune system toward 
less atopy, which is contrary with post-term infants (Goedicke-Fritz et al. 2017; Zhu 
et al. 2018). Health risks associated with post-term birth, including increased risk of 
atopic dermatitis, might be related to underlying maternal risk factors for post-term 
pregnancy, such as obesity and advanced age (Galai et al. 2012). Other hormonal and 
immunological processes or the decreased capacity of the placenta to transport 
oxygen and nutrients to fetus after expected date of delivery might be contributing 
44 
to this. However, the pathogenesis of post-term pregnancy is not yet clearly 
understood (Galai et al. 2012). 
2.7.3 Newborn-related and postnatal factors 
Restricted fetal growth through adaptive processes in utero may predispose infants 
to reduced lung function with smaller airways and respiratory diseases later in life 
(Duijts 2012). Previous results suggest that SGA children seem to carry a greater risk 
of bronchiolitis/bronchitis (Miller et al. 2016; Paranjothy et al. 2013; Green et al. 
2016). A link between low birth weight and childhood wheezing disorders has been 
reported, although some results have been inconsistent (Mebrahtu et al. 2015). A 
meta-analysis assessed the association of preterm birth (gestational age <37 weeks) 
and low birth weight (<2,500 g) with childhood asthma outcomes. Associations 
between low birth weight adjusted for gestational age at birth with preschool 
wheezing (pooled OR, 1.10; 95% CI, 1.00-1.21) and school-age asthma (pOR, 1.13; 
95% CI, 1.01-1.27) were detected. An increased risk of preterm birth was, however, 
seen independent of birth weight (Sonnenschein-der Voort et al. 2014). An 
association between anthropometric parameters at birth and later atopic tendency 
has been suggested, but the findings in relation to atopic dermatitis have been 
inconsistent (Bolte et al. 2004). 
Male sex has been associated with wheezing (Taussig et al. 2003; Blanken et al. 
2016; Caudri et al. 2013), as well as an increased risk of asthma (Trønnes et al. 2013; 
Göskor et al. 2013) and atopic dermatitis (Moore et al. 2004) in infancy and 
childhood. A large worldwide systematic analysis found a consistently higher 
incidence of admissions for severe acute LRTIs in boys than in girls (Nair et al. 2013). 
The physiological basis for this incidence is not fully understood, but in boys growth 
of the airways lags behind that of the lung parenchyma resulting in disparity between 
airway caliber and lung size compared with girls (Liptzin et al. 2015; Kotecha el al. 
2018). 
Some reports have linked early antibiotic exposure during the first week of life to 
asthma (Göskor et al. 2011; Raymond et al. 2017; Stromberg et al. 2018), but the link 
to LRTIs is not yet well established. Antibiotics affect the infant’s gastrointestinal 
microbiota and maturation of the immune system and may disrupt the development 
of immunological tolerance (Zwittink et al. 2017). The first weeks of life probably 
represent the most important time window for changes in the intestinal microbiota 
caused by antibiotics (Collado et al. 2015). This mechanism is suggested for the 
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association with early antibiotics and atopic dermatitis (Tsakok et al. 2013). Some 
confounding factors may play a role, including the fact that antibiotic therapy is more 
common in infants who are admitted to a neonatal ward. Perinatal infection itself 
may also modify immune programming (Stromberg et al. 2018). 
Infants needing mechanical ventilation in the neonatal period have increased risks 
of wheezing and asthma later in life (Greenough 2013) and also after adjustment for 
GA (Källen et al. 2013). Neonatal ventilator-induced lung injury especially to 
structurally immature, compliant airway structures in preterm infants has been 
previously well described (Reyburn et al. 2012). It seems that regardless of the 
etiology of lung disease, ventilator therapy in the neonatal period may be associated 
with long-term respiratory consequences. Asthma and airway hyperresponsiveness 
after preterm birth have been suggested to differ from typical childhood asthma, 
showing more association with neonatal respiratory problems and oxygen therapy 
than with current inflammation (Halvorsen et al. 2005).  
2.7.4 Other risk factors  
Other environmental factors after birth such as nutrition may influence the risk of 
asthma and atopic dermatitis. Breastfeeding (minimum of three months) may have a 
protective effect against childhood asthma (Sonnenschein-van der Voort et al. 2012). 
Instead, the meta-analysis by Yang et al. showed no strong evidence of a protective 
effect of at least three months’ exclusive breastfeeding against atopic dermatitis 
(Yang et al. 2009). 
Postnatal exposure to smoking is a known risk factor for wheezing in early 
childhood and LRTIs in preǦschool children (Jones et al. 2011). It is also suggested 
that exposure to tobacco smoke might be a trigger of lower respiratory symptoms, 
such as cough and wheeze, rather than enhancing the susceptibility to infections 
(Vissing et al. 2018). 
Air pollution has also been a risk factor for asthma (Burbank & Peden 2018). In 
a recent Taiwanese study, relative risks of hospitalization due to asthma in children 
associated with exposure to varying levels of air pollutants were identified. The 
relative risks for asthma hospitalization associated with air pollutants were higher 
among children aged 0-5 years than aged 6-18 years and were higher among males 
than females. The effects of air pollution on childhood asthma were greater in the 
higher-level air pollution regions, while no association was observed in the lower-
level air pollution regions (Kuo et al. 2019). 
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Being the first-born child has been found to be protective against childhood 
wheezing (Lodge et al. 2014), but first-born children have presented with a greater 
risk of atopic dermatitis (Upchurch et al. 2010). Twins also seem to be less prone to 
develop asthma and atopic dermatitis than singletons (McKeever et al 2001). The 
presence of older siblings has been associated with a higher risk of early wheezing 
but with a lower risk of late-onset asthma or wheeze (Ball et al. 2000; McKeever et 
al. 2001). In addition, a higher number of siblings has been protective against the 
development of atopic dermatitis (McKeever et al. 2001; Karmaus et al. 2002). The 
mechanisms behind this process are unclear but increased exposure to infections 
transmitted by siblings and maternal microbial pressure affecting the in utero 
environment have been suggested (Benn et al 2004). Previous results also suggest 
that the presence of older siblings and daycare attendance increase the risk of RSV 
infection hospitalization (Haerskjold et al. 2016) and transient wheezing in early 
childhood (Blanken et al. 2016; Caudri et al. 2013). It has been previously proposed 
that early-life LRTIs caused by RSV and rhinovirus are strongly associated with an 
increased asthma risk (“viral march”) (Jartti 2011; Lukkarinen et al. 2017). It is also 
suggested that early-life contact with microbes can be protective against allergy, but 
severe early-life infection can lead to prolonged Th2-type responses (Strachan 1989; 
von Mutius 2007).  
As suggested by the ‘hygiene hypothesis’, recent changes in lifestyle and reduced 
microbial exposure during childhood may lead to an imbalance in the developing 
immune system and subsequently increase the risk of allergic diseases. In contrast, 
the protective effect of the farm environment, regular contact with farm animals and 
farm milk consumption, in childhood has been associated with a lower risk of asthma 
and allergies in later life in previous studies (von Mutius & Vercelli 2010). Previous 
research on the association between household pet keeping and the development of 
childhood asthma or allergies has shown contradictory results. In a meta-analysis 
including children from European birth cohort studies, no association was found 
between contact with furry pets in early life and asthma or allergic rhinitis (Lødrup 
Carlsen et al. 2012). Recently the prevalence of allergic disease (any of asthma, 
allergic rhinoconjunctivitis, or eczema) in children aged 7-9 years has been reported 
to be reduced in a dose-dependent fashion with the number of household pets living 
with the child during their first year of life (Hesselmar et al. 2018). Living with furry 
pets has been associated with changes in the child’s gut microbiota in infancy 
(Stewart et al. 2018). Accordingly, so called “biodiversity hypothesis” proposes that 
contact with diverse environmental microbiome and natural environments enriches 
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the human microbiota, promotes immune balance and protects from allergy and 
inflammatory disorders (Haahtela 2019). 
 
In summary, possible pathways and early-life risk factors associated with 
respiratory morbidity (asthma, LRTIs) and atopic dermatitis are illustrated in Figure 
3. Several factors seem to play a role especially in the respiratory vulnerability of 
premature infants: prenatal factors, prematurity with its inherent developmental and 
physiologic components, neonatal respiratory morbidity, increased susceptibility to 
viruses (i.e. RSV) and other environmental factors (Colin et al. 2010; Greenough 
2013; Kugelman & Colin 2013).  
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3 AIMS OF THE STUDY 
The aims of this study were to evaluate the long-term respiratory outcomes and 
atopic dermatitis among moderately preterm (MP) and late preterm (LP) infants in 
relation to very preterm and term infants and among the term subgroups of infants. 
An additional aim was to identify perinatal and neonatal risk factors associated with 
a risk of asthma, atopic dermatitis and lower respiratory tract infections (LRTIs) in 
relation to gestational age (GA) at birth. 
The specific aims were: 
1. To evaluate the association between MP and LP births and the risk of asthma and 
severe atopic dermatitis and to compare the peri- and neonatal risk factors for 
asthma and atopic dermatitis by school age among very preterm, MP, LP and term 
groups. A further aim was to assess the risk factors for childhood asthma and atopic 
dermatitis according to the degree of prematurity (I). 
2. To evaluate whether or not MP and LP birth increase the risk of hospital 
admissions for LRTIs and to assess the role of perinatal and neonatal risk factors for 
LRTI hospitalization up to the age of seven years (II). 
3. To evaluate the incidence and risk factors of asthma and atopic dermatitis by seven 
years of age in term subgroups of the children: early-term, full-term, late-term and 
with a special emphasis on post-term children (III). 
4. To determine the association of early-, late- and post-term birth on the rate of 
hospital admissions for LRTIs up to the age of seven years. An additional aim was 
to explore maternal and perinatal factors associated with the risk of admissions for 
LRTIs in these GA groups, also focusing especially on the post-term group (IV). 
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4 MATERIALS AND METHODS 
4.1 Study design 
This is a retrospective register study, based on a cohort of population derived from 
national administrative health registers. The data were linked from several national 
registers, and the primary cohort consisted of all live born children in Finland 
between 1991 and 2008 according to the Medical Birth Register (MBR). A flow chart 
of the study is presented in Figure 3. 
4.1.1 National health registers 
4.1.1.1 Medical Birth Register (MBR) 
The MBR maintained by the National Institute for Health and Welfare (THL) 
contains data from maternity hospitals and home births, the Population Information 
System of the Population Register Centre, and Statistics Finland. Data collection and 
reporting to the register-holding authority are obligated by Finnish legislation (Act 
on National Personal Data Registers Kept under the Health Care System). The MBR 
includes data on live births and stillbirths of fetuses with a birth weight of at least 
500 g or with a gestational age of at least 22 weeks. The data content of the mothers 
includes information on personal background factors and previous and present 
pregnancies and deliveries. It also includes data on the infants’ care interventions and 
diagnoses by the age of seven days. The MBR was established in 1987. The reforms 
of the Register in 1990, 1996, and 2004 were aimed at improving its reliability. The 
MBR data have been shown to be well established and validated, and reliable in 
register studies (Teperi 1993; Gissler et al. 1995; Gissler & Shelley 2002).  
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Figure 4.  Flow chart of the study.  
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4.1.1.2 Hospital Discharge Register (HDR) 
The HDR maintained by the THL contains information on patients discharged from 
hospitals between 1969 and 1993. The term HDR was replaced with the Care 
Register for Health Care in 1994. The Care Register has more comprehensive data 
on admission and discharge dates, diagnoses and procedures regarding all inpatient 
visits to all hospitals in Finland and since 1998 specialized outpatient healthcare in 
all public hospitals. Diagnoses are coded according to the International Classification 
of Diseases, 9th Revision (ICD-9) in 1987-1995 and according to the 10th Revision 
(ICD-10) from 1996. The data derived from both HDR and the Care Register for 
Health Care are used in the present study and considered to be reliable in register 
studies (Sund 2012). 
4.1.1.3 Register of Congenital Malformations 
The THL maintains the Register of Congenital Malformations, which contains data 
on congenital structural anomalies and chromosomal abnormalities. The data are 
obtained from birth hospitals and genetic laboratories, as well as from other health 
registers including the MBR and the HDR. Diagnoses are coded according to ICD 
codes, and minor abnormalities are excluded according to international consensus 
(EUROCAT Guide 1.3 and reference documents, 2005). 
4.1.1.4 Causes of Death Register, Statistics Finland 
Statistics Finland keeps the Causes of Death Register, which is based on death 
certificates that are complemented with data on deaths from the Population 
Information System. This validated register contains data on causes of death, 
demographic factors, and the circumstances of death, as well as data on perinatal, 
neonatal, and infant mortality (Lahti & Penttilä 2001). 
4.1.1.5 Register of Social Insurance Institution (KELA) 
KELA keeps a register of granted reimbursements for medicine expenses. 
Entitlement to special reimbursement for medication can be granted for chronic 
diseases if certain diagnostic criteria set by KELA are fulfilled. The KELA database 
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is considered a valid source of prevalence data and the ability to accurately identify, 
for example, asthma cases in the general population (Nwaru et al. 2011). 
4.2 Study population 
4.2.1 Cohort 
The study population was derived from the MBR cohort of all live births 
(n=1,039,263) in Finland between 1991 and 2008. Infants who died before one year 
of age (n=2,659) were excluded, had at least one major congenital anomaly 
(n=13,007) or whose profile had missing data on GA (n=5,520) were excluded 
(studies I-IV). The infant mortality data were updated between studies I and II, 
leading to exclusion of 46 infants who died before the age of one year in studies II-
IV (Figure 3). 
4.2.2 Gestational age groups 
The remaining cohort of 1,018,256 infants was divided according to GA into four 
subgroups: very preterm (< 32+0 weeks, n=6,329), MP (32+0-33+6 weeks, n=6,796), 
LP (34+0-36+6 weeks, n=39,928) and term (≥37 weeks, n=965,203) (studies I and II). 
The distribution of excluded infants who died before one year of age in each GA 
group was: very preterm (n=1,419), MP (n=107), LP (n=179) and term (n=919). In 
addition, children born after 37 weeks (n=965,203) were divided into four 
subgroups: early-term (37+0-38+6 weeks, n=181,667), full-term (39+0-40+6 weeks, 
n=546,845), late-term (41+0-41+6 weeks, n=189,373) and post-term (≥42, n=47,318) 
(studies III and IV). 
4.3 Main end points 
Diagnoses of main end points, respiratory morbidity and atopic dermatitis were 
retrieved from the HDR and the register of the KELA using ICD codes. These 
collected diagnoses were coded according to the ICD-9 for 1991–1995 and 
according to ICD-10 from 1996. All dates of specialized health care hospital 
admissions to and discharges from public hospitals with these as the main or 
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secondary diagnoses were collected. Diagnoses were also collected separately for 
three age categories: 0-11 months, 12-35 months and 36-84 months (studies II and 
IV). The age at diagnosis was the age of the child when the first detection was 
recorded in the registers. Data of the children were followed up to seven years of 
age or to the end of 2009.  
4.3.1 Asthma (I, III)  
A child was considered to have asthma if ICD-9 code 493 and ICD-10 code J45, J46 
(including allergic, non-allergic, unspecified and acute severe asthma) or asthma 
medication reimbursement was recorded in the registers. According to the Finnish 
Current Care Guidelines, the diagnosis of childhood asthma is based on the presence 
of typical symptoms and signs and/or pulmonary function tests confirming the 
variable or reversible airway obstruction depending on the age of the child. In small 
children, aged less than three years, the diagnostic criteria for asthma include three 
to four episodes of wheezing bronchitis within one year. The final asthma diagnosis 
is confirmed by a specialist, usually a pediatrician. To be eligible for the asthma 
medication reimbursement, a patient must provide a doctor’s certificate confirming 
an asthma diagnosis and preceding need for inhaled corticosteroid treatment for 
more than six months (Current Care Guidelines 2012). 
4.3.2 Atopic dermatitis (I, III) 
A child was considered to have atopic dermatitis if the following diagnoses were 
detected in the register: ICD-9 codes 691.8 and 693.1 and ICD-10 L20.0 and L27.2 
for atopic dermatitis or dermatitis due to ingested food. These diagnoses were 
combined in analyses of atopic dermatitis. The definition of atopic dermatitis is a 
chronic, pruritic, inflammatory skin disease with dermatitis in typical anatomical 
sites. The diagnosis of atopic dermatitis is made clinically and is based on specific 
criteria that take into account the patient’s history and clinical manifestations. 
Children hospitalized due to atopic dermatitis are those with a more severe disease 
who need specialized care consultation or treatment. 
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4.3.3 Bronchiolitis/Bronchitis (II, IV) 
The diagnostic parameters for bronchiolitis/bronchitis used in the present study 
covered all hospital admissions due to acute bronchiolitis and bronchitis, including 
wheezing bronchitis. The collected diagnoses for bronchiolitis/bronchitis were all 
ICD-9 codes 466 and ICD-10 codes J20-J21. The ICD-10 code J21.9 for acute 
wheezing bronchitis was available between 1996 and 2008. The diagnoses were 
collected directly from the register and definitions presented below did not directly 
influence the case definition and selection. According to the Finnish guidelines, 
bronchiolitis is defined as the first virus-induced wheezing episode in infants under 
the age of 12 months. Acute childhood bronchitis is defined as an acute cough 
associated with viral respiratory infections lasting less than three weeks. Wheezing 
(obstructive) bronchitis is defined as any wheezing in children aged 12 to 36 months 
during an acute respiratory viral infection or repeated wheezing in children aged six 
to 12 months. The diagnosis of bronchiolitis and wheezing bronchitis is clinical and 
based on typical symptoms and signs (Current Care Guidelines 2015).  
4.3.4 Pneumonia (II, IV) 
With regard to outcome measures, the study subjects were considered to have had 
pneumonia if ICD-9 codes 480-486 and ICD-10 codes J12-18 for pneumonia 
(including all viral, bacterial or unspecified pneumonia codes) had been recorded. 
The general definition of pneumonia includes viral or bacterial infection of the 
pulmonary alveoli or interstitial tissue, and pneumonia can be diagnosed by chest 
radiography and/or on the basis of clinical findings, such as the presence of fever 
and acute respiratory symptoms (Current Care Guidelines 2015).  
4.4 Predictive variables 
Maternal background characteristics, pregnancy- and delivery-related factors; and 
infants’ characteristics, procedures and treatments provided during the neonatal 
period were considered risk factors for respiratory morbidity and atopic dermatitis.  
Maternal smoking included smoking during pregnancy and diabetes included the 
mother’s gestational diabetes and type 1 and 2 diabetes. Cesarean sections were 
classified as elective (decided upon and undertaken before labor) or emergency 
(undertaken according to maternal or fetal indications during labor) procedures.  
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SGA infants were defined as those with a birth weight more than 2.0 SD below 
the average for GA and LGA infants as those with a birth weight above than 2.0 SD 
over the mean weight for GA (Pihkala et al. 1989). Resuscitation at birth included 
intubation and/or chest compressions in the delivery unit. Ventilator therapy 
included invasive ventilation (i.e. all endotracheal mechanically assisted ventilation). 
Antibiotic therapy included administration of antibiotics during the first week of life. 
Finland was divided into five geographical areas according to level III hospital 
catchment regions (IV). 
4.5 Data linkages 
Statistics Finland performed data linkages between registers by using unique personal 
identity codes anonymized by the register-holding authorities. The study group 
received unidentifiable data using a very secure system called the Micro Data Remote 
Access System, which is run by the Finnish Information Centre for Register 
Research and the IT Center for Science Ltd (a non-profit, state-owned company 
administered by the Ministry of Education and Culture). 
4.6 Statistical analysis 
The background characteristics of infants and their mothers were described by 
means and SDs in the case of normal distributed continuous variables and by 
medians with an interquartile range (IQR) in skew distributed variables and were 
expressed as numbers and percentages if the variables were categorical. The 
background characteristics of the study population and differences between the GA 
groups were analyzed using Pearson's chiǦsquare test and Fisher’s exact test 
(categorical variables), and continuous variables were analyzed using the Mann-
Whitney U test, the oneǦway analysis of variance (ANOVA), Welch’s t-test or the 
KruskalǦWallis test. Non-normal distributions were first normalized by base e-
logarithm. P-values <0.001 were considered statistically significant in group 
comparisons (I–IV). 
Risk factors for asthma medication reimbursement and hospital visits due to 
atopic dermatitis were sought with Cox regression analysis using a multivariable 
model for each GA group. All variables were entered simultaneously into the model 
for each GA group (I). The association between GA groups and asthma medication 
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reimbursement or hospital visits due to atopic dermatitis was studied by including 
GA groups in the multivariable model using the term group as a reference. Results 
were expressed as hazard ratios (HR) and 95 % confidence intervals (95 % CI). Cox 
regression models were performed on IBM SPSS Statistics version 23.0 (SPSS, 
Chicago, Illinois). 
A Generalized linear mixed model was used to search for risk factors for 
respiratory morbidity (asthma and LRTIs) and atopic dermatitis (II-IV). To take into 
account the number of deliveries by one mother, the Generalized linear mixed model 
with an lmer function was used. All explanatory variables were modeled as fixed 
variables and the number of deliveries per mother was added as a random effect. 
The analyses were performed in the whole study population and also in the post-
term subgroup (III, IV). Results were presented as ORs with 95% CIs. All p-values 
were two-tailed and values <0.001 (I, II, IV) or <0.05 (III, IV) were considered 
statistically significant in the multivariable models. The Generalized Linear Mixed 
Model analyses were performed with the Statistical Package R version 3.3.0 package 
lme4 (www.r-projcet.org). 
Population attributable risks (PARs, %) for the variables included in the 
multivariable models were calculated to assess the risk factors for asthma medication 
reimbursement and hospital visits due to atopic dermatitis (III). PAR was calculated 
by equation: PAR (f [OR − 1]) / (1 + f [OR − 1]), where f is the frequency of the 
risk factor in the population and OR is the OR for disease due to that exposure (III) 
(Rockhill et al. 1998). 
4.7 Ethical aspects 
This study was based on register data and patients were not contacted. Study subjects 
were pseudo-anonymized by codes in the register-holding institutions. Permissions 
to use registries were obtained from THL (Dnro THL/1637/5.05.00/2009), KELA 
(Kela 75/522/2009), and Statistics Finland (TK-53-1541-09). An approval statement 
was obtained from the national data protection ombudsman. The regional Ethics 
Committee of Tampere University Hospital approved the study (ETL R09218).  
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5 RESULTS 
5.1 Characteristics of the infants and their mothers (I-IV) 
Peri- and neonatal characteristics are presented separately for the whole study 
population in Table 2 (I, II) and for the term subgroups in Table 3 (III, IV). Of all 
live-births, the preterm birth rate was 5.1%. MP and LP births accounted for 88.1% 
of all preterm births (Figure 3). Early-term births accounted for 18.8% and post-
term births for 4.9% of all term births (Figure 4). Maternal smoking during 
pregnancy was more common in the preterm groups and in the post-term group. 
During the study period the cesarean section rate was 16.1% and 38.8% of preterm 
infants were delivered by cesarean section. Among the term subgroups, the 
frequency of elective cesarean section was highest in the early-term group and 
emergency cesarean section was most common in the post-term group.  
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Figure 5.  Proportions of preterm births between 1991 and 2008 in Finland (n=53,053).  
 
 
Figure 6.  Proportions of term births between 1991 and 2008 in Finland (n=965,203). 
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5.2 Asthma and atopic dermatitis (I, III) 
5.2.1 Cumulative incidence of asthma and atopic dermatitis 
Of all 1,018,302 children, whose data were recorded up to the age of seven years, 
39,991 (3.9 %) received reimbursement for asthma medication. In all, 51,532 (5.1%) 
needed hospital care due to asthma and 52,191 (5.1%) due to atopic dermatitis. 
Children in the MP and LP groups received asthma medication reimbursement more 
frequently than term controls (8.0% and 5.7% vs. 3.8%), but less frequently than 
very preterm children (15.4%). Hospital visits due to asthma were more common 
among MP (10.6%) and LP (7.3%) children than term children (4.8%) but less 
common than in very preterm children (20.1%). Hospital visits due to atopic 
dermatitis was more frequent among term children (5.2%) compared with MP 
(4.2%), LP (4.7%), and very preterm (3.9%) children. The decreasing trend was seen 
in the cumulative incidence of hospital visits due to asthma with increasing GA while 
hospital visits due to atopic dermatitis became more common with increasing GA 
(Figure 5). 
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Figure 7.  Cumulative incidences of hospital visits due to asthma and atopic dermatitis per 1,000 
births by seven years of age in relation to gestational age week at birth, birth years 1991-
2008 (N=1,018,302). 
 
Among term-born children (n= 965,203), the frequencies of asthma medication 
reimbursement and hospital visits due to asthma were highest in the early-term 
group, and hospital visits due to atopic dermatitis were most common in the post-
term group (Table 4).  
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Table 4.  Reimbursement for asthma medication and hospital visits due to asthma and atopic 
dermatitis in infants born at ≥37 weeks of gestation in 1991–2008 and followed-up to 
seven years of age (N=965,203).  
 
  Early term 
37+0-38+6 wk 
 (n=181,667) 
 Full term 
39+0-40+6 wk 
(n=546,845) 
 Late term 
41+0-41+6 wk 
(n=189,373) 
 Post term 
≥42 wk 
(n=47,318) 
             
             
Reimbursement for asthma medication, 
n (%) 
 8,166 (4.5)  20,180 (3.7)  6,330 (3.3)  1,534 (3.2) 
Age at 1st reimbursement,   
Md (IQR) in years 
 2.7 (1.6-
4.3) 
 2.9 (1.8-
4.5) 
 3.0 (1.8-
4.6) 
 3.0 (1.8-
4.5) 
             
Hospital visits due to asthma,  
n (%) 
 10,351 (5.7)  25,937 (4.7)  8,372 (4.4)  1,976 (4.2) 
Hospital visits due to atopic dermatitis, 
n (%) 
 9,359 (5.2)  28,032 (5.1)  9,836 (5.2)  2,568 (5.4) 
Age at 1st visit, Md (IQR)  1.1 (0.6-
2.4) 
 1.1 (0.6-
2.4) 
 1.1 (0.6-
2.4) 
 1.0 (0.6-
2.3) 
             
Statistical differences were tested by Pearson's chiǦsquare test, Fishers exact test, or the KruskallǦWallis test.  
IQR, interquartile range; Md, median 
 
5.2.2 Predictors for asthma and atopic dermatitis 
5.2.2.1 Association of gestational age at birth 
In the fully adjusted models, compared with the term-born children, preterm birth 
was associated with an increased hazard of asthma medication reimbursement and 
HRs were for very preterm group 3.18 (95 % CI 2.91–3.46), MP group 1.77 (95 % 
CI 1.61–1.94), and LP group 1.40 (95 % CI 1.33–1.47). However, preterm birth was 
associated with a decreased hazard of hospital visits due to atopic dermatitis 
compared with the term group, as follows: very preterm group HR 0.64 (95 % CI 
0.56–0.74), MP group HR 0.67 (95 % CI 0.59–0.76), and LP group HR 0.84 (95 % 
CI 0.79–0.88). 
Among term subgroups of children early-term birth was associated with an 
increased odds of asthma OR 1.20 (95% CI 1.17Ǧ1.23), while late-term birth OR 0.91 
(95% CI 0.89Ǧ0.93) and post-term birth OR 0.87 (95% CI 0.83Ǧ0.92) associated with 
decreased odds of asthma. Post-term birth predicted atopic dermatitis with an OR 
1.06 (95% CI 1.01Ǧ1.10).  
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5.2.2.2 Gestational age group-specific risk factors  
Ventilator therapy was associated with asthma medication reimbursement among all 
preterm groups: very preterm (HR 1.43, 95% CI 1.22-1.46), MP (HR 1.26, 95% CI 
1.01-1.57) and LP (HR 1.42, 95% CI 1.18-1.71). Maternal smoking during pregnancy 
was associated with asthma medication among MP (HR 1.32, 95% CI 1.08-1.63), LP 
(HR 1.21, 95% CI 1.09-1.35), and term groups (HR 1.14, 95% CI 1.11-1.18), but 
such an association was not seen in the very preterm group. Maternal diabetes 
seemed to predict asthma medication in the MP group (HR 1.62, 95% CI 1.02–2.58). 
Antenatal steroid was associated with asthma medication in LP (HR 1.46, 95% CI 
1.46-2.09) and term groups (HR 1.72, 95% CI 1.27-2.33) but such an association was 
not seen in the very preterm group (HR 0.69, 95% CI 0.49-0.95).  
 The risk factor analyses for hospital visits due to atopic dermatitis showed 
weaker association with peri- and neonatal factors. Male sex was associated with 
hospital visits due to atopic dermatitis among MP (HR 1.35, 95% CI 1.06–1.72), LP 
(HR 1.29, 95% CI 1.17–1.41) and term children (HR 1.25, 95% CI 1.23–1.28). 
Maternal diabetes was associated with atopic dermatitis in very preterm (HR 2.25, 
95% CI 1.09-4.63) and term groups (HR 1.42, 95% CI 1.31-1.54). Early antibiotic 
therapy seemed to predict atopic dermatitis in very preterm (HR 1.61, 95% CI 1.13-
2.30) and term groups (HR 1.19, 95% CI 1.12-1.26). Being first-born or a twin in the 
LP and term groups was negatively associated with atopic dermatitis. 
5.2.2.3 Common risk factors in all gestational age groups and among term-born 
children 
Male sex was associated with receiving asthma medication reimbursement among all 
GA groups: very preterm (HR 1.60, 95% CI 1.41–1.83), MP (HR 1.74, 95% CI 1.46–
2.09), LP (HR 1.65, 95% CI 1.51–1.80) and term (HR 1.73, 95% CI 1.70–1.77). Birth 
by cesarean section was associated with asthma medication only in the term group 
(HR 1.17, 95% CI 1.14-1.21). Being first-born or being born in a level II hospital 
was negatively associated with asthma medication in all GA groups. 
Among term-born children the most relevant risk factors for asthma medication 
reimbursement from a population point of view were male sex, hospital visits due to 
atopic dermatitis (as a surrogate for atopic tendency), maternal smoking during 
pregnancy, and birth by elective cesarean section. Maternal age of 40 years or more, 
being first-born or being born in a level II hospital were associated with a decreased 
risk of asthma. According to PAR analyses, male sex, being first-born, birth in a level 
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II hospital and birth by emergency cesarean section were the most relevant risk 
factors for atopic dermatitis, whereas smoking during pregnancy and place of birth 
other than a level III or level II hospital were associated with a reduced risk. 
In the subgroup analysis among post-term children, no association was found 
between birth by cesarean section and asthma medication reimbursement. Ventilator 
therapy OR 1.78 (95% CI 1.00-3.18) was associated with an increased risk of asthma 
medication reimbursement. Birth by emergency cesarean section OR 1.19 (95% CI 
1.07-1.33) emerged as a risk factor for hospital visits due to atopic dermatitis, 
whereas birth by elective cesarean section did not. 
5.3 Lower respiratory tract infections (II, IV) 
5.3.1 Cumulative incidence of bronchiolitis/bronchitis and pneumonia 
In all, 60,588 (6.0%) children had been admitted to hospital for 
bronchiolitis/bronchitis and 25 575 (2.5%) for pneumonia by seven years of age. Of 
all, 4,738 (7.8%) bronchiolitis/bronchitis admissions and 1,639 (6.4%) pneumonia 
admissions occurred among MP and LP children. Hospital admissions for LRTIs 
were more common in the MP and LP groups than in the term group but less 
common than in the very preterm group (Table 5, Figure 8). The length of hospital 
stay due to bronchiolitis/bronchitis was longer in the MP and LP groups than in the 
term group (Table 5). The frequency of both viral and bacterial LRTI decreased with 
increased gestational age (Table 6).  
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Table 5.  Hospital admissions for LRTIs up to the age of seven years among very preterm, MP, 
LP and term groups, years 1991-2008 (n=1,018,256). 
 
   Very preterm 
<32 wk 
(n=6,329) 
 Moderately preterm  
32+0-33+6 wk 
(n=6,796) 
 Late preterm  
34+0-36+6 wk 
 (n=39,928) 
 Term 
≥37 wk 
(n=965,203) 
             
             
Acute bronchiolitis/bronchitis, n (%)  1,542 (24.4)  942 (13.9)  3,796 (9.5)  54,308 (5.6) 
Age at diagnosis             
0-11 months, n (%)  920 (59.7)  600 (63.7)  2,184 (57.5)  27,787 (51.2) 
12-35 months, n (%)  513 (33.3)  279 (29.6)  1,295 (34.1)  20,589 (37.9) 
36-84 months, n (%)  109 (7.1)  63 (6.7)  317 (8.4)  5,932 (10.9) 
Number of visits, Md (IQR)  2  (1-3)  2 (1-3)  2 (1-3)  2 (1-2) 
Days in hospital, Md (IQR)  6 (3-14)  6 (3-11)  5 (2-10)  4 (2-7) 
Pneumonia, n (%)  560 (8.8)  307 (4.5)  1,332 (3.3)  23,376 (2.4) 
Age at diagnosis             
0-11 months, n (%)  121 (21.6)  67 (21.8)  225 (16.9)  3,562 (15.2) 
12-35 months, n (%)  270 (48.2)  150 (48.9)  656 (49.2)  11,799 (50.5) 
36-84 months, n (%)  169 (30.2)  90 (29.3)  451 (33.9)  8,015 (34.3) 
Number of visits, Md (IQR)  1 (1-2)  1 (1-2)  1 (1-2)  1 (1-2) 
Days in hospital, Md (IQR)  5 (3-10)  4 (1-6)  4 (2-7)  4 (2-5) 
             
Statistical differences were tested by Pearson's chiǦsquare test or by Welch test.  
IQR, interquartile range; Md, median 
 
Table 6.  The distribution of LRTI diagnoses with viral or bacterial etiology between years 1996Ǧ
2008 (N = 709,534). 
 
  Very preterm 
<32 wk 
 (n=4,549) 
 Moderately 
preterm  
32+0-33+6 wk  
(n=4,859) 
 Late preterm  
34+0-36+6 wk 
(n=28,151) 
 Term 
≥37 wk 
(n=671,975) 
 Total 
(n=709,534) 
  n %  n %  n %  n %  n % 
                
RSV pneumonia 
(J12.1) 
 13 (0.3)  3 (0.1)  21 (0.1)  250 (0.04)  287 (0.04) 
Other viral 
pneumonia (J12) 
 37 (0.8)  18 (0.4)  77 (0.3)  874 (0.1)  1,006 (0.1) 
Bacterial 
pneumonia  
(J13-18) 
 441 (9.7)  257 (5.3)  1,104 (3.9)  20,140 (3.0)  21,942 (3.1) 
RSV bronchiolitis 
(J21.0) 
 378 (8.3)  230 (4.7)  850 (3.0)  10,353 (1.5)  11,811 (1.7) 
Viral or bacterial 
wheezing 
bronchitis (J21.9) 
 712 (15.7)  454 (9.3)  1,822 (6.5)  25,579 (3.8)  28,567 (4.0) 
                
Statistical differences were tested by Pearson's chiǦsquare test. 
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Figure 8.  Cumulative incidences of hospital admissions for LRTIs per 1000 births by seven years of 
age in relation to GA group at birth, birth years 1991Ǧ2008 (N = 1,018,256). 
 
Among infants born at ≥37 weeks of gestation, the rates of hospital admission 
for LRTIs were highest in the early-term group (Table 7). Post-term children were 
admitted at an older age. The majority of all admissions because of LRTIs in all GA 
groups took place before the age of 36 months, representing approximately 90% of 
bronchiolitis/bronchitis and 65% of pneumonia admissions. 
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Table 7.  Hospital admissions for LRTIs up to the age of seven years among early-, full-, late- 
and post-term children, years 1991–2008 (N=965,203). 
 
   Early-term 
37+0–38+6 wk 
(n=181,667) 
 Full-term  
39+0–40+6  wk 
(n=546,845) 
 Late-term  
41+0–41+6  wk 
 (n=189,373) 
 Post-term 
≥ 42 wk 
(n=47,318) 
         
             
Acute bronchiolitis/bronchitis, 
n (%) 
 12,359 (6.8)  30,086 (5.5)  9,605 (5.1)  2,258 (4.8) 
Age at diagnosis, Md (IQR), in 
months  
 10  (4-21)  11 (4-21)  12 (4-23)  12 (4-24) 
0-11 months, n (%)  6,747 (54.6)  15,197 (50.5)  4,728 (49.2)  1,115 (49.4) 
12-35 months, n (%)  4,434 (35.9)  11,538 (38.4)  3,769 (39.2)  848 (37.6) 
36-84 months, n (%)  1,178 (9.5)  3,351 (11.1)  1,108 (11.5)  295 (13.1) 
Pneumonia, n (%)  5,012 (2.8)  12,926 (2.4)  4,372 (2.3)  1,066 (2.3) 
Age at diagnosis, Md (IQR), in 
months 
 25 (15-43)  25 (15-43)  26 (15-44)  27 (16-45) 
0-11 months, n (%)  828 (16.5)  1,965 (15.2)  621 (14.2)  148 (13.9) 
12-35 months, n (%)  2,452 (48.9)  6,599 (51.1)  2,231 (51.0)  517 (48.5) 
36-84 months, n (%)  1,732 (34.6)  4,362 (33.7)  1,520 (34.8)  401 (37.6) 
             
Statistical differences were tested by Pearson’s chi-square test or the Kruskal-Wallis test.  
IQR, interquartile range; Md, median 
 
5.3.2 Predictors for bronchiolitis/bronchitis and pneumonia 
5.3.2.1 Association of gestational age at birth 
In the fully adjusted models, compared with the term group, very preterm, MP and 
LP birth were associated with bronchiolitis/bronchitis (very preterm OR 3.33; 95% 
CI 3.09Ǧ3.59, MP 1.89; 1.75Ǧ2.03, LP 1.51; 1.45Ǧ1.56) and pneumonia (very preterm 
OR 2.59; 95% CI 2.32–2.89, MP 1.49; 1.32Ǧ1.67, LP 1.25; 1.18Ǧ1.33) admissions. 
Among infants born at ≥37 weeks of gestation, early-term birth was associated 
with an increased risk of admission for bronchiolitis/bronchitis (OR 1.23, 95% CI 
1.20, 1.25) and pneumonia (OR 1.16, 95% CI 1.12, 1.20), while late-term (OR 0.93, 
95% CI 0.91, 0.95) and post-term births (OR 0.89, 95% CI 0.85, 0.93) were 
associated with a decreased risk of bronchiolitis/bronchitis admission. 
5.3.2.2 Common risk factors in all gestational age groups and among term-born 
children 
In risk factor analyses regarding the whole study population, in the fully adjusted 
models, maternal smoking during pregnancy (adjusted OR 1.47; 95% CI 1.44–1.50), 
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being first-born (1.74; 1.14–1.21), birth by cesarean section (1.15; 1.13–1.18), male 
sex (1.61; 1.58–1.64), being born SGA (1.09; 1.03Ǧ1.15), admission to a neonatal unit 
(1.24; 1.20Ǧ1.29), ventilator therapy (1.27; 1.18Ǧ1.36) and neonatal antibiotic therapy 
(1.15; 1.09Ǧ1.20) were associated with an increased risk of hospital admissions for 
bronchiolitis/bronchitis. Weaker associations were found between hospital 
admissions for pneumonia and perinatal and neonatal factors. Maternal smoking 
(1.10; 1.07–1.14), birth by cesarean section (1.08; 1.04–1.12), male sex (1.13; 1.10Ǧ
1.16), admission to a neonatal unit (1.21; 1.15Ǧ1.27) and ventilator therapy (1.32; 
1.19Ǧ1.46) were associated with pneumonia. 
When analyzing infants born at ≥37 weeks of gestation, young maternal age (<20 
years), maternal smoking, male sex, cesarean section, ventilator therapy and neonatal 
antibiotic therapy were associated with an increased risk of admission for all LRTIs. 
Being first-born, SGA and having a low 1-min Apgar score predicted admission for 
bronchiolitis/bronchitis. Being born in a level II hospital and in the Northern region 
reduced the risk of admission for all LRTIs. Higher maternal age (>31 years) and 
being a twin were associated with a decreased risk of admission for 
bronchiolitis/bronchitis.  
In the post-term subgroup, maternal smoking, birth in other than the Northern 
region, ventilator therapy and neonatal antibiotic therapy were associated with an 
increased risk of all admissions for LRTIs. Young maternal age (<20 years), being 
first-born and male sex remained risk factors for admission for 
bronchiolitis/bronchitis. No significant association was found between birth by 
cesarean section and LRTIs. 
5.4 Summary of the results (I-IV) 
The results of the study are shown in Figure 9 as cumulative incidences of respiratory 
morbidity (asthma, bronchiolitis/bronchitis and pneumonia) and atopic dermatitis. 
There is a decreasing trend in the cumulative incidences of respiratory morbidity 
with increasing GA. Conversely, the cumulative incidence of atopic dermatitis shows 
slight increasing trend with increasing GA. 
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Figure 9.  Cumulative incidences of respiratory morbidity and atopic dermatitis per 1000 births by 
seven years of age in relation to gestational age week at birth in 1991-2008. 
 
The results of the associations of respiratory morbidity and atopic dermatitis 
according to different preterm GA groups compared with the term group (≥37 
weeks) are summarized in Table 8 and according to term sub-groups compared with 
the full-term group (39+0-40+6) are summarized in Table 9. 
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Table 8.  Summary of the results from separate multivariable models: The associations of 
respiratory morbidity and atopic dermatitis by seven years of age with birth in preterm 
GA group using term (≥37 weeks) group as reference (adjusted HR/OR, 95%CI), 
years 1991Ǧ2008 (N = 1 018 256). 
 
   
Very preterm  
<32 wk 
(n=6,329) 
  
Moderately preterm  
32+0Ǧ33+6 wk 
(n=6,796) 
 
  
Late preterm  
34+0Ǧ36+6 wk  
(n=39,928) 
  
Term 
≥37+0 wk  
(n=965,203) 
 
  n OR/HR 
(95% CI) 
 n OR/HR 
(95% CI) 
 n OR/HR 
(95% CI) 
 n OR/HR (95% 
CI) 
 
              
Asthma1  979 3.18  
(2.92-3.47) 
 543 1.77  
(1.61-1.94) 
 2,259 1.40  
(1.34-1.46) 
 36,210 1.00   
Atopic 
dermatitis1 
 249 0.64  
(0.56–0.74) 
 283 0.67  
(0.59–0.76) 
 1,864 0.84  
(0.79–0.88) 
 49,795 1.00   
Bronchiolitis/ 
bronchitis2 
 1,542    3.33  
(3.09Ǧ3.59) 
 942 1.89  
(1.75-2.03) 
 3,796 1.51  
(1.45-1.56) 
 54,308 1.00   
Pneumonia2  560 2.59  
(2.32–2.89) 
 307 1.49  
(1.32-1.67) 
 1,332 1.25  
(1.18-1.33) 
 23,376 1.00   
              
1 Cox regression multivariable model, results given as the HRs and 95% CIs (Study I)  
2 Multivariable generalized linear mixed model, results given as the ORs and 95% CIs (Study III-IV) 
 
 
Table 9.  Summary of the results from separate multivariable models: The associations of 
respiratory morbidity and atopic dermatitis by seven years of age with birth in term 
sub-groups using full-term (39+0-40+6) group as reference (adjusted OR, 95%CI), years 
1991Ǧ2008 (N = 965,203). 
 
   
Early term 
37+0-38+6 wk  
(n=181,667) 
 
  
Late term  
41+0-41+6 wk 
(n=189,373) 
  
Post term  
≥42 wk 
(n=47,318) 
  
Full-term 
39+0-40+6 wk  
(n=546,845) 
 
  n OR (95% CI)  n OR (95% 
CI) 
 n OR (95% 
CI) 
 n OR (95% CI)  
              
Asthma  8,166 1.20  
( 1.17Ǧ1.23) 
 6,330    0.91  
(0.89Ǧ0.93) 
 1,534    0.87  
(0.83Ǧ0.92) 
 20,180 1.00   
Atopic 
dermatitis 
 9,359 0.99  
(0.96Ǧ1.01) 
 9,836    0.99  
(0.99Ǧ1.04) 
 2,568    1.06  
(1.01Ǧ1.10) 
 28,032 1.00   
Bronchiolitis/ 
bronchitis 
 12,359 1.23  
(1.20-1.25) 
 9,605    0.93  
(0.91-0.95) 
 2,258    0.89  
(0.85-0.93) 
 30,086 1.00   
Pneumonia  5,012 1.16   
(1.12-1.20) 
 4,372    0.98  
(0.95-1.01) 
 1,066    0.96  
(0.90-1.02) 
 12,926 1.00    
              
Multivariable generalized linear mixed model, results given as the ORs and 95% CIs (Study III-IV)  
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6 DISCUSSION 
6.1 Asthma and atopic dermatitis (I, III) 
In this large national register study, the overall frequency of asthma medication 
reimbursement and hospital visits due to asthma by seven years of age corresponded 
to the expected rate in Finland (Current Care Guidelines 2012). The significant 
finding was that MP and LP children received reimbursement for asthma medication 
and needed hospital care due to asthma more often than the term controls but less 
frequently than very preterm children by seven years of age. These findings are in 
accordance with previous reports on the association between MP and LP birth and 
asthma in childhood (Been et al. 2014; Harju et al. 2015; Trønnes et al. 2013). The 
present study also found a decreasing trend of GA in the frequency of asthma 
medication reimbursement and the need for hospital visits due to asthma by seven 
years of age in children born at ≥37 weeks of GA. After controlling for several 
perinatal and neonatal confounding factors, early-term birth was associated with an 
increased risk of asthma, whereas late- and post-term births appeared to reduce this 
risk. The finding of an increased risk of asthma in early-term children is in 
accordance with previous studies (Vogt et al 2011; Boyle et al. 2012; Edwards et al. 
2015; Harju et al. 2014). Moreover, in a large Swedish cohort study, early-term 
children had an increased risk of inhaled corticosteroid use, evaluated by registered 
drug retrievals, compared with those born at 39-41 weeks of gestation (Vogt et al. 
2011). A previous Finnish hospital-based register study found that the burden of 
asthma in children was particularly associated with deliveries at 37-38 weeks of 
gestation (Harju et al. 2014). In the Millenium Cohort Study in the UK, the incidence 
of asthma and wheeze was increased at three and five years of age in MP, LP and 
early-term compared with term children, as was the risk of needing asthma treatment 
with increasing prematurity (Boyle et al. 2012). It may be explained by that both 
spontaneous and iatrogenic preterm and early-term deliveries have common causes 
and that there are similar exposures to postnatal treatments such as those needed for 
neonatal respiratory problems (Sengupta et al. 2013). In the current study, post-term 
birth was associated with a decreased risk of early childhood asthma despite the 
increased frequency of neonatal respiratory problems defined as the need for 
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ventilator therapy in the post-term group. Similar findings among late-term (Harju 
et al. 2014) and post-term (Leung et al. 2016) children have previously been reported. 
This seems to represent part of a continuum of the first study, in which the decreased 
risk of asthma was associated with increasing GA from very preterm birth to term, 
possibly due to continuous intrauterine maturation of the airways. 
Of all children followed up to the age of seven years, 5.1% needed hospital care 
due to atopic dermatitis, which represents those children with a more severe disease 
needing specialized care consultation or treatment. The true incidence of atopic 
dermatitis could not be analyzed in the present cohort due to the lack of data on 
cases of mild atopic dermatitis usually diagnosed and treated in the primary health 
care system at this age group. Risk factors for severe disease may be different than 
those for mild and moderate diseases. The important finding of the present study is 
that hospital visits due to atopic dermatitis became more frequent with increasing 
GA, and post-term birth emerged as a risk factor for hospital visits due to atopic 
dermatitis. In accord with these results, others have observed an increased risk of 
atopic dermatitis with increasing GA and the risk may be reduced in children born 
preterm (Barbarot et al. 2013; Zhu et al. 2018). Instead, a previous prospective 
follow-up study on 609 children (193 preterm and 416 term) found no difference in 
the prevalence of atopic dermatitis between preterm and term children in the first 
two years of life (Kvenshagen et al. 2009). Supporting the results of the present study, 
an increased risk of atopic dermatitis by school age in children born post-term was 
seen in a large Norwegian birth cohort study (Trønnes et al 2013). 
The findings in the first study suggest that some peri- and neonatal risk factors 
for asthma are the same in all GA groups (e.g., maternal smoking during pregnancy, 
male sex) and some differ in term and preterm groups (e.g., ventilator therapy). This 
supports the concept of different asthma etiologies in preterm and term infants 
(Halvorsen et al. 2005). The first study found that asthma was more common in 
preterm children while atopic dermatitis was more frequent in term children 
suggesting that assisted ventilation could induce non-allergic asthma. In other words, 
asthma in preterm children might be associated with neonatal respiratory 
complications, reduced airway size, and decreased lung function (Havoresn et al 
2005). Some of the risk factors were previously well described, such as male sex, 
maternal smoking and birth by cesarean section. Maternal diabetes seemed to be 
associated with asthma in the MP group and this finding may also be related to other 
underlying factors that complicate diabetic pregnancy (Rusconi et al. 2017). 
Accordingly, among term subgroups of children, from a population point of view, 
the most relevant risk factors for asthma were male sex, atopic tendency, maternal 
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smoking during pregnancy and elective cesarean section, and those of atopic 
dermatitis were male sex, being first-born, birth in a level II hospital, and birth by 
emergency cesarean section. Among term subgroups of children, hospital visits due 
to atopic dermatitis were used as a surrogate for severe atopic tendency in the risk-
factor analyses for asthma. There are only a few previous studies evaluating the 
association of antibiotic therapy during the first week of life and the risk of asthma 
or atopic dermatitis (Goksör et al. 2013; Raymond et al. 2017; Stromberg et al. 2018). 
The present study found an association between antibiotic therapy and both asthma 
medication reimbursement and atopic dermatitis, suggesting long-lasting effects of 
neonatal antibiotic exposure. However, this risk factor was not very relevant from a 
population point of view among term subgroups, having low PAR% values. Birth in 
a level II hospital was associated with a decreased risk of the need for asthma 
medication in all GA groups, probably because high-risk infants, who need invasive 
treatments, are more commonly born in level III hospitals. In contrast, birth in other 
than a level III or level II hospital seemed to decrease the risk of atopic dermatitis. 
6.2 Lower respiratory tract infections (II, IV) 
In this large cohort, the associations between GA and LRTI hospitalization were 
detected both in incidences and adjusted ORs. The clinical pictures of LRTIs may 
overlap and it is especially challenging to differentiate between diagnoses of 
bronchiolitis and wheezing bronchitis. As in many previous studies, we analyzed 
bronchiolitis and wheezing bronchitis together. In the present study, 6% of all 
children were hospitalized because of bronchiolitis/bronchitis by the age of seven 
years, about half of them by 12 months of age. This is in accordance with previous 
reports, which shows that 2-3% of all children were hospitalized because of 
bronchiolitis during their first year of life (Green et al. 2016). In all, 2.5% of all 
children were admitted for pneumonia by seven years of age. The true incidence of 
pneumonia could not be analyzed in this cohort due to the lack of data on cases of 
pneumonia diagnosed and treated in primary health care settings. Current hospital 
admission rates due to pneumonia are in accordance with the reported annual 
incidence of community-acquired pneumonia ranging from 0.2-0.33% to 3.5-4% in 
children of less than five years of age. Approximately half of the children with 
pneumonia at this age group are treated in hospital (McIntosh 2002; Tapiainen et al. 
2016).  
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The present study found that MP and LP children were more often admitted to 
hospital for LRTIs than term controls but less often than very preterm children up 
to the age of seven years. These results on the association between MP and LP birth 
and an increased incidence of hospital admissions for LRTIs are in line with previous 
findings (Miller et al. 2016, Parajonthy et al. 2013, Blanken et al. 2016, Vrijlandt et. 
al 2013). No data could be obtained on bronchiolitis confirmed by positive RSV 
tests, but the distribution of the ICD 10 diagnoses supports the previous findings 
on the increased risk of hospital admission for RSV in children born MP and LP 
(Helfrich et al. 2015). Susceptibility to LRTIs during infancy in children born MP 
and LP might be a consequence of preterm birth and immature development of the 
immune system and the lungs (Pike et al. 2015). 
The major finding among term subgroups of children was that early-term birth 
emerged as a risk factor for hospital admission for all LRTIs up to seven years of 
age, while increasing GA, as well as late- and post-term birth, were associated with a 
decreased risk of admission for bronchiolitis/bronchitis. These results on the 
association between early-term birth and the risk of hospital admission for LRTIs 
support previous findings (Tickell et al. 2016; Walfisch et al. 2017; Miller et al. 2016). 
In a large Australian register study, increased relative risks of admission for LRTIs 
by 18 years of age were found in children born at 37-38 weeks, whereas birth at 41 
weeks or later was associated with modestly reduced rates of admissions (Miller et 
al. 2016). Similarly, the present study also found lower rates of admission for all 
LRTIs in children born late- and post-term. This association could be partly 
explained by continuous intrauterine maturation of the airways. On the other hand, 
the last weeks of gestation represent a critical period of lung growth and 
development with both short- and long-term health consequences in early-term 
infants (Colin et al. 2010; Pike et al. 2015). 
The perinatal and neonatal risk factors for hospital admissions for LRTIs among 
the whole study population included maternal smoking, cesarean delivery, male sex, 
admission to a neonatal unit and ventilator therapy. In addition, being first-born, 
being born SGA, and neonatal antibiotic therapy were associated with 
bronchiolitis/bronchitis. Generally, hospital admissions for pneumonia showed 
weaker associations with perinatal and neonatal factors. Among term subgroups of 
children, several maternal and perinatal factors remained risk factors for LRTIs after 
exclusion of preterm infants and those with congenital anomalies. The most relevant 
risk factors for admission for LRTIs were maternal smoking during pregnancy, 
cesarean section, male sex, neonatal ventilator therapy and early antibiotic therapy. 
Infants admitted to a neonatal unit are usually those suffering from early neonatal 
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respiratory morbidity or infections, and this could explain the association with an 
increased risk of LRTIs. Differences in early microbial exposure related to the mode 
of delivery may also have an impact on immunomodulation. Studying respiratory 
outcomes after early-term birth is confounded by higher rates of deliveries by 
cesarean section in this GA group (Kotecha et al. 2016). Current results suggest that 
both early-term birth and cesarean delivery are independent risk factors for 
admission for LRTIs. Interestingly, no association was found between cesarean 
delivery and LRTIs in the post-term subgroup. This could be explained by the higher 
rate of elective cesarean section in the early term group, and emergency cesarean 
section was most frequent in the post-term group. Infants born by elective cesarean 
delivery are exposed differently to maternal hormones and microbiota compared 
with those born by vaginal delivery, and these differences could predispose the infant 
to an adverse respiratory outcome (Indraccolo et al. 2019). The process of labor may 
promote the production of various cytokines and activate the immune system 
(Moore et al. 2012). The indication of caesarean delivery could also be a reflection 
of other risk factors influencing the outcome. Data on underlying reason for the 
obstetric intervention were not available in the present register study. Interestingly 
and in contrast to the results of a previous study (Lodge et al. 2014), in the present 
study, first-born children had an increased risk of bronchiolitis/bronchitis, but this 
association was not seen for pneumonia. It is suggested that children with older 
siblings suffer from more respiratory infections than first-born children, but on the 
other hand, children with older siblings may experience an earlier immune 
maturation and a subsequent improved resistance against infections later in 
childhood (Vissing et al. 2018). This might also be related to the suggestion that first-
born children may have a reduced anti-inflammatory profile in their T-cells at birth 
and thus an enhanced risk of later developing immune-related diseases (Kragh et al. 
2016). 
6.3 Strengths and limitations (I-IV) 
The study population was substantial consisting of 98% of all infants born between 
1998 and 2008 in Finland. The strengths of this study are the reliable national 
population-based well established and validated register data (Gissler et al. 1995; 
Gissler et al 1998; Gissler & Sheleley 2002; Sund & Lahti 2012). By using this large 
register data in the present study, it was possible to explore common childhood 
diseases and take into account many confounding peri- and neonatal factors, which 
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is challenging in clinical settings. In Finland, public healthcare is easily accessible to 
all and all children’s hospitals are public. Therefore, in this age group all hospital 
admissions for asthma and atopic dermatitis, as well as LRTIs, can be derived reliably 
from the registers. In Finnish guidelines, an asthma diagnosis made by a pediatrician, 
is required to qualify for medication reimbursement. The KELA database is held as 
a valid source of prevalence data and affords researchers the ability to accurately 
identify asthma cases in the general population (Nwaru et al. 2011). Due to 
difficulties in ascertaining the diagnosis of asthma in infants, asthma medication 
reimbursement was used, a parameter based on national criteria, as the main 
outcome measure in the risk factor analyses. The primary health care data were not 
available in this study, but the asthma medication reimbursements cover all asthma 
diagnoses, including those made in primary health care settings. 
The current study has some limitations. The recording practices for 
administrative health register data may vary among staff and regions and over time 
periods. During the earlier years of the catchment period the diagnosis and treatment 
of asthma in young children aged less than five years differed from the current 
practice. Regional variations between hospital districts in the diagnosis and treatment 
of childhood asthma also existed based on a previous research in Finland (Virta & 
Mäki 2003). The national asthma program in 1994 emphasized earlier diagnosis and 
active treatment with inhaled corticosteroids also in young children. Since 1995 
asthma medication reimbursement was granted for children aged less than five years 
when the need of regular maintenance medication was considered to continue at 
least for six months. After releasing more precise diagnostic criteria for pediatric 
asthma, the number of children receiving reimbursements for asthma medication 
was reduced in the early 2000s and turned downwards during the recent decade 
(Haahtela et al. 2013). In spite of differences in the treatment practices over the time 
periods, the GA groups were comparable throughout the study period in the present 
study setting. 
In this study the infants, who died before one year of age were excluded. It is 
possible that this changes the composition of the surviving preterm population in 
terms of the risk of asthma and atopic dermatitis. This can be regarded as a weakness. 
However, most of the mortality in very preterm infants usually occurs already during 
the neonatal period. The current study did not take into account children, who 
emigrated during the study period. According to Statistics Finland the proportion of 
children aged 0-14 years who emigrated from Finland during the years 1987-2014 
was low, approximately 0.1-0.2% (Kivijärvi & Peltola 2016). 
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Some unknown confounding factors may exist in the large register data. Because 
of the study design, children born in the most recent years of the study period had 
shorter follow-up times than those born in earlier years. However, the median age at 
first reimbursement for asthma medication was 2.0-2.9 years, and approximately 
90% of admissions for bronchiolitis/bronchitis and 65% of those for pneumonia 
occurred before the age of three and most infants were followed up for longer than 
that. No data were obtained on parental asthma, indications for cesarean delivery, 
psychosocial factors, duration of breastfeeding, postnatal smoke exposure, or other 
environmental conditions. Reliable data on maternal socioeconomic status were also 
unavailable. However, the information on maternal smoking can be regarded as a 
surrogate marker of SES, because smoking during pregnancy correlates strongly with 
lower maternal SES in Finland (Rumrich et al. 2018). Generally, it is a time-
consuming process of acquiring permissions and data collection with linkages 
preceding access to national health data, and this creates a gap between follow-up 
time and published data. 
6.4 Implications for clinical practice 
Much is still unknown about the risk factors for childhood asthma, atopic dermatitis 
and LRTIs, but the current results suggest that early-life exposures seem to play an 
important role. Methods of affecting significant underlying risk factors should be 
considered. Avoidance of smoking during pregnancy and following strict indications 
for cesarean delivery may improve the respiratory outcome of the offspring. 
Minimizing the duration and invasiveness of ventilator therapy might be beneficial 
for all infants with respect to later risk of asthma or LRTIs. Indications to use 
antibiotics during the neonatal period should be considered. 
Recently updated Finnish guidelines recommend administration of antenatal 
corticosteroids to women at risk for delivery at 35+0-36+6 weeks to reduce the rate 
of neonatal respiratory complications and in cases of elective cesarean delivery 
(Current care guidelines 2018). All infants, especially MP and LP born infants, should 
be properly monitored after birth for the possible complications without interfering 
normal adaptation. Family centered care, encouraging mothers for breastfeeding and 
parents for providing early skin-to-skin contact is important also for preterm infants. 
 80 
6.5 Challenges for future research 
As the results the of this study revealed, children born MP, LP and early-term are at 
risk of long-term respiratory morbidity in childhood, and many peri- and neonatal 
factors are associated with this risk. In the field of perinatal care, it is still important 
to develop methods for identifying fetal risks and the timing of delivery according 
to the competing risks of continuing pregnancy and possible consequences of 
preterm or early-term delivery. Strict medical indications for elective induction of 
labor and elective cesarean section should be addressed and followed. Trials on cases, 
where elective cesarean section cannot be avoided, are needed and going on, in order 
to find ways to modulate the adverse effects of the elective cesarean section on the 
microbiome of the infant. It is a challenge to recognize whether there is a specific 
group of MP/LP and early-term infants at particular risk for later morbidity related 
to their GA at birth and to potentially target early intervention for these infants. In 
the field of neonatal care, a better understanding of how GA at birth affects the 
developing immune system and susceptibility to infection, and how extensive 
antibiotic treatment early in life affects the long-term outcome, including asthma, 
atopic dermatitis and LRTIs, are important points. Studying multifactorial diseases 
is challenging since it is important to adequately control for the known confounders 
and to find out new relevant connections. In addition, future studies are needed 
concerning long-term consequences after MP/LP and early-term birth in 
adolescence and adulthood (Kajantie et al. 2019). It still remains partly unclear why 
preterm infants have a reduced risk of atopic dermatitis compared with term-born 
infants and why post-term birth may increase this risk, and future research should 
further explore potential pathways behind this.  
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7 CONCLUSIONS 
The following conclusions can be drawn on the basis of the present register linkage 
follow-up study: 
1. Children born moderately preterm (MP) and late preterm (LP) received asthma 
medication reimbursement and were hospitalized due to asthma more often than 
term controls but less frequently than very preterm children. There is a decreasing 
trend in hospital visits due to asthma with increasing gestational age (GA). 
Conversely, the incidence of hospital visits due to atopic dermatitis rises with 
increasing GA. Male sex, maternal smoking, maternal diabetes, and ventilator 
therapy were associated with asthma medication in the MP and/or LP children. 
2. Children born MP and LP were admitted to hospital for lower respiratory tract 
infections (LRTIs) more often than the term controls but less frequently than very 
preterm children. Preterm children had longer hospital stays due to 
bronchiolitis/bronchitis. These results suggest that, in addition to very preterm birth, 
MP and LP births also have a significant impact on the use of healthǦcare services 
due to LRTIs. Associated risk factors for LRTIs included maternal smoking, birth 
by cesarean section, male sex, admission to a neonatal unit and ventilator therapy. 
3. Early-term birth was a predictor of asthma, and post-term birth was associated 
with an increased risk of atopic dermatitis. Late- and post-term births appeared to 
be associated with a decreased risk of asthma compared with full-term birth. The 
most relevant risk factors for asthma were male sex, smoking during pregnancy, and 
birth by elective cesarean section, while for atopic dermatitis, the most relevant risk 
factors were male sex, being first-born, birth in a level II hospital, and birth by 
cesarean section. 
4. Early-term birth was associated with increased rates and risk of hospital 
admission for all LRTIs, while late- and post-term birth reduced the risk of 
admission for bronchiolitis/bronchitis compared with full-term birth. Modifiable 
risk factors for LRTIs were smoking during pregnancy, elective cesarean delivery, 
ventilator therapy and neonatal antibiotic therapy. 
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Abstract  
This national register study aimed to evaluate the need of asthma medication reimbursement and hospitalization due to 
asthma and atopic dermatitis up to 7 years of age in moderately preterm (MP) (32-33 weeks) and late preterm (LP) (34-
36 weeks) children compared to very preterm (VP) (< 32 weeks) and term (37 weeks) children. Altogether 1 018 302 
children born in Finland between 1991 and 2008 were assessed.  
The MP and LP groups received asthma medication reimbursement more frequently than term controls (8.0% and 5.7% 
vs. 3.8%), but less frequently than VP children (15.4%). Hospitalization due to asthma was more common among MP 
(10.6%) and LP (7.3%) children than term children (4.8%) but less common than in VP children (20.1%). 
Hospitalization due to atopic dermatitis was more frequent among term (5.2%) compared to MP (4.2%) and LP (4.7%) 
children. Male sex, maternal smoking, maternal diabetes and ventilator therapy predicted asthma medication in the MP 
and/or LP children. 
Conclusion: MP and LP children seem to need medication and hospitalization for asthma more often than term controls 
but less frequently than VP children followed by 7 years of age. Hospitalization due to atopic dermatitis becomes more 
common with increasing gestational age.  
Keywords: asthma, atopic dermatitis, moderately preterm, late preterm, preterm 
Abbreviations: AGA - appropriate for gestational age; AHR - airway hyper-responsiveness; GA - gestational age; 
LGA - large for gestational age; LP - late preterm; MP - moderately preterm; MBR- medical birth register; PROM - 
premature rupture of membranes; SD - standard deviation; SGA - small for gestational age; VP- very preterm 
What is Known:  
x MP and LP infants have an increased risk for early respiratory morbidity and to asthma. 
x Less is known on the occurrence of atopic dermatitis in this patient group. 
 What is New:  
x Medication and hospital care due to asthma were more frequent in school-aged MP and LP than in term 
infants. Male sex, maternal smoking, maternal diabetes and ventilator therapy predicted asthma. 
x Hospitalization due to atopic dermatitis became more common with increasing gestational age. 
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Introduction 
 
Moderately and late preterm (MP and LP) children born at 32-36 weeks of gestational age (GA) currently constitute 
over 80% of all preterm births [31]. These infants have an increased risk of early respiratory morbidities such as 
respiratory distress syndrome and transient tachypnea of the newborn compared to term infants [8].  
Asthma and atopic dermatitis are common problems in childhood. Fetal and perinatal exposures are thought to have a 
role in the development of these diseases [4,23]. An association between extremely preterm birth and chronic 
respiratory morbidity, including asthma, has been established [5]. Asthma and airway hyper-responsiveness (AHR) 
subsequent to extremely premature birth seem to differ from typical childhood asthma, showing more association with 
neonatal respiratory problems and oxygen therapy than with current inflammation [15]. Few studies have evaluated the 
development of asthma in MP and LP children compared to children born VP and term [5,6,16,36]. Atopic dermatitis is 
the most common inflammatory condition in children [4]. Prematurity has been linked to a decreased long-term risk of 
atopic sensitization [32] and atopic dermatitis [4], but the findings are inconsistent [22].  
We aimed to: 1) evaluate the association between moderately and late preterm birth and the risk of asthma and severe 
atopic dermatitis and 2) to compare the peri- and neonatal risk factors for asthma and atopic dermatitis by school age 
among VP, MP, LP and term groups. We assumed that the risk factors of childhood asthma might differ according 
to the degree of prematurity. 
 
Materials and methods 
 
The national register-based population was acquired from the Medical Birth Register (MBR). Data on deaths were 
obtained from the Cause of Death Register and data on major structural anomalies and chromosomal defects [9] from 
the Register of Congenital Malformation. The data collection has been explained in detail in our previous publication 
[17]. Altogether 1 039 263 infants were born alive in Finland between 1991 and 2008. Infants who died before 1 year of 
age (n=2 576, 0.25%), had major congenital anomalies (n=13 007, 1.25%) or had missing data on GA (n= 5 520, 0.5%) 
were excluded. The remaining 1 018 302 (98.0%) cases were analyzed in VP (< 32+0 weeks, n=6 347, 0.6%), MP (32+0-
33+6 weeks, n=6 799, 0.7%), LP, (34+0-36+6 weeks, n=39 932, 3.9%) and term (37 weeks, n=965 224, 94.8%) groups. 
Infants were followed up to 7 years of age or to 2009. Data on all specialized health care outpatient (since 1998) and 
inpatient visits in public hospitals were collected from the Hospital Discharge Register. A child was considered to have 
the disease if the following diagnosis was recorded in the register by the end of 2009 (International Classification of 
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Disease 9th Revision ICD-9 in the years 1991-1995 and 10th Revision ICD-10 in the years 1996-2008): asthma (493 and 
J45, J46), atopic dermatitis (691.8, L20.0) or dermatitis due to ingested food (693.1, L27.2). It was not possible to 
differentiate between primary and secondary diagnoses. Data on children entitled to asthma medication reimbursement 
were collected from Finland's Social Insurance Institution database. To be eligible for the reimbursement, a patient must 
provide a doctor’s certificate confirming that asthma has been diagnosed according to the National Finnish Current Care 
Guidelines [2]. We defined an asthma case as a child who had asthma medication reimbursement recorded. Register 
data were linked with a unique anonymized identification code.  
 
Only variables with good validity in the registers were included in the analysis [11,33]. As possible confounders for the 
associations between GA groups and asthma and atopic dermatitis, we included maternal and delivery related factors 
(age, smoking, first delivery, diabetes, assisted reproduction technology, antenatal steroid, number of fetuses, premature 
rupture of membranes (PROM), level of hospital, mode of delivery) and newborn related factors (sex, gestational 
weight, admission to neonatal unit, ventilator and antibiotic therapy). 
The GA was based on early pregnancy ultrasound, which was nationally used during the study period. A correction of 
GA was made if the ultrasound-based estimation had a discrepancy of more than 5-7 days compared to last menstrual 
period [11]. Maternal smoking included smoking during pregnancy and diabetes included mother’s gestational diabetes 
and type 1 and 2 diabetes. Small for GA (SGA) infants were defined as those with a birth weight more than 2.0 standard 
deviation (SD) below the average for GA and large for GA (LGA) infants as those with a birth weight more than 2.0 SD 
over the mean weight for GA [28]. PROM was defined as onset of labour more than 24 hours after rupture. 
 
Statistical analysis 
 
The background parameters of the study population and differences between the GA groups were tested in categorical 
variables by Pearson’s chi-square test or Fisher’s exact test and in continuous variables by Mann-Whitney test. Risk 
factors for asthma medication reimbursement and hospital visits due to atopic dermatitis in each GA group were sought 
by Cox logistic regression analysis using multivariate enter models in which all variables were entered simultaneously 
into the model for each GA category (Table 3, 4). The association between GA groups and asthma medication 
reimbursement or hospital visits due to atopic dermatitis was studied by adjusting the multivariate model by GA 
categories, using term group as reference. Results were expressed as hazard ratios (HR) and 95% confidence intervals 
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(95% CI). Statistical analyses were performed on IBM SPSS Statistics version 20.0.0 (SPSS, Chicago, Illinois). P-
values <0.05 were considered statistically significant. 
 
Results 
 
The characteristics of infants and their mothers’ are presented in Table 1. Of all 1 018 302 children followed-up to the 
age of 7 years, 39 991 (3.9%) received reimbursement for asthma medication, 51 532 (5.1%) needed hospital care due 
to asthma and 52 191 (5.1%) due to atopic dermatitis. The frequencies of asthma medication reimbursement and 
hospital visits due to asthma increased with decreasing GA (Table 2). All preterm groups received the first 
reimbursement at younger ages compared to term children. The nonlinear decreasing trend in the incidence of hospital 
visits due to asthma with increasing GA and the steepest decline at 30-32 weeks’ gestation is shown in Figure 1. In the 
multivariate risk factor analyses male sex and ventilator therapy increased the risk of asthma medication reimbursement 
among all preterm groups and maternal smoking increased this risk among MP, LP and term children (Table 3). 
Maternal diabetes predicted asthma medication in the MP group. Independent HRs for asthma medication 
reimbursement compared to the term group were in the VP group 3.18 (95% CI 2.91-3.46), in the MP group 1.77 (95% 
CI 1.61-1.94) and in LP group 1.40 (95% CI 1.33-1.47).  
Hospital visits due to atopic dermatitis became more common with increasing GA (Table 2, Figure 1). Among children 
with asthma medication reimbursement (n = 39 991), the frequencies of hospital visits due to atopic dermatitis in the 
VP, MP, LP and term groups were 70 (7.2%), 59 (10.9%), 303 (13.4%) and 6318 (17.4%), respectively (p<0.001). The 
risk factor analyses for hospital visits due to atopic dermatitis showed a less strong association with peri- and neonatal 
factors (Table 4). Male sex predicted an increased risk of hospital visits among MP, LP and term children. Independent 
HRs for hospital visits due to atopic dermatitis compared to the term group were in the VP group 0.64 (95% CI 0.56-
0.74), in the MP group 0.67 (95% CI 0.59-0.76) and in the LP group 0.84 (95% CI 0.79-0.88). 
 
Discussion 
 
MP and LP children received reimbursement for asthma medication and needed hospital care due to asthma more often 
than term controls but less frequently than VP children by 7 years of age. Hospital visits due to asthma became less 
common and those due to atopic dermatitis more frequent with increasing GA. As expected, the risk factors for asthma 
were somewhat different across the GA groups. 
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Others have also reported the association between MP and LP birth and asthma in childhood [5,6,16,36]. A 
retrospective cohort study found persistent asthma and use of inhaled corticosteroids more often in LP infants by 18 
months compared to those born at term [12]. The incidence of asthma and wheeze was increased at 3 and 5 years of age 
in MP or LP compared with term children, as was the risk of needing asthma treatment with increasing prematurity [6]. 
By contrast, no association was found between LP birth and the risk of developing asthma in a population of 
approximately 500 LP infants aged 2-83 months [1]. 
Data on the prevalence of atopic dermatitis in premature children compared with term children are conflicting partly 
due to differences in study design. A prospective follow-up study found no difference in the prevalence of atopic 
dermatitis between preterm and term children in the first 2 years of life [22]. In accord with our results, others have 
observed an increased risk of atopic dermatitis with increasing GA [4,26,36]. 
Supporting previous work [13], we found an association between maternal smoking during pregnancy and asthma 
medication reimbursement of the child. Maternal daily smoking during pregnancy is relatively well covered in the 
Finnish MBR, though the data is based on self-reporting [19]. According to meta-analysis, exposure to prenatal 
smoking has increased the risk of wheezing in <6 year-old and the risk of wheezing or asthma in 6-year-old children 
[34]. Tobacco smoke exposure has an effect on fetal lung development. It may predispose the mother to preterm 
delivery [37], and thus increase the risk of early pulmonary problems of the infant. Postnatal exposure to smoking could 
not be established in our study.  Avoidance of smoking during pregnancy seems to be one means to improve the 
respiratory outcome of the offspring.  
In our study cesarean delivery appeared to be associated with an increased risk of asthma medication only in the term 
group. Contrary to previous results cesarean section also predicted atopic dermatitis in the term group [3]. Lack of 
influence of the maternal vaginal and intestinal flora on the infant’s gastrointestinal microbiota in cesarean sections may 
have a role in the development of asthma, atopy and allergy [4,18,23]. Preterm infants are more frequently delivered by 
cesarean section than term infants. In meta-analyses both cesarean delivery and prematurity have been associated with 
an increased risk of asthma [3,5,35]. 
Mechanical ventilation has been associated with an increased asthma risk after adjustment for GA [20]. Infants born 
very preterm may have insufficiently developed airways which makes them more prone to recurrent wheezing in early 
childhood [14]. Accordingly, our results on the increased asthma risk associated with ventilator therapy in MP and LP 
infants suggest that even slight prematurity may predispose an infant to harmful effects of mechanical ventilation. 
Minimizing the duration and invasiveness of ventilator therapy might be beneficial for all preterm infants with respect 
to later asthma risk. 
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We found maternal diabetes to signify a risk of needing asthma medication among MP children. Fetal exposure to 
hyperglycaemia affects lung growth and alveolization [21], may increase the risk of neonatal respiratory problems [25], 
and thus to the subsequent development of asthma. Maternal diabetes has predisposed the mother to premature delivery 
[7], causing a greater risk for surfactant deficiency at birth. Furthermore, high blood glucose levels may inhibit 
surfactant synthesis and secretion, most markedly in late gestation [25]. The asthma risk in the offspring may be 
diminished by achieving a good glucose balance in diabetic pregnancies.  
Antenatal steroid treatment predicted asthma risk among LP and term infants. Prenatal corticosteroid therapy has also 
previously been associated with childhood asthma, the association being strongest between 3 and 5 years of age [29]. 
The effects of corticosteroids on the hypothalamus-pituitary-axis, the immune function [30] as well as the effects on 
kidneys, and subsequent hypertension may have a role in the development of asthma [29].  
In our study firstborn children had a lower risk of asthma medication. They might be better protected from infectious 
epidemics possibly inducing wheeze. Supporting previous results [24], our MP and LP twins seemed to be less prone to 
develop asthma and atopic dermatitis than singletons. This finding needs to be confirmed in further studies. 
Birth in a level II hospital was associated with a decreased risk of needing asthma medication in all GA groups, 
probably because high-risk infants, who need invasive treatments, are more commonly born in level III hospitals. 
Supporting our results, male sex has increased the risk of asthma [36] and atopic dermatitis [26] in infancy and 
childhood.  
 
Our findings suggest that some peri- and neonatal risk factors for asthma are the same in all GA groups (e.g. maternal 
smoking, male sex) and some differ in full-term and preterm groups (e.g. ventilator therapy). This supports the 
conception of different asthma etiologies in premature and term infants [15]. Our finding that asthma was more 
common in preterm children, while atopic dermatitis was more frequent in term children suggests that assisted 
ventilation could induce non-allergic asthma.  
 
We found preterm children to need hospital care due to atopic dermatitis less frequently than term children, both in the 
whole study population and among children with asthma medication reimbursement. Antenatal exposures or earlier 
exposure to extrauterine environment may modulate the disease risk through influencing the Th1/Th2 balance [23]. The 
decreased risk of atopic dermatitis in VP children might also be related to their functionally impaired skin barrier 
resulting in early transcutaneous exposure to antigens and the development of tolerance or their reduced diversity of 
intestinal microflora [4]. 
8 
 
The limitation in register-derived data is the possible variation in recording practices. In our study children born after 
the year 2002 were followed up to 1 to 6 years of age. This might decrease the incidence of asthma during the latest 
study years. However, the median age at first reimbursement for asthma medication was 2.0-2.9 years. Thus, most 
infants were followed up longer than that. The primary health care data were not available in this study, but the asthma 
medication reimbursements covers all asthma diagnoses, including those made in primary health care. The information 
on ethnicity was not included, but the Finnish population is fairly homogenous. No data were obtained on parental 
asthma or atopy, maternal education or breastfeeding. It was not possible to differentiate non-atopic asthma from atopic 
asthma. Furthermore, the purchase of the asthma medication was not analyzed here.  
The strength of this study is an excellent health information system in Finland based on national registers of high 
quality and good coverage [10,11,33]. The present study population was substantial. In Finland, asthma diagnoses given 
by a pediatrician, preceded by the need of inhaled corticosteroid treatment for six months, is required to qualify for 
medication reimbursement [2]. Social Insurance Institution database is as a valid source of prevalence data and able to 
accurately identify asthma cases in the general population [27]. Due to the lack of private children’s hospitals in 
Finland, all hospital visits due to asthma and atopic dermatitis are derived reliably from the registers. Children 
hospitalized due to atopic dermatitis are those with a more severe disease needing specialized care consultation or 
treatment. Risk factors for severe disease may be different than those of mild and moderate disease.  
 
Conclusion 
 
MP and LP children appear to receive asthma medication reimbursement and to be hospitalized due to asthma more 
often than term controls but less frequently than VP children by 7 years of age. There is a nonlinear decreasing trend in 
hospital visits due to asthma with increasing GA. Instead, the incidence of hospital visits due to atopic dermatitis rises 
with increasing GA. Moderately and late preterm births might constitute prominent risk factors for the development of 
asthma and for increased health service use due to asthma in early childhood. Counselling against smoking during 
pregnancy and minimizing the harmful effects of neonatal mechanical ventilation may be means to decrease the risk of 
asthma in MP and LP children. 
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Figure 1. Incidences of hospital visits due to asthma and atopic dermatitis per 1 000 births by 7 years of 
age in relation to gestational age at birth, birth years 1991-2008 (N=1,018,302).  
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Abstract
Objective: To evaluate the frequency and predictors of hospital admissions for lower
respiratory tract infections (LRTIs) inmoderately preterm (MP, 32+0 to 33+6weeks) and
late preterm (LP, 34+0 to 36+6weeks) infants compared to term (T ≥37weeks) and very
preterm (VP, <32+0 weeks) infants.
Study Design: This national register-based study covered all infants born in Finland in
1991-2008. Data on 1 018 256 infants were analyzed in four gestational age-based
groups: VP (n = 6329), MP (n = 6796), LP (n = 39 928), and T (n = 965 203) groups. Data
on hospital admissions due to bronchiolitis/bronchitis and pneumonia were collected
up to the age of 7 years.
Results: Hospital admissions for LRTIs were more common in the MP and LP groups
than in the T group but less frequent than in the VP group: bronchiolitis/bronchitis (VP
24.4%, MP 13.9%, LP 9.5%, and T 5.6%) and pneumonia (VP 8.8%, MP 4.5%, LP 3.3%,
and T 2.4%). Compared to the term group, MP and LP birth predicted bronchiolitis/
bronchitis (MP OR 1.89; 95%CI 1.75-2.03, LP 1.51; 1.45-1.56) and pneumonia (MP
1.49; 1.32-1.67, LP 1.25; 1.18-1.33) admissions. Statistically significant risk factors for
LRTIs included maternal smoking, cesarean section, male sex, admission to a neonatal
unit and ventilator therapy. In addition, being first-born, being born SGA and neonatal
antibiotic therapy were associated with bronchiolitis/bronchitis.
Conclusions: MP and LP births, in addition to VP birth, have a significant impact on
respiratory infectious morbidity and the need of hospital admissions for LRTIs.
K E YWORD S
bronchiolitis, bronchitis, hospitalization, pneumonia, wheezing bronchitis
1 | INTRODUCTION
Moderately preterm (MP, born at 32+0 to 33+6 weeks) and late preterm
(LP, born at 34+0 to 36+6 weeks) infants account for over 80% of all
preterm births.1 These infants have an increased risk of early-childhood
as well as later respiratory morbidity, such as asthma.2,3 Lower
respiratory tract infections (LRTIs) are the leading cause of hospitaliza-
tion in preschool children.4 Many previous studies have focused on the
Abbreviations: AGA, appropriate for gestational age; CI, confidence interval; GA, gestational age; HDR, hospital discharge register; HR, hazard ratio; ICD, International Classification of
Diseases; IQR, interquartile range; LGA, large for gestational age; LP, late preterm; LRTI, lower respiratory tract infection; MBR, medical birth register; MP, moderately preterm; OR, odds
ratio; RSV, respiratory syncytial virus; SD, standard deviation; SGA, small for gestational age; T, term; VP, very preterm.
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respiratory health outcome of children born very preterm (VP), that is,
before 32 weeks of gestational age (GA). Less data is available on LRTI
hospitalizations among MP and LP children. Findings from recent
population-based cohort studies5–7 and also from those focusing onMP
and LP children8,9 have shown an increasing risk of hospital admission
for respiratory infectionswith decreasingGA. It has alsobeen suggested
that not only prematurity but also some perinatal factors such as mode
ofdeliveryorbeingbornsmall forgestational age (SGA)may increase the
risk of infections in early childhood.10,11
We have previously analyzed data on all 1 018 256 infants born in
Finland in 1991-2008, using national registers.12,13 According to our
results, hospitalization for asthma was more common in MP and LP
groups than among term controls, but less common than in the VP
group.12 On the other hand, hospitalization for atopic dermatitis was
more common among term controls than in theMPor LP groups.12 The
aims of the present study were to evaluate whether or not moderately
and late preterm birth increases the risk of hospital admissions for LRTI
in the same population and to assess the role of perinatal and neonatal
risk factors of LRTI hospitalization up to the age of 7 years.
2 | MATERIALS AND METHODS
The national register-based study population was acquired from the
Finnish Medical Birth Register (MBR), which collects information on
maternal health and interventions during pregnancy and delivery, and
on infant health and medical procedures undergone during the first
week of life. The data were linked to data from the Cause of Death
Register and the Register of CongenitalMalformations. Data collection
has been described in more detail in our previous publications.12,13
Altogether, 1 039 263 infantswere born alive in Finland between 1991
and 2008. Infants who died before 1 year of age (n = 2 659, 0.25%), or
who had at least one major congenital anomaly (n = 13 007, 1.25%), or
with missing data on GA (n = 5520, 0.5%) were excluded. The
remaining cohort of 1 018 256 infants (98.0% of all) was analyzed in
four GA-based groups: VP (<32+0 weeks, n = 6 329, 0.6%), MP (32+0 to
33+6 weeks, n = 6 796, 0.7%), LP, (34+0 to 36+6 weeks, n = 39 928,
3.9%) and term (≥37 weeks, n = 965 203, 94.8%).
Perinatal and neonatal data were obtained from the MBR. The GA
data were based on early-pregnancy ultrasonography, which was
performed nationally during the study period. A correction to GA was
made if the ultrasonographic estimation showed a discrepancy of more
than 5-7 days compared with GA based on the last menstrual period.
Morbidity data were collected from the Hospital Discharge Register
(HDR). This data includes admission and discharge dates, diagnoses and
procedures regarding all specialized outpatient healthcare in all public
hospitals (since 1998) and inpatient visits to all hospitals in Finland.
Infants were followed up to 7 years of age or to the end of 2009.
With regard to outcome measures, the study subjects were
considered to have had LRTI if the following diagnoses had been
recorded in theHDR by the end of 2009 (International Classification of
Diseases 9th Revision ICD-9 in 1991-1995 and 10th Revision ICD-10
in 1996-2008): acute bronchiolitis/bronchitis (all ICD-9 codes 466 and
ICD-10 codes J20-J21) and pneumonia (all ICD-9 codes 480-486 and
ICD-10 codes J12-18). All dates of hospital admissions and discharges
with these as the main or secondary diagnoses were collected.
Diagnoses were also collected separately for three age categories: 0-
11, 12-35, and 36-84 months. The ICD-10 diagnoses between
years 1996 and 2008 were also collected separately as respiratory
syncytial virus (RSV) pneumonia (J12.1), other viral pneumonia (J12),
bacterial pneumonia (J13-18), RSV bronchiolitis (J21.0), and viral or
bacterial wheezing bronchitis (J21.9). All data linkageswere carried out
by using a unique anonymized identification code.
2.1 | Definitions
The parameter bronchiolitis/bronchitis used in the present study
covered all hospital admissions due to acute bronchiolitis and
bronchitis, including wheezing bronchitis, a diagnosis commonly
used in the Nordic countries.14 We collected the diagnoses directly
from the register, using both primary and secondary diagnoses. The
definitions presented below did not directly influence the case
definition and selection.
According to the Finnish Current Care Guidelines (www.
kaypahoito.fi), bronchiolitis is defined as the first virus-induced
wheezing episode in infants under the age of 12 months.15 Acute
childhood bronchitis is defined as an acute cough associated with viral
respiratory infections lasting less than threeweeks.15 The ICD-10 code
for acute wheezing bronchitis was available in 1996-2008. In Finland,
wheezing (obstructive) bronchitis is defined as any wheezing in
children aged 12-36 months during an acute respiratory viral infection
or repeated wheezing in children aged 6-12 months.15,16 The
definition of pneumonia includes viral or bacterial infection of the
pulmonary alveoli or interstitial tissue and can be diagnosed by chest
radiography and on the basis of clinical findings, such as the presence
of fever and acute respiratory symptoms.15,17,18
2.2 | Ethics
The regional Ethics Committee approved the study. The National
Institute for Health and Welfare and Statistics Finland gave their
permission to use sensitive health data for research.
2.3 | Statistical analysis
The background parameters of the study population and differences
between the GA groups were analyzed by using Pearson's chi-square
test (categorical variables) and continuous variables were analyzed by
using One-way Anova or Welch test or Kruskal-Wallis test
(Tables 1–3). Non-normal distributions were first normalized by
base e-logarithm (Table 2). Only variables that have been reliably
recorded with good validity and very low amount of missing or false
data in the registers were analyzed.19
To take into account for the number of deliveries per one mother,
risk factors for hospital visits due to bronchiolitis/bronchitis and
pneumonia were sought by Generalized Linear Mixed Model with an
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lmer function (Table 4). All explanatory variables were modeled as a
fixed variable and the number of deliveries per mother were added as
random effect. Results were presented as odds ratios (OR) with 95%
confidence intervals (CI). Values of p less than 0.001 (two-tailed) were
considered statistically significant. The independent maternal and
delivery-related factors (age, smoking, first delivery, number of
fetuses, level of hospital, mode of delivery) and newborn-related
factors (sex, gestational weight, admission to a neonatal unit,
ventilator, and antibiotic therapy) with good validity in the registers
were included in the mixed models.
The Generalized Linear Mixed Model analyses were performed
with the Statistical Package R version 3.3.0 package lme4 (www.r-
TABLE 1 Characteristics of infants and their mothers
Very preterm <32wk
(n = 6329)
Moderately preterm 32+0-33+6
wk (n = 6796)
Late preterm 34+0-36+6 wk
(n = 39 928)
Term ≥37wk
(n = 965 203)
Mother
Age, Mean (SD) 30.2 (5.8) 29.8 (5.7) 29.7 (5.5) 29.2 (5.3)
Smoking, n (%) 1187 (18.8) 1184 (17.4) 6602 (16.5) 144 094 (14.9)
First delivery, n (%) 3314 (52.4) 3792 (55.8) 20 040 (50.2) 392 574 (40.7)
Previous deliveries,
Md (IQR)
0 (0-1) 0 (0-1) 0 (0-1) 1 (0-2)
Number of fetuses at birth, n (%)
1 4517 (71.4) 4591 (67.6) 31 062 (77.8) 948 695 (98.3)
2 1614 (25.5) 1954 (28.8) 8548 (21.4) 16 489 (1.7)
≥3 198 (3.1) 251 (3.7) 318 (0.8) 19 (<0.1)
Place of birth, n (%)
University hospital
(level III)
4943 (78.1) 3993 (58.8) 17 154 (43.0) 299 470 (31.0)
Central hospital (level
II)
1340 (21.2) 2726 (40.1) 17 551 (44.0) 444 952 (46.1)
Othera 41 (0.6) 77 (1.1) 5220 (13.1) 220 654 (22.9)
Mode of delivery, n (%)
Vaginal 2524 (39.9) 3211 (47.2) 26 685 (66.8) 820 942 (85.1)
Cesarean section 3793 (59.9) 3582 (52.7) 13 210 (33.1) 143 491 (14.9)
Newborn
Boys, n (%) 3428 (54.2) 3728 (54.9) 21 658 (54.2) 490 211 (50.8)
Birth weight, g, Md
(IQR)
1290 (1000-1570) 1970 (1730-2200) 2670 (2360-2985) 3590 (3276-3910)
Gestational age, n (%)
SGA 1019 (16.1) 883 (13.0) 3245 (8.1) 16 662 (1.7)
AGA 4972 (78.6) 5637 (82.9) 34 681 (86.9) 919 970 (95.3)
LGA 284 (4.5) 276 (4.1) 2002 (5.0) 28 571 (3.0)
Apgar 1min, Md (IQR) 7 (5-8) 8 (7-9) 9 (8-9) 9 (9-9)
Apgar 1min 0-3, n (%) 1001 (15.8) 325 (4.8) 890 (2.2) 7491 (0.8)
Resuscitation at birth, n
(%)
1901 (30.1) 625 (9.2) 795 (2.0) 3074 (0.3)
Admission to neonatal
unit, n (%)
5692 (89.9) 5972 (87.9) 19 155 (48.0) 58 365 (6.0)
Ventilator therapy, n (%) 3656 (57.8) 1413 (20.8) 1667 (4.2) 2793 (0.3)
Phototherapy, n (%) 4202 (66.4) 3821 (56.2) 14 153 (35.4) 36 671 (3.8)
Antibiotic therapy, n (%) 4505 (71.2) 2958 (43.5) 5038 (12.6) 23 849 (2.5)
Years 1991-2008 (N = 1 018 256; infants who died under 1 year of age and infants with major congenital malformations excluded). Statistical differences
were tested by Pearson chi-square test or by One-way Anova or by Kruskall-Wallis test. All P values between GA groups were P < 0.001.
AGA, appropriate for gestational age; IQR, interquartile range; LGA, large for gestational age;Md,median; SD, standarddeviation; SGA, small for gestational age.
aRegional hospital, private hospital, health center, home birth.
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projcet.org) and the remaining analyses by using IBM SPSS Statistics
version 23.0 software (IBM SPSS, Chicago, IL).
3 | RESULTS
Background characteristics of the infants and their mothers are
presented in Table 1. Overall, 60 588 (6.0%) children followed for up
to 7 years of age had experienced hospital admission for bronchiolitis/
bronchitis, and 25 575 (2.5%) for pneumonia. In all, 4738 (7.8%)
bronchiolitis/bronchitis admissions and 1639 (6.4%) pneumonia admis-
sionsoccurredamongMPandLPchildren.Hospital admissions forLRTIs
weremore common in theMPandLPgroups than in theTgroupbut less
frequent than in the VP group (Table 2). The data showed a decreasing
trend with GA in the incidence of hospital admissions for LRTI (Table 2,
Figure 1). The majority of all admissions because of LRTIs took place
before the age of 36months. The figureswere 93.0% (VP group), 93.3%
(MP group), 91.6% (LP group), and 89.0% (T group) for bronchiolitis/
bronchitis admissions, and 69.8% (VP group), 70.7% (MP group), 66.1%
(LPgroup), and65.7% (Tgroup) for pneumonia admissions. The lengthof
hospital staydue tobronchiolitis/bronchitiswas longer in theMPandLP
groups than in the T group (Table 2). The distribution of LRTI diagnoses
with viral or bacterial etiology between years 1996-2008 (N = 709 534)
is presented in Table 3. The frequency of both viral and bacterial LRTI
seemed to decrease by increasing gestational age.
In the risk factor analyses, maternal smoking, being first-born,
cesarean section, male sex, being born SGA, admission to neonatal
unit, ventilator therapy, and neonatal antibiotic therapy were
associated with an increased risk of hospital admissions for
bronchiolitis/bronchitis (Table 4). The OR for hospital admission due
to bronchiolitis/bronchitis (compared to the term controls) was 3.33
(95%CI 3.09-3.59) in the VP group, 1.89 (95%CI 1.75-2.03) in the MP
group and 1.51 (95%CI 1.45-1.56) in the LP group. The risk factor
analysis regarding hospital admissions for pneumonia showed weaker
associations with perinatal and neonatal factors. Maternal smoking,
cesarean section, male sex, admission to a neonatal unit and ventilator
therapywere associatedwith pneumonia. Correspondingly, theOR for
hospital admission for pneumonia (compared with the term controls)
was 2.59 (95%CI 2.32-2.89) in the VP group, 1.49 (95%CI 1.32-1.67) in
the MP group, and 1.25 (95%CI 1.18-1.33) in the LP group. Lower
maternal age and birth in a level-II hospital seemed to decrease the risk
of hospital admission for LRTI.
4 | DISCUSSION
ModeratelypretermandLPchildrenweremoreoftenadmitted tohospital
for LRTIs than termcontrols, but less often thanVP children, up to the age
of seven.We detected associations betweenGA and LRTI hospitalization
both in incidences and adjusted ORs. The perinatal and neonatal risk
factors regarding hospital admissions for LRTIs included maternal
smoking, cesarean section, male sex, admission to a neonatal unit and
ventilator therapy. In addition, being first-born, being born SGA and
neonatal antibiotic therapywere associatedwith bronchiolitis/bronchitis.
Strengths of this study include the large amount of population-
based register data with national coverage, and the substantial number
TABLE 2 Hospital admissions for lower respiratory tract infections up to the age of 7 years among very preterm, moderately preterm, late
preterm and term 1 year survivors
Very preterm <32wk
(n–= 6329)
Moderately preterm 32+0-
33+6wk (n = 6796)
Late preterm 34+0-
36+6wk (n = 39 928)
Term ≥37wk
(n = 965 203)
Acute bronchiolitis/bronchitis
(466, J20-J21), n (%)
1542 (24.4) 942 (13.9) 3796 (9.5) 54 308 (5.6)
Age at diagnosis
0-11 months, n (%) 920 (59.7) 600 (63.7) 2,184 (57.5) 27,787 (51.2)
12-35 months, n (%) 513 (33.3) 279 (29.6) 1,295 (34.1) 20,589 (37.9)
36-84 months, n (%) 109 (7.1) 63 (6.7) 317 (8.4) 5,932 (10.9)
Number of visits, Md (IQR) 2 (1-3) 2 (1-3) 2 (1-3) 2 (1-2)
Days in hospital, Md (IQR) 6 (3-14) 6 (3-11) 5 (2-10) 4 (2-7)
Pneumonia (480-486, J12-18),
n (%)
560 (8.8) 307 (4.5) 1332 (3.3) 23 376 (2.4)
Age at diagnosis
0-11 months, n (%) 121 (21.6) 67 (21.8) 225 (16.9) 3,562 (15.2)
12-35 months, n (%) 270 (48.2) 150 (48.9) 656 (49.2) 11,799 (50.5)
36-84 months, n (%) 169 (30.2) 90 (29.3) 451 (33.9) 8,015 (34.3)
Number of visits, Md (IQR) 1 (1-2) 1 (1-2) 1 (1-2) 1 (1-2)
Days in hospital, Md (IQR) 5 (3-10) 4 (1-6) 4 (2-7) 4 (2-5)
Years 1991-2008 (n = 1 018 256). Differences between GA groups were assessed by using Pearson's chi-square test or by Welch test. All P values were
P < 0.001. Non-normal distributions were first normalized by base e-logarithm.
IQR, interquartile range; Md, median.
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of infants. The reliability of the Finnish MBR and HDR has been
demonstrated in previous studies.20,21 In Finland there are only public
children's hospitals, and therefore all hospital admissions for LRTIs we
consider to have been derived reliably from the registers. The available
data allowed adjustments with multiple maternal-, delivery-, and
newborn- related background factors.
The weaknesses of our study, as in all register-based studies and
analyses of routinely collected data, include the fact that recording
practices may vary between regions and time periods. Undoubtedly,
the definitions also varied during the 18 years of follow-up.
Misclassification in the coding of diagnoses in regard to hospital
admissions and discharges is possible. Because of our study design, the
children born after 2002 had a follow-up period shorter than 7 years.
However, approximately 90% of bronchiolitis/bronchitis and 65% of
pneumonia admissions occurred before the age of 3 years and most
infants were followed up for longer than that. Data on general-practice
visits could not be obtained in this study. Owing to the lack of data on
parental asthma and duration of breastfeeding, we could not adjust for
these confounding factors. Reliable data on socioeconomic status
were also missing, since it is difficult to determine such status among
young women of childbearing age. We did, however, have information
on maternal smoking, which strongly correlates with socioeconomic
status in Finland.22
The clinical pictures of LRTIs such as bronchiolitis, wheezing
bronchitis and pneumonia may overlap. Therefore, it is challenging to
differentiate between diagnoses of wheezing bronchitis and bronchi-
olitis, especially in children less than 3 years of age. In previous studies
these have often been analyzed together.14,16 In our study, 6% of all
children were hospitalized because of bronchiolitis/bronchitis by 7
years of age; about half of them by 12 months of age. This is in
accordance with previous literature, where 2-3% of all children were
hospitalized because of bronchiolitis during their 1st year of life.10 In
another population-based birth cohort studied in England, it was
estimated that 21% of hospitalized infants had experienced more than
one admission because of bronchiolitis during the 1st year of life.23 The
true incidence of pneumonia could not be analyzed here due to the lack
of data on cases of pneumonia diagnosed and treated in general
practice. The annual incidence of pneumonia in children of less than 5
years of age has been reported to range from 0.2-0.33% to 3.5-4% and
approximately half of the children with pneumonia at this age group
are treated in hospital.17 This is in accordance with our hospital
admission rates due to pneumonia.
Our results on the association between MP and LP birth and an
increased incidence of hospital admissions for LRTIs are in line with
previous findings.5–9 A Canadian retrospective health record linkage
studyofa totalof35 733 infants including2,051LP (33-36weeks) births
revealed increased risk of acute bronchiolitis/bronchitis (OR 1.64, 95%
CI 1.13-2.39) and pneumonia (OR 1.17, 95%CI 1.05-1.30) in the first
3 years of life in LP infants compared with term infants.24 In a recent
Spanish prospective observational study including 2468 hospital
admissions for respiratory conditions,MP children (32-36weeks) under
the age of 14 years needed more medical support and more frequent
intensive care, and wheezy MP children needed longer hospital stays
than full-term children.25 Additionally, in our study, MP and LP children
had longer hospital stays due to bronchiolitis/bronchitis than term
children. Previous studiesonbronchiolitis due toRSV infectiondistinctly
show an increased risk of hospital admission in MP and LP versus term
children.26,27 In our register study we were not able to obtain data on
bronchiolitis confirmed by positive RSV test, but the distribution of the
ICD 10 diagnoses supports the previous findings.
Susceptibility to LRTIs during early infancy in children born MP
and LP might be a consequence of incomplete transfer of maternal
antibodies as a result of premature birth and an immature neonatal
immune system. Final maturation of the immune system occurs during
the first six months of life.28 Premature birth also interrupts lung
development, since alveoli are not completely mature until 36 weeks
of GA.2 This causes inadequate maintenance of functional residual
capacity, decreased compliance, and smaller airway diameters
compared to term infants. Together with an infection early in the
course of immune maturation causing a greater inflammatory
response, these features make MP and LP infants susceptible to
more severe symptoms of LRTIs.2,3
TABLE 3 Lower respiratory tract infection diagnoses according to viral or bacterial etiology up to the age of 7 years among very preterm,
moderately preterm, late preterm and term 1 year survivors between years 1996 and 2008 (N = 709 534)
n%
Very preterm <32
wk (n = 4549)
Moderately preterm 32+0-
33+6 wk (n = 4859)
Late preterm 34+0-36+6
wk (n = 28 151)
Term ≥37 wk
(n = 671 975)
Total
(n = 709 534)
RSV pneumonia (J12.1) 13 (0.3) 3 (0.1) 21 (0.1) 250 (0.04) 287 (0.04)
Other viral pneumonia
(J12)
37 (0.8) 18 (0.4) 77 (0.3) 874 (0.1) 1006 (0.1)
Bacterial pneumonia
(J13-18)
441 (9.7) 257 (5.3) 1104 (3.9) 20 140 (3.0) 21 942 (3.1)
RSV bronchiolitis (J21.0) 378 (8.3) 230 (4.7) 850 (3.0) 10 353 (1.5) 11 811 (1.7)
Viral or bacterial wheezing
bronchitis (J21.9)
712 (15.7) 454 (9.3) 1822 (6.5) 25 579 (3.8) 28 567 (4.0)
Differences between GA groups were assessed by using Pearson's chi-square test. All P values were P < 0.001.
RSV, respiratory syncytial virus.
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TABLE 4 Risk factor analysis for hospital admissions for bronchiolitis/ bronchitis (n = 60 588) and pneumonia (n = 25 575) by the age of 7 years in
1991-2008 (N = 1 018 256)
Bronchiolitis/bronchitis (n = 60 588) Pneumonia (n = 25 575)
n OR (95%CI) OR (95%CI)
Gestational age
Term ≥37wk 965 203 1.00 1.00
Very preterm <32 wk 6329 3.33 (3.09-3.59) 2.59 (2.32–2.89)
Moderately preterm 32+0-33+6 wk 6796 1.89 (1.75–2.03) 1.49 (1.32–1.67)
Late preterm 34+0-36+6 wk 39 928 1.51 (1.45–1.56) 1.25 (1.18–1.33)
Mothers’ age 1 018 256 0.98 (0.98–0.98) 0.99 (0.99–1.00)
Smoking
No 841 835 1.00 1.00
Yes 153 067 1.47 (1.44–1.50) 1.10 (1.07–1.14)
First delivery
No 598 536 1.00 1.00
Yes 419 720 1.74 (1.14–1.21) 0.96 (0.92-1.00)
Number of fetuses
1 988 965 1.00 1.00
2 28 605 0.91 (0.87-0.95) 0.92 (0.85–0.98)
3-4 786 0.76 (0.62–0.92) 0.72 (0.57–0.91)
Birth hospital
University (level III) 325 560 1.00 1.00
Central (level II) 466 569 0.95 (0.94–0.97) 0.94 (0.91–0.96)
Othera 225 992 0.88 (0.86–0.90) 0.97 (0.94–1.01)
Mode of delivery
Vaginal 853 362 1.00 1.00
Cesarean section 164 076 1.15 (1.13–1.18) 1.08 (1.04–1.12)
Sex
Boy 519 025 1.61 (1.58–1.64) 1.13 (1.10-1.16)
Girl 499 231 1.00 1.00
Gestational weight
AGA 965 260 1.00 1.00
SGA 21 809 1.09 (1.03-1.15) 1.08 (1.00-1.17)
LGA 31 133 0.99 (0.94-1.04) 0.96 (0.90-1.03)
Admission to neonatal unit
No 929 068 1.00 1.00
Yes 89 184 1.24 (1.20-1.29) 1.21 (1.15-1.27)
Ventilator therapy
No 1 008 727 1.00 1.00
Yes 9529 1.27 (1.18-1.36) 1.32 (1.19-1.46)
Antibiotic therapy
No 981 906 1.00 1.00
Yes 36 350 1.15 (1.09-1.20) 1.04 (0.97-1.12)
Multivariable Generalized LinearMixedModelswere used,with results given as the odds ratios (OR) and 95%confidence intervals (CI). Statistically significant
results (P < 0.001) are bolded. Categories with missing values are not shown.
AGA, appropriate for gestational age; LGA, large for gestational age; SGA, small for gestational age.
aRegional hospital, private hospital, health center, home birth.
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Supporting previous work,8,10,29,30 we found an association
between maternal smoking during pregnancy and bronchiolitis/
bronchitis and pneumonia of the offspring. Data on daily maternal
smoking during pregnancy are relatively well covered in the Finnish
MBR.22 We could not establish postnatal exposure to smoking, which
is a known risk factor of wheezing in early childhood29 and LRTIs in
pre-school children.30 Avoidance of smoking during and after
pregnancy is one means to improve the respiratory health of children.
In our study, birth by cesarean section was associated with
increased risk of hospital admission because of bronchiolitis/bronchitis
and pneumonia. This is in line with the results of a recent Danish
national register-based cohort study showing that children delivered
by elective cesarean section had an increased risk of LRTIs.11
Differences in early microbial exposure related to the mode of delivery
might be of importance in immunomodulation. In an elective cesarean
section, the membranes are usually intact, which is in contrast to the
situation in acute cesarean section or vaginal delivery.11,31 Following
strict indications for delivery via cesarean section might have a
beneficial influence on the long-term respiratory outcome of neonates.
Male sex appeared to increase the risk of hospital admission for
both bronchiolitis/bronchitis and pneumonia. Our results are consis-
tent with those of previous studies showing associations between
male sex and increased risk of childhood wheezing8,32 and RSV
hospitalization33 and pneumonia.4
In line with the previous results SGA children seemed to carry a
greater risk of bronchiolitis/bronchitis.6,7,10,34 Past epidemiological
studies have reported the link between low birth weight and childhood
wheezing disorders, although some results have been inconsistent.34
Admission to a neonatal unit also seemed to be associated with
increased risk of LRTIs. These infants are usually those suffering from
early neonatal respiratory morbidity or infection.
In our study, ventilator therapy during the neonatal period
predicted LRTIs. Very preterm children need ventilator support after
birth more often and have long-term respiratory problems such as
bronchopulmonary dysplasia, which is a known risk factor of
bronchiolitis and recurrent wheezing in early childhood.35 Avoiding
ventilator treatment and using less invasive respiratory management
practices, thus minimising ventilator induced lung injury, might also
improve the long-term respiratory outcome formoremature neonates.
Our finding that antibiotic therapy during the first week of life
predicted the risk of hospital admission for bronchiolitis/bronchitis is in
line with the results of the Swedish birth-cohort study, in which the
treatment with broad-spectrum antibiotics during the 1st week of life
increased the risk of recurrent wheezing at preschool age.36 However,
the association between wheezing and early antibiotic treatment is
controversial.37 The first weeks of life probably represent the most
important timewindow for changes in the intestinal microbiota caused
by antibiotics.31 Perinatal infection itself may also modify immune
programming.31 Cautious use of antibiotics during the neonatal period
is recommended.
Interestingly, in our study, first-born children had an increased risk
of bronchiolitis/bronchitis. This may be partially explained by the
previous finding that first-born children at birth have reduced anti-
inflammatory profile in T-cells and possibly the enhanced risk of
developing later immune-related diseases.38 Being first-born has
elsewhere been found to be protective as regards childhood
wheezing.39 Twins seemed to have a decreased risk of bronchiolitis/
bronchitis. Supporting this finding, the protective effect of twin birth
against RSV hospitalization in preterm children has been described.33
Previous results suggest that the presence of older siblings and day-
care attendance increase the risk of RSV infection hospitalization33
and transient wheezing in early childhood.8,32
Lower maternal age and birth in a level-II hospital seemed to
decrease the risk of hospital admission for LRTI. This might be related
to a previous finding on the association with higher maternal age and
neonatal risks40 and the fact that deliveries associated with higher risk
are treated in level-II hospitals.
5 | CONCLUSIONS
Children born MP and LP appear to be admitted to hospital for LRTIs
more often than term controls but less frequently thanVP children by 7
years of age. Preterm children had longer hospital stays due to
FIGURE 1 Incidences of hospital admissions for lower respiratory tract infections per 1000 births by 7 years of age in relation to
gestational age group at birth; birth years 1991-2008 (N = 1 018 256)
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bronchiolitis/bronchitis. These results suggest that MP or LP births
have a significant impact on the use of health-care services.
Interventions to affect the underlying risk factors such as maternal
smoking, birth by caesarean section, neonatal ventilator therapy and
early antibiotic therapy should be considered.
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Abstract
Objective:Toassess the incidence and risk factors of asthma and atopic dermatitis by
seven years of age after early-term (ET) (37+0-38+6 weeks), full-term (FT) (39+0-40+6
weeks), late-term (LT) (41+0-41+6 weeks), and especially post-term (PT) (≥42 weeks)
birth.
Methods:Altogether, 965 203 infants born between 1991 and 2008 in Finlandwere
investigated in ET, FT, LT, and PT groups. Data on asthmamedication reimbursement
and hospital visits for atopic dermatitis were retrieved from national health
databases.
Results: The frequencies of asthmamedication reimbursement in the ET, FT, LT, and
PT groups were 4.5%, 3.7%, 3.3%, and 3.2%, respectively. Hospital visits due to
atopic dermatitis were most common after PT birth. Compared with FT births, ET
births were associated with an increased risk of asthma (adjusted odds ratio (aOR),
95% confidence interval (CI) 1.20, 1.17-1.23), while LT (aOR, 95%CI 0.91, 0.89-0.93)
births and PT (aOR, 95%CI 0.87, 0.83-0.92) births decreased this risk. PT birth (aOR,
95%CI 1.06, 1.01-1.10) predicted atopic dermatitis. From a population point of view,
the most relevant risk factors for asthma were male sex, ET birth, smoking during
pregnancy and birth by elective cesarean section, and for atopic dermatitis male sex,
first delivery, birth in a level II hospital and birth by cesarean section.
Abbreviations: AGA, appropriate for gestational age; CI, confidence interval; CS, cesarean section; ET, early term; FT, full term; GA, gestational age; HDR, Hospital Discharge Register;
ICD, International Classification of Diseases; LGA, large for gestational age; LT, late term; MBR, Medical Birth Register; OR, odds ratio; PAR, population attributable risk; PROM, premature
rupture of membranes; PT, post term; SD, standard deviation; SGA, small for gestational age.
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Conclusions: Early-term birth was a predictor of asthma, and PT birth was associated
with atopic dermatitis. Counseling against smoking and following strict indications for
planned ET deliveries and cesarean sections may bemeans to reduce the risk of later
asthma.
K E YWORD S
cesarean section, hospital admission, reimbursement, risk factor, tobacco smoke exposure
1 | INTRODUCTION
Children born prematurely appear to carry an increased risk of asthma
and/or asthma-like symptoms in childhood,1–3 whereas their risk of
atopic dermatitis has been found to be decreased3–5 compared with
children born at a later gestational age (GA).
Because of the reported health risks of themother and infant after
elective deliveries prior to 39 weeks of GA, sub-grouping the
traditional “term birth” into early-term (ET, 37+0-38+6 weeks), full-
term (FT, 39+0-40+6 weeks), late-term (LT, 41+0-41+6weeks), and post-
term (PT, ≥42 weeks) birth has been recommended.6 Although milder
and less common than in the most premature groups, the health
problems of ET, LT, and PT infants may result in a substantial burden to
society owing to the high number of infants.7-9
Early-term birth has been associated with an increased risk of
childhood asthma,1,7,8,10 whereas birth at ≥41 weeks’ GA10 and PT
birth11 have been associated with a decreased risk compared with FT
birth. An increased risk of atopic dermatitis by school age has been
suggested in children born PT,4 but further studies on this risk in GA
subgroups are warranted.
In our previous study on 1 018 302 children born in Finland
between 1991 and 2008, the risk of receiving reimbursement for
asthmamedication by seven years of agewas higher inmoderately and
late-preterm children comparedwith term controls, whereas the risk of
hospitalization due to atopic dermatitis increased with GA.3 In the
present study, we evaluated further the incidence and risk factors of
asthma and atopic dermatitis by seven years of age in term subgroups
of the same population, with a special emphasis on PT children.
2 | MATERIALS AND METHODS
The study population was derived from the cohort of all live-births
(N = 1 039 263) in Finland in 1991-2008, described in detail else-
where.3,12 Data on GA were missing in 5520 infants. A subgroup of
infants born at ≥37 weeks of GA (N = 978 224) was chosen, excluding
those with major congenital anomalies (N = 12 123) and those who
died before one year of age (N = 898). Selection was based on data
from the Medical Birth Register (MBR), the Register of Congenital
Malformations and the Cause of Death Register. The final study
population included 965 203 (98.7% of all) infants who were analyzed
in ET (N = 181 667), FT (N = 546 845), LT (N = 189 373), and PT
(N = 47 318) groups. The cases were followed-up to seven years of age
or up to the year 2009.
Perinatal and neonatal data were obtained from the MBR.
Pregnancy- and delivery-related diagnoses of the mothers were
collected from the Hospital Discharge Register (HDR). Details of data
collection have been presented earlier.12 Gestational agewas based on
early pregnancy ultrasonography, and corrected according to men-
strual anamnesis in cases of discrepancy of 5-7 days or more between
evaluations. Cesarean sections (CS) were classified as elective (decided
upon and undertaken before labor) or emergency (undertaken
according to maternal or fetal indications during labor) procedures.
The collected parameters are listed in Table 1.
In Finland, a child with asthma diagnosed according to national
current care guidelines13 is entitled to receive reimbursement
(currently 65%) for asthma medication costs. In small children, the
diagnostic criteria of asthma include three to four episodes of
wheezing bronchitis within one year. Data on asthma medication
reimbursement were retrieved from the Social Insurance Institution
database and data on inpatient (thewhole study period) and outpatient
(since 1998) visits to all public hospitals because of asthma and atopic
dermatitis were gathered from the HDR. The International Classifica-
tion of Disease 9th Revision (ICD-9) was used in 1991-1995 and 10th
Revision (ICD-10) thereafter to detect diagnoses of asthma (J45, J46),
atopic dermatitis (L20.0) and dermatitis due to ingested food (L27.2).
The two latter were combined in analyses of atopic dermatitis. Register
datawere linked bymeans of a unique anonymized identification code.
The regional Ethics Committee approved the study. The register-
ing organizations (the National Institute for Health and Welfare, the
Social Insurance Institution and Statistics Finland) gave permission to
use sensitive health data for research.
2.1 | Statistical methods
Differences betweenGAgroups in categorical variableswere tested by
Pearson's chi-square test or Fisher's exact test and those in continuous
variables by analysis of variance, Mann-Whitney U-test or Kruskal-
Wallis test. To account for the number of deliveries of one mother, risk
factors for asthma medication reimbursement and hospital visits due
to atopic dermatitis were sought by Generalized Linear Mixed Model
with an lmer function. The outcome variables were analyzed as
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dichotomic variables. All explanatory variablesweremodeled as a fixed
variable and the number of deliveries permother was added as random
effect. Results were presented as odds ratios (OR) with 95%
confidence intervals (CI). Values of P less than 0.05 (two-tailed)
were considered statistically significant. Variables with good validity in
the registers were selected as independent variables, including
maternal (age, smoking during pregnancy, primiparity, place of birth,
and mode of delivery) and newborn (sex, gestational weight, ventilator
or antibiotic therapy) characteristics. Categorization of variables is
presented in Table 1. As a surrogate for severe atopic tendency, need
of hospital visits due to atopic dermatitis by seven years of age was
included in the multivariate model for asthma medication. The
Generalized Linear Mixed Model analyses were performed with the
Statistical Package R version 3.3.0 package lme4 (www.r-projcet.org)
and the remaining analyses by using IBM SPSS Statistics version 23.0
software (IBM SPSS, Chicago, Illinois).
To study the relevance of the risk factors from public health and
clinical point of view, we calculated population attributed risks (PAR,
%) for the variables included in the multivariate models assessing the
risk factors of asthma medication reimbursement and hospital visits
TABLE 1 Perinatal and neonatal characteristics of the mothers and the infants born at ≥37weeks of gestation in 1991-2008 and followed-up to
7 years of age (N = 965 203)
Early-term 37+0-38+6wk
(n = 181 667)
Full-term 39+0-40+6wk
(n = 546 845)
Late-term 41+0-41+6 wk
(n = 189 373)
Post-term ≥42wk
(n = 47 318)
Mother
Age, years, Mean (SD) 29.7 (5.4) 29.2 (5.3) 28.9 (5.2) 28.9 (5.3)
40 years or more, n (%) 6978 (3.8) 15 987 (2.9) 4604 (2.4) 1149 (2.4)
Smoking, n (%) 28 215 (15.5) 79 713 (14.6) 28 414 (15.0) 7752 (16.4)
First delivery, n (%) 71 578 (39.4) 214 262 (39.2) 81 677 (43.1) 25 057 (53.0)
Previous deliveries, Md (IQR) 1 (0-2) 1 (0-2) 1 (0-1) 1 (0-1)
Number of fetuses at birth, n (%)
1 168 239 (92.6) 543 815 (99.4) 189 325 (100) 47 316 (100)
2 or more 13 428 (7.4) 3030 (0.6) 48 (0.0) 2 (0.0)
Birth hospital, n (%)
University (level III) 59 972 (33.0) 167 964 (30.7) 55 942 (29.5) 15 592 (33.0)
Central (level II) 81 413 (44.8) 252 010 (46.1) 89 406 (47.2) 22 123 (46.8)
Othera 40 260 (22.2) 126 798 (23.2) 44 003 (23.2) 9593 (20.3)
Mode of delivery, n (%)
Vaginal 139 104 (76.6) 473 812 (86.6) 169 151 (89.3) 38 875 (82.2)
Elective CS 26 168 (14.4) 39 932 (7.3) 3178 (1.7) 1092 (2.3)
Emergency CS 16, 259 (8.9) 32 642 (6.0) 16 04 (8.9) 7316 (15.5)
Newborn
Boys, n (%) 96 029 (52.9) 275 714 (50,4) 94 257 (49.8) 24 211 (51.2)
Birth weight, g, Md (IQR) 3275 (2970-3590) 3600 (3310-3900) 3775 (3490-4080) 3850 (3560-4150)
Gestational weight, n (%)
SGA 6346 (3.5) 8056 (1.5) 1958 (1.0) 302 (0.6)
AGA 167 611 (92.3) 523 946 (95.8) 182 891 (96.6) 45 522 (96.2)
LGA 7710 (4.2) 14 843 (2.7) 4524 (2.4) 1494 (3.2)
Apgar 1min, Md (IQR) 9 (9-9) 9 (9-9) 9 (8-9) 9 (8-9)
Less than 4 1573 (0.9) 3609 (0.7) 1691 (0.9) 618 (1.3)
Resuscitation at birth, n (%) 655 (0.4) 1385 (0.3) 716 (0.4) 318 (0.7)
Admission to neonatal unit, n (%) 18 386 (10.1) 26 681 (4.9) 10 067 (5.3) 3231 (6.8)
Ventilator therapy, n (%) 827 (0.5) 1163 (0.2) 575 (0.3) 228 (0.5)
Antibiotic therapy in the first
week of life, n (%)
4810 (2.6) 11 464 (2.1) 5626 (3.0) 1949 (4.1)
Statistical differences were tested by Pearson's chi-square test, Fisher's exact test, or the Kruskal-Wallis test. All P-values were <0.001.
AGA, appropriate for gestational age; CS, cesarean section; ET, early-term; FT, full-term; IQR, interquartile range; LGA, large for gestational age; LT, late-term;
Md, median;
PT, post-term; SD, standard deviation; SGA, small for gestational age.
aRegional hospital, private hospital, health center, and home birth.
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due to atopic dermatitis (yes/no). PAR provides the proportion of
incidence of disease in the population that is due to exposure. This is
the incidence of a disease that would be eliminated in the population if
the exposure were removed. PAR was calculated as (f [OR − 1]) / (1 + f
[OR − 1]), where f is the frequency of the risk factor in the population
and OR is the OR for disease due to that exposure.
3 | RESULTS
Background characteristics are presented in Table 1. Birth by CS,
admission to a neonatal unit and ventilator therapy were most
common in the ET group. The frequency of elective CS was highest in
the ET and lowest in the LT group. Emergency CSwasmost common in
the PT group. Post-term infants were most often first-born and
exposed to maternal smoking during pregnancy and to postnatal
antibiotic therapy.
In mothers aged 40 years or more, smoking during pregnancy was
less common (1894 (10.7%) vs 142 200 (15.0%), P < 0.001) and CS
more common (4328 (24.5%) vs 139 163 (14.7%), P < 0.001) than in
younger mothers.
In all, 36 210 (3.8%) children received asthma medication
reimbursement. Hospital visits by seven years of age were reported
in 46 636 (4.8%) children as a result of asthma and in 49 795 (5.2%)
children as a result of atopic dermatitis. The frequencies of asthma
medication reimbursement and hospital visits due to asthma were
highest in the ET group, and hospital visits due to atopic dermatitis
were most common in the PT group (Table 2).
The results of risk factor analyses regarding asthma medication
reimbursement in thewhole study population are presented in Table 3.
Both in the uni- and multivariate analysis, ET birth was associated with
an increased risk, and LT and PT births with decreased risks of asthma
medication reimbursement, compared with FT birth. In the latter, the
OR (95%) CI was 1.20 (1.17-1.23) in the ET group, 0.91 (0.89-0.93) in
the LT group and 0.87 (0.83-0.92) in the PT group. According to PAR
analyses, the most relevant risk factors of asthma from a population
point of view were male sex, hospital visits due to atopic dermatitis (as
a surrogate for atopic tendency), tobacco smoke exposure during
pregnancy, ET birth, and birth by elective CS (Table 3). Maternal age of
40 years or more, being first-born or born in a level-II hospital were
associated with a decreased risk of asthma.
The results of risk factor analyses regarding hospital visits due to
atopic dermatitis in the whole study population are presented in
Table 3. PT birth was associated with an increased risk (OR 1.10 (1.06-
1.15) for hospital visits due to atopic dermatitis. According to PAR
analyses, male sex, first delivery, birth in a level II hospital and birth by
emergencyCSwere themost relevant risk factors for atopic dermatitis,
whereas smoking during pregnancy and place of birth other than a
level-III or level-II hospital seemed to decrease this risk (Table 3).
In the subgroup analysis among PT children (Table 4), no
association was found between birth by CS and asthma medication
reimbursement. Ventilator therapy seemed to increase the risk of
asthmamedication reimbursement. Birth by emergencyCS emerged as
a risk factor for hospital visits due to atopic dermatitis, whereas birth
by elective CS did not (Table 4). Otherwise the results of the risk factor
analyses in the PT group resembled those performed in the whole
study population.
4 | DISCUSSION
In this large national register study on children born at ≥37 weeks of
GA, we found a decreasing trend with GA in the frequency of asthma
medication reimbursement and need of hospital visits due to asthma
by seven years of age. Even after controling for several confounding
factors, ET birth was associated with an increased risk of asthma,
TABLE 2 Reimbursement for asthmamedication and hospital visits due to asthma and atopic dermatitis in infants born at ≥37weeks of gestation
in 1991-2008 and followed-up to 7 years of age (N = 965 203)
Early-term 37+0-38+6wk
(n = 181 667)
Full-term 39+0-40+6wk
(n = 546 845)
Late-term 41+0-41+6wk
(n = 189 373)
Post-term ≥42wk
(n = 47 318) P
Reimbursement for asthma
medication, n (%)
8166 (4.5) 20,180 (3.7) 6330 (3.3) 1534 (3.2) <0.001
Age at 1st reimbursement,
Md (IQR) in years
2.7 (1.6-4.3) 2.9 (1.8-4.5) 3.0 (1.8-4.6) 3.0 (1.8-4.5) <0.001
Hospital visits due to asthma,
n (%)
10 351 (5.7) 25 937 (4.7) 8372 (4.4) 1976 (4.2) <0.001
Number of visits, Md (IQR) 4 (2-7) 3 (2-7) 3 (2-6) 3 (1-6) 0.001
Hospital visits due to atopic
dermatitis, n (%)
9359 (5.2) 28 032 (5.1) 9836 (5.2) 2568 (5.4) 0.034
Number of visits, Md (IQR) 2 (1-5) 2 (1-5) 2 (1-5) 2 (1-5) 0.030
Age at 1st visit, Md (IQR) in
years
1.1 (0.6-2.4) 1.1 (0.6-2.4) 1.1 (0.6-2.4) 1.0 (0.6-2.3) <0.001
Statistical differences were tested by Pearson's chi-square test, Fisheŕs exact test, or the Kruskall-Wallis test.
IQR, interquartile range; ET, early-term; FT, full-term; LT, late-term; Md, median; PT, post-term.
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TABLE 3 Risk factor analysis regarding asthmamedication reimbursement (n = 36 210) and hospital visits due to atopic dermatitis (n = 49 795) by
the age of 7 years in the whole study population in 1991-2008 (N = 965 203)
Dependent variables
Asthma medication reimbursement
n = 36 210/N = 965 203
Hospital visits due to atopic dermatitis
n = 49 795/N = 965 203
Independent variables n OR 95%CI PAR (%)a n OR 95%CI PAR (%)
Univariate analysis
Gestational age group
Early-term 8166 1.23 1.20-1.26 9359 1.06 0.98-1.03
Full- term 20 180 1.00 28 032 1.00
Late-term 6330 0.91 0.88-0.93 9836 1.02 1.00-1.05
Post-term 1534 0.89 0.85-0.93 2568 1.10 1.06-1.15
Multivariate analysisb
Gestational age group
Early-term 8166 1.20 1.17-1.23 3.63 9359 0.99 0.96-1.01 −0.19
Full-term 20 180 1.00 28 032 1.00
Late-term 6330 0.91 0.89-0.93 −1.80 9836 1.02 0.99-1.04 0.39
Post-term 1534 0.87 0.83-0.92 −0.64 2568 1.06 1.01-1.10 0.29
Mother's age
Less than 40 years 35 374 1.00 48 319 1.00
40 years or more 836 0.69 0.63-0.76 −0.93 1476 1.02 0.95-1.09 0.06
Smoking
No 29 229 1.00 42 297 1.00
Yes 6193 1.23 1.20-1.27 3.32 6363 0.85 0.82-0.87 −2.29
First delivery
No 22 283 1.00 29 841 1.00
Yes 13 927 0.95 0.92-0.98 −2.08 19 954 1.61 1.56-1.66 19.9
Birth hospital
University (level III) 11 904 1.00 15 384 1.00
Central (level II) 15 512 0.86 0.84-0.88 −6.90 24 257 1.08 1.06-1.10 3.56
Otherc 8792 1.02 0.99-1.05 0.46 10 146 0.90 0.88-0.93 −2.34
Mode of delivery
Vaginal 30 184 1.00 41 700 1.00
Elective CS 3106 1.14 1.10-1.18 1.01 3835 1.08 1.05-1.12 0.51
Emergency CS 2892 1.06 1.01-1.10 0.45 4225 1.14 1.10-1.18 1.05
Sex
Girl 13 057 1.00 21 760 1.00
Boy 23 153 1.71 1.67-1.74 26.5 28 035 1.26 1.24-1.28 11.7
Gestational weight
SGA 683 1.04 0.97-1.12 0.07 796 0.91 0.85-0.98 −0.16
AGA 34 382 1.00 47 437 1.00
LGA 1145 1.03 0.97-1.09 0.09 1562 1.04 0.99-1.09 0.12
Ventilator therapy
No 36 067 1.00 49 631 1.00
Yes 143 1.24 1.07-1.43 0.14 164 0.90 0.79-1.03 −0.03
(Continues)
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whereas LT and PTbirths appeared to decrease this risk. In contrast, PT
birth emerged as a risk factor as regards hospital visits due to atopic
dermatitis. From a population point of view, the most relevant risk
factors of asthma were male sex, atopic tendency, tobacco smoke
exposure during pregnancy, ET birth and elective CS, and those of
atopic dermatitis male sex, first delivery, birth in a level II hospital, and
birth by emergency CS.
Our finding of an increased risk of asthma in ET children is in line
with previous reports.1,7,8,10 In a large Swedish cohort of 1 100 826
children and young people (6-19 years old), ET children had an
increased risk of inhaled corticosteroid use, evaluated by registered
drug retrievals, compared with those born at 39-41 weeks of
gestation.1 Some other investigators have analyzed data based on
parental reports7 or questionnaires.8 A hospital-based Finnish register
study on 44 173 women delivering during a 10-year period revealed a
negative association between asthma medication reimbursement and
GA at birth of the offspring. The burden of asthma in children was
particularly associatedwith deliveries at 37-38weeks of gestation.10 It
may be that both spontaneous and iatrogenic preterm and ET
deliveries have common causes and that there are similar exposures
to postnatal treatments, such as those needed for neonatal respiratory
problems.14 The effect of smaller airway size at birth on the risk of
asthma in preterm and ET infants seems to be less likely, because small-
for-GA birth weight was not a significant predictor in multivariate
analysis in our study.
According to our hypothesis, PT birth was associated with a
decreased risk of childhood asthma, despite the increased frequency of
neonatal respiratory problems defined as need of ventilator therapy in
the PT group. Similar findings among LT10 and PT10,11,15 children have
been reported previously. This seems to represent part of a continuum
found in our previous study, where the risk of asthma decreased with
increasing GA from very preterm birth to term,3 possibly due to
continuous intrauterine maturation of the airways.
In line with previous results,4 post-maturity emerged as a
predictor of atopic dermatitis. However, the PAR of PT birth for
atopic dermatitis was low. The possible roles of maturation of the
mucosal and skin barriers, and immunotolerance, are of interest.4,5
Supportingour findings, exposure tomaternal prenatal smoking has
been reported to increase the risk of wheezing or asthma among
children aged six years or more.16 Exposure to tobacco smoke has an
effect on fetal lung development. It may alter the expression of
susceptibility genesassociatedwith respiratorydiseases, predispose the
mother to preterm delivery,17 and increase the risk of early pulmonary
problemsof the infant. In our study,maternal smokingduringpregnancy
was associated with a decreased risk of atopic dermatitis in offspring.
Tobacco smokeexposureduringpregnancymightprecludesensitization
through an immunosuppressive effect.18 It was not possible to establish
the degree of postnatal exposure to smoking in our population.
A meta-analysis has shown a 20% increase in asthma risk in
childhood after birth via elective and emergency CS.19 In one study,
the risk of later asthma has been increased especially after elective
CS,20 in another after emergency CS.21 Background factors related to
the association between birth by CS and later asthma might be an
increased risk of neonatal respiratory problems and effects on gut
microbiota and the Th1/Th2 balance.21 Lack of microbial exposure
during labor results in delayed and altered colonization of the infant
gut. In deliveries by elective CS, the membranes are usually intact, and
the probability of colonization with vaginal bacteria is even smaller
than in emergency CS. The maternal and fetal conditions leading to
emergencyCSmight partly explain the association betweenCS and the
risk of asthma.21 Different levels of adaptive stress at the time of birth
as well as altered epigenetic regulation might be further mechanisms
connecting CS and development of the immune system.22
The association of the mode of delivery with the risk of atopic
dermatitis is controversial. Some investigators have found no
association,23 whereas others have.24 In our study, emergency CS in
TABLE 3 (Continued)
Dependent variables
Asthma medication reimbursement
n = 36 210/N = 965 203
Hospital visits due to atopic dermatitis
n = 49 795/N = 965 203
Independent variables n OR 95%CI PAR (%)a n OR 95%CI PAR (%)
Antibiotic therapy
No 35 162 1.00 48 182 1.00
Yes 1048 1.09 1.02-1.16 0.47 1613 1.30 1.24-1.37 0.74
Hospital visits due to atopic dermatitis - - -
No 29 892 1.00 - - - -
Yes 6318 4.23 4.11-4.35 14.3 - - - -
Binomial linear mixed models with lmer function were used. The number of deliveries per mother was added as random effect.
CI, confidence interval; CS, cesarean section; AGA, appropriate for gestational age; LGA, large for gestational age; OR, odds ratio; PAR, population attributed
risk; SGA, small for gestational age.
Statistically significant odds ratios and confidence intervals are bolded.
aPAR was calculated as (f [OR − 1]) / (1 + f [OR − 1]), where f is the frequency of the risk factor in the population and OR is the OR for disease due to that
exposure.
bIn multivariate analysis, all variables were entered simultaneously into the model.
cRegional hospital, private hospital, health center, home birth.
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particular emerged as a risk factor of atopic dermatitis in the PT group,
supporting the role of mediators other than the effect on the
microbiota between CS and the occurrence of atopic dermatitis. The
smaller number of infants in the PT group may account for some
differences between this group and others.
Higher maternal age has been associated with compromised
neonatal outcome25,26 and, supporting our results, a higher rate of
CS.26 Interestingly, in our study maternal age of 40 years or more was
associated with a decreased risk of asthma. Smoking during pregnancy
was less common and delivery by CSmore frequent among these older
TABLE 4 Multivariate risk factor analysis regarding asthma medication reimbursement (n = 1534) and hospital visits due to atopic dermatitis
(n = 2568) by the age of 7 years among post-term children in 1991-2008 (N = 47 318)
Dependent variables
Asthma medication reimbursement
n = 1534/N = 47 318
Hospital visits due to atopic dermatitis
n = 2568/N = 47 318
Independent variables n OR 95%CI n OR 95%CI
Mother's age
Less than 40 years 1515 1.00 2511 1.00
40 years or more 19 0.38 0.19-0.73 57 0.92 0.65-1.30
Smoking
No 1207 1.00 2146 1.00
Yes 297 1.29 1.13-1.47 373 0.88 0.78-0.98
First delivery
No 741 1.00 1163 1.00
Yes 793 0.90 0.81-1.01 1405 1.81 1.55-2.11
Birth hospital
University (level III) 538 1.00 844 1.00
Central (level II) 675 0.87 0.77-0.98 1218 1.03 0.94-1.12
Othera 321 0.97 0.84-1.12 506 0.97 0.87-1.09
Mode of delivery
Vaginal 1241 1.00 2046 1.00
Elective CS 36 1.03 0.73-1.45 57 1.02 0.78-1.33
Emergency CS 256 1.06 0.92-1.22 463 1.19 1.07-1.33
Sex
Girl 543 1.00 1099 1.00
Boy 991 1.72 1.55-1.92 1469 1.28 1.18-1.39
Gestational weight
SGA 9 0.87 0.45-1.71 14 0.85 0.50-1.44
AGA 1476 1.00 2488 1.00
LGA 49 1.04 0.77-1.39 66 0.78 0.61-1.01
Ventilator therapy
No 1520 1.00 2556 1.00
Yes 14 1.78 1.00-3.18 12 0.75 0.42-1.34
Antibiotic therapy
No 1454 1.00 2428 1.00
Yes 80 1.12 0.88-1.44 140 1.32 1.10-1.59
Hospital visits due to atopic dermatitis
No 1233 1.00 - - -
Yes 301 4.59 4.02-5.25 - - -
In multivariate analysis, all variables were entered simultaneously into the model. Binomial linear mixed models with lmer function were used. The number of
deliveries per mother was added as random effect.
Statistically significant (P < 0.05) odds ratios and confidence intervals are bolded.
CI, confidence interval; CS, cesarean section; AGA, appropriate for gestational age; LGA, large for gestational age;OR, odds ratio; SGA, small for gestational age.
aRegional hospital, private hospital, health center, and home birth.
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mothers, but the protective effect remained after controlling for these
factors in the analyses. A negative association has been suggested
between the number of siblings and atopic asthma or dermatitis.27 In
our analyses adjusted for atopic tendency, first-born status emerged
protective as regards asthma medication reimbursement. This may be
associated with fewer infection contacts compared with those with
more siblings. Supporting previous results,28 first-born children
presented with a greater risk of atopic dermatitis. A reduced anti-
inflammatory profile in T-cells has been found in first-born children at
birth, possibly contributing to the later development of immune-
mediated diseases by increasing overall immune reactivity.29
In linewith the results of another study,male sex increased the risk
of asthma30 as well as the risk of atopic dermatitis. Children born SGA
seemed to carry less risk of atopic dermatitis. An association between
anthropometric parameters at birth and later atopic tendency has been
suggested, but the findings concerning atopic dermatitis have been
inconsistent.31
In a Finnish register study, very premature infants treated in or
transferred to level-II hospitals from level-III hospitals presentedwith a
similar occurrence of asthma at five years of age.32 We found a
decreased risk of asthma in children born in level-II hospitals. More
risk-associated deliveries are treated in level-III hospitals. The risk of
hospital visits due to atopic dermatitis was higher in infants born in
level-II facilities, but lower in other places of birth comparedwith level-
III hospitals, despite adjustment for several perinatal and neonatal
factors. The reason for this association is not clear.
Antibiotic therapy during pregnancy33 and exposure to broad-
spectrum antibiotics during the first week of life30 have been described
as risk factors of childhood asthma. The comparability of our results
with those reported previously is limited by the fact that we had access
to data on antibiotic treatment during the first week of life but not on
maternal antibiotic therapy or later antibiotic courses given to the
infant. We found an association, between antibiotic therapy and both
asthma medication reimbursement and atopic dermatitis, suggesting
long-lasting effects of neonatal antibiotic exposure. However, this risk
factor was not very relevant from a population point of view, having a
PAR below one per cent. Antibiotics may be more often prescribed to
infants who are admitted to a neonatal ward and to those whose
mothers have signs of other infections. Suggested mechanisms
mediating the effects of antibiotics include changes in the gut
microbiota and alteration of the immunological balance towards the
Th2 model of allergic asthma.34
Differences in recording practices in different hospitals and
regions are a common limitation in register studies. However, the
Finnish health information system is based on national registers of high
quality and with good coverage.35–37 The study population was
substantial. In Finland, asthma diagnoses given by a pediatrician are
required for all children to qualify for medication reimbursement.13
The Social Insurance Institution database is held as a valid source of
prevalence data.38 The overall prevalence of asthma medication
reimbursement and hospital visits due to asthma by seven years of age
in our study cohort corresponds to the expected rate in Finland.13 No
data were obtained on ethnic background, parental asthma or atopy,
indications for CS, psychosocial factors, breastfeeding or environmen-
tal conditions. Reliable data on socioeconomic status were also
missing, since it is difficult to determine such a status for youngwomen
of childbearing age. We had, however, information on maternal
smoking, which strongly correlates with socioeconomic status in
Finland.39 Because of our study design, children born in the latest years
of the study period had shorter follow-up times than those born in
earlier years. The youngest were less than one year of age at the time
of first hospital visit due to asthma. Due to difficulties in ascertaining
the diagnosis of asthma in infants, we decided to use asthma
medication reimbursement, a parameter based on national criteria,
as the main outcome measure in the risk factor analyses. The median
age at first reimbursement for asthma medication was three years or
less in all GA groups. Hospital visits due to atopic dermatitis were used
as a surrogate for severe atopic tendency in the risk-factor analyses for
asthma. Mild atopic dermatitis is usually treated in the primary health
care system. In our study, cases with atopic dermatitis were identified
through hospital visits only, thus representing severe disease.
5 | CONCLUSIONS
Early-term birth was associated with an increased risk of asthma by
seven years of age compared with full-term birth. Late- and post-term
births appeared to be associated with a decreased risk of asthma.
Counseling against smoking during pregnancy and strict indications for
elective CS might be important tools in preventing later asthma in
offspring. Post-term birth and especially emergency CS were
associated with an increased risk of atopic dermatitis, referring to
the importance of optimal timing of delivery after due date.
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